<!DOCTYPE html>
<html class="no-js" lang="en">
<head>
  <meta charset="utf-8" />
  <meta http-equiv="x-ua-compatible" content="ie=edge" />
  <title>
    PharmCAT Report [pharmcat.example2]
  </title>

  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <!-- HTML5 shim and Respond.js for IE8 support of HTML5 elements and media queries -->
  <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
  <!--[if lt IE 9]>
  <script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
  <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
  <![endif]-->
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" />
  <style>
    html {
      font-size: 16px;
      background-color: #666666;
    }
    body {
      font-weight: 300;
      -moz-osx-font-smoothing: grayscale;
      -webkit-font-smoothing: antialiased;
      line-height: 1.5;
      font-size: 1rem;
      font-family: "Museo Sans W01 Rounded",Arial,Helvetica,sans-serif;
      color: rgb(25, 31, 42);
      background-color: #ffffff;
      margin: 0 auto;
      max-width: 70em;
      padding: 0;
    }
    .browserUpgrade {
      background: #ccc;
      color: #000;
      padding: 1em;
    }
    header {
      margin-bottom: 1em;
    }
    main {
      margin: 1em 1em 0 1em;
      padding-bottom: 2em;
    }
    h1, h2, h3, h4 {
      margin-top: 0.5rem;
      margin-bottom: 0.5rem;
    }
    a, h1, h2, h3, h4, h5, h6 {
      color: #3e4c6c;
    }
    h1 {
      font-size: 2em;
      font-weight: 100;
    }
    h2, h3, h4 {
      font-weight: 300;
    }
    h2 {
      font-size: 1.8em;
    }
    h3 {
      font-size: 1.5em;
    }
    h4 {
      font-size: 1.2em;
    }
    p {
      margin-top: 0;
      margin-bottom: 1em;
    }
    section {
      margin-bottom: 2.5rem;
    }
    table, ul {
      margin-bottom: 1.5rem;
    }
    table {
      min-width: 100%;
      border-collapse: collapse;
      border-color: grey;
      font-size: 0.9rem;
    }
    td, th {
      border: 1px solid rgba(62, 76, 108, 0.1);
      max-width: 600px;
      word-wrap: break-word;
      padding: 1em 1.3em;
    }
    td p:last-child {
      margin-bottom: 0;
    }
    th {
      text-align: left;
    }
    tr.top-aligned td,th {
      vertical-align: top;
    }
    .table-small th {
      font-weight: normal;
      font-style: italic;
      width: 10em;
    }
    .table-small th, .table-small td {
      padding:.2em;
      font-size: .8em;
      border: 0;
    }
    table.diplotype {
      margin-bottom: 0;
    }
    table.genotypeSummary thead th {
      padding-bottom: 0;
    }
    table.diplotype td {
      width: 33%;
      padding: .2em .2em .2em 1em;
      border-width: 1px 0 0 0;
    }
    table.diplotype tbody tr:first-child td {
      border-top: 0;
    }
    tr.lowestFunctionDiplotype td {
      color: #3f3f3f;
    }
    tr.lowestFunctionDiplotype + tr td {
      border-top: 0;
    }
    table.diplotype tbody tr td:first-child {
      padding: .2em;
      border-left-width: 0;
    }
    table.diplotype tbody tr td {
      border-left-width: 1px;
    }


    .pageHeader {
      display: flex;
      align-items: center;
      padding: 1em 1em;
      background-color: #3e4c6c;
      color: #ffffff;
      min-width: 20em;
    }
    .pageHeader .title {
      font-weight: bold;
      font-size: 2em;
      min-width: 10em;
      width: 30%;
    }
    .pageHeader .subtitle {
      margin-left: .5em;
      font-size: .75em;
    }
    .pageHeader .metadata {
      min-width: 10em;
      width: 69%;
    }
    .pageHeader .metadata table {
      line-height: 1;
      margin: 0 .5em 0 auto;
      min-width: unset;
    }
    .pageHeader .metadata th {
      padding: 0 .5em 0 0;
      font-size: .8em;
      font-style: normal;
      font-weight: normal;
      text-align: right;
      vertical-align: top;
      white-space: nowrap;
    }
    .pageHeader .metadata td {
      font-size: .8em;
      padding: 0;
      vertical-align: top;
    }

    p.tdNote {
      margin-top: 1.2em;
      margin-bottom: 0;
      font-size: 0.9em;
    }
    p.tdNote + p.tdNote {
      margin-top: 1em;
      margin-bottom: 0;
      font-size: 0.9em;
    }

    hr {
      margin-bottom: 2em;
    }
    section.gene, section.guideline {
      margin-top: 2em;
      margin-bottom: 2em;
      border-bottom: 1px solid #DDD;
    }
    section.gene:last-child, section.guideline:last-child {
      border-bottom: 0;
    }

    ol.noPadding, ul.noPadding {
      padding-inline-start: 1rem;
    }
    ol.noBullet, ul.noBullet {
      list-style-type: none;
      padding-left: 0;
    }

    dl.compact dd {
      margin-left: 1em;
    }

    div.hint {
      text-transform: capitalize;
      font-size: .8em;
      color: #666666;
    }

    .alert {
      margin: 1em 0;
      padding: 0.6em;
      border-radius: 4px;
      text-shadow: 0 1px 0 rgba(255, 255, 255, 0.5);
      print-color-adjust: exact !important;
    }
    .alert-info {
      background-color: #d9edf7;
      border-color: #bce8f1;
      color: #3a87ad;
    }
    .alert-secondary {
      background-color: #f6f6f6;
      border-color: rgba(62, 76, 108, 0.1);
    }
    .alert-warning {
      background-color: #fcf8e3;
      border-color: #faebcc;
      color: #8a6d3b;
    }
    .alert-danger {
      background-color: #EAD6D5;
      border-color: #EFDFDE;
      color: #7C3A37;
    }
    .alert-danger h4 {
      color: #7C3A37;
      font-weight: bold;
    }
    .alert-debug {
      padding: 0.2em;
      background-color: #ffeeff;
    }

    .noGeneData {
      font-size: .8em;
      margin: 0 0.5em;
    }
    .drugName, .noWrap {
      white-space: nowrap;
    }
    .normalWrap {
      white-space: normal;
    }

    td.missingVariant {
      background-color: lightsalmon;
      print-color-adjust: exact !important;
    }

    td.mismatch {
      font-weight: bold;
    }
    .nonwild {
      background-color: palegoldenrod;
      print-color-adjust: exact !important;
    }

    td.drugRecommendation ul {
      /* same as noPadding above */
      padding-inline-start: 1rem;
    }

    .mt-0 {
      margin-top: 0;
    }
    .mt-1 {
      margin-top: 0.5em;
    }
    .mb-0 {
      margin-bottom: 0;
    }
    .mb-1 {
      margin-bottom: 0.5em;
    }
    .mb-2 {
      margin-bottom: 1em;
    }

    div.callMessage {
      font-style: italic;
      font-weight: normal;
    }
    
    .geneCall {
      font-size: 1.2em;
    }

    .footnote {
      padding: .25em .5em;
      font-size: .8em;
    }
    .citations {
      font-size: .9em;
    }
    .footnote + .citations {
      margin-top: 1.5rem;
    }
    .sources {
      font-size: .8em;
    }
    .smallFont {
      font-size: .9em;
    }

    .footnote sup {
      font-style: normal;
      font-size: 1em;
    }

    #liability {
      font-size: 1.2em;
      color: darkred;
    }

    .warfarinFlowchart {
      text-align: center;
    }
    .warfarinFlowchart img {
      width: 100%;
      height: auto;
    }

    .warningList {
      margin: 0;
      list-style: none;
      padding-left: 0;
    }

    sup a {
      text-decoration: none;
    }

    .tag {
      align-items: center;
      background-color: #ffc107;
      border-radius: .2rem;
      display: inline-flex;
      justify-content: center;
      padding: .1em .4em .15em;
      text-transform: none;
      white-space: nowrap;
      margin-bottom: .5rem;
    }
    .tag.noAction {
      background-color: #d8dbe2;
    }

    @media print {
      html {
        font-size: 12px;
      }

      body {
        width: 100%;
        max-width: none;
        margin: 0;
      }

      a {
        text-decoration: none;
      }

      img, pre, blockquote, table, figure, p {
        page-break-inside: avoid;
      }
    }
  </style>


</head>
<body>
<!--[if lt IE 9]>
<div class="browserUpgrade">You are using an <strong>outdated</strong> browser. Please <a href="https://browsehappy.com/">upgrade your browser</a> to improve your experience.</div>
<![endif]-->
<header class="pageHeader">
  <div class="title">
    PharmCAT Report
    <div class="subtitle">pharmcat.example2</div>
  </div>
  <div class="metadata">
    <table>
      <tr><th>Date created</th><td>August 27, 2024</td></tr>
      <tr><th>PharmCAT Version</th><td>v2.15.2-10-g6ef47ccb</td></tr>
      <tr><th>Data Version</th><td>2024-08-27-21-12</td></tr>
    </table>
  </div>
</header>
<main>
  <section>
    <h2>Sections</h2>
    <ol type="I">
      <li><a href="#section-i">Genotype Summary</a></li>
      <li><a href="#section-ii">Prescribing Recommendations</a></li>
      <li><a href="#section-iii">Allele Matching Details</a></li>
      <li><a href="#disclaimer">Disclaimers</a></li>
    </ol>

    <div class="alert alert-info">
      <em>Disclaimer:</em> PharmCAT is only able to generate recommendations based on the information provided to the
      software. The gene and variant information for all reported sections are interpreted directly from user-supplied data.
      The user recognizes they are using PharmCAT at their own risk. For a full list of disclaimers and limitations see
      <a href="#disclaimer">Section IV</a>.
    </div>
  </section>


  <section id="section-i">
    <h2>Section I: Genotype Summary</h2>

    
    
      <p>Genotypes called: 18 / 19 </p>

      <table class="genotypeSummary">
        <thead>
        <tr>
          <th>Drugs</th>
          <th>Gene</th>
          <th>
            Genotypes
            <table class="diplotype table-small">
              <tbody>
              <tr>
                <td>Genotype</td>
                <td>Allele Functionality</td>
                <td>Phenotype</td>
              </tr>
              </tbody>
            </table>
          </th>
        </tr>
        </thead>
        <tbody>
        
          <tr class="top-aligned gs-ABCG2">
            <td>
              
                <div class="drugName">
                  
                    <a href="#allopurinol">allopurinol</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#rosuvastatin">rosuvastatin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#ABCG2" class="normalWrap">ABCG2</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>rs2231142 reference (G)/rs2231142 reference (G)</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Function</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CACNA1S">
            <td>
              
                <div class="drugName">
                  
                    <a href="#desflurane">desflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#enflurane">enflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#halothane">halothane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#isoflurane">isoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#methoxyflurane">methoxyflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sevoflurane">sevoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#succinylcholine">succinylcholine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CACNA1S" class="normalWrap">CACNA1S</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>Reference/Reference</td>
                      <td>Two Normal function alleles</td>
                      <td>Uncertain Susceptibility</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CFTR">
            <td>
              
                <div class="drugName">
                  
                    <a href="#ivacaftor">ivacaftor</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CFTR" class="normalWrap">CFTR</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>Reference/Reference</td>
                      <td>Two ivacaftor non-responsive alleles</td>
                      <td>ivacaftor non-responsive in CF patients</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP2B6">
            <td>
              
                <div class="drugName">
                  
                    <a href="#efavirenz">efavirenz</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sertraline">sertraline</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP2B6" class="normalWrap">CYP2B6</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*6</td>
                      <td>One Decreased function allele and one Normal function allele</td>
                      <td>Intermediate Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP2C19">
            <td>
              
                <div class="drugName">
                  
                    <a href="#abrocitinib">abrocitinib</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#amitriptyline">amitriptyline</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#belzutifan">belzutifan</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#brivaracetam">brivaracetam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#carisoprodol">carisoprodol</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#citalopram">citalopram</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#clobazam">clobazam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#clomipramine">clomipramine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#clopidogrel">clopidogrel</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#dexlansoprazole">dexlansoprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#diazepam">diazepam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#doxepin">doxepin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#escitalopram">escitalopram</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#esomeprazole">esomeprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#flibanserin">flibanserin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fosphenytoin">fosphenytoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#imipramine">imipramine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#lansoprazole">lansoprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#mavacamten">mavacamten</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#omeprazole">omeprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pantoprazole">pantoprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#phenytoin">phenytoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#rabeprazole">rabeprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sertraline">sertraline</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#trimipramine">trimipramine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#voriconazole">voriconazole</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP2C19" class="normalWrap">CYP2C19</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*2/*2</td>
                      <td>Two No function alleles</td>
                      <td>Poor Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP2C9">
            <td>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#celecoxib">celecoxib</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#flurbiprofen">flurbiprofen</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fluvastatin">fluvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fosphenytoin">fosphenytoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#ibuprofen">ibuprofen</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#lornoxicam">lornoxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#meloxicam">meloxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#phenytoin">phenytoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#piroxicam">piroxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#siponimod">siponimod</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#tenoxicam">tenoxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#warfarin">warfarin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP2C9" class="normalWrap">CYP2C9</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two 1.0 (Normal function) alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP3A4">
            <td>
              
                <div class="drugName">
                  
                    <a href="#quetiapine">quetiapine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP3A4" class="normalWrap">CYP3A4</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP3A5">
            <td>
              
                <div class="drugName">
                  
                    <a href="#tacrolimus">tacrolimus</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP3A5" class="normalWrap">CYP3A5</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP4F2">
            <td>
              
                <div class="drugName">
                  
                    <a href="#warfarin">warfarin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP4F2" class="normalWrap">CYP4F2</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>N/A</td>
                      <td>N/A</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-DPYD">
            <td>
              
                <div class="drugName">
                  
                    <a href="#capecitabine">capecitabine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#flucytosine">flucytosine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fluorouracil">fluorouracil</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#tegafur">tegafur</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#DPYD" class="normalWrap">DPYD</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  
                    <tr class="lowestFunctionDiplotype gs-dip_lowestFunction">
                      <td colspan="3"><b>Reference/Reference</b></td>
                    </tr>
                  
                  
                    <tr class="top-aligned gs-dip_component">
                      <td>Reference</td>
                      <td>1.0 (Normal function)</td>
                      <td>See drug section</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-G6PD">
            <td>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#dapsone">dapsone</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#methylene_blue">methylene blue</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#nitrofurantoin">nitrofurantoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pegloticase">pegloticase</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#primaquine">primaquine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#rasburicase">rasburicase</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#tafenoquine">tafenoquine</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#toluidine_blue">toluidine blue</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#G6PD" class="normalWrap">G6PD</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>B (reference)/B (reference)</td>
                      <td>Two IV/Normal alleles</td>
                      <td>Normal</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-IFNL3_4">
            <td>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#IFNL3_4" class="normalWrap">IFNL3/4</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>rs12979860 reference (C)/rs12979860 reference (C)</td>
                      <td>Two Favorable response allele alleles</td>
                      <td>n/a</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-NUDT15">
            <td>
              
                <div class="drugName">
                  
                    <a href="#azathioprine">azathioprine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#mercaptopurine">mercaptopurine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#thioguanine">thioguanine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#NUDT15" class="normalWrap">NUDT15</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-RYR1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#desflurane">desflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#enflurane">enflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#halothane">halothane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#isoflurane">isoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#methoxyflurane">methoxyflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sevoflurane">sevoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#succinylcholine">succinylcholine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#RYR1" class="normalWrap">RYR1</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  
                    <tr class="lowestFunctionDiplotype gs-dip_lowestFunction">
                      <td colspan="3"><b>Reference/Reference</b></td>
                    </tr>
                  
                  
                    <tr class="top-aligned gs-dip_component">
                      <td>Reference</td>
                      <td>Normal function</td>
                      <td>See drug section</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-SLCO1B1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#atorvastatin">atorvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fluvastatin">fluvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#lovastatin">lovastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pitavastatin">pitavastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pravastatin">pravastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#rosuvastatin">rosuvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#simvastatin">simvastatin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#SLCO1B1" class="normalWrap">SLCO1B1</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Function</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-TPMT">
            <td>
              
                <div class="drugName">
                  
                    <a href="#azathioprine">azathioprine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#mercaptopurine">mercaptopurine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#thioguanine">thioguanine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#TPMT" class="normalWrap">TPMT</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-UGT1A1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#atazanavir">atazanavir</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#irinotecan">irinotecan</a>
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
                <div class="drugName">
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#UGT1A1" class="normalWrap">UGT1A1</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-VKORC1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#acenocoumarol">acenocoumarol</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#phenprocoumon">phenprocoumon</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#warfarin">warfarin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#VKORC1" class="normalWrap">VKORC1</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>rs9923231 reference (C)/rs9923231 reference (C)</td>
                      <td>N/A</td>
                      <td>N/A</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
        </tbody>
      </table>

      

      
      
        <div class="footnote" id="genotypes-dagger">
          <sup>&dagger;</sup> Check <a href="#section-iii">Section III</a> for more details about this call.
        </div>
      
      
        <div class="footnote" id="genotypes-ddagger">
          <sup>&ddagger;</sup> PharmCAT reports the genotype(s) that receive the highest score during the matcher process.
          In case of unphased data, additional genotypes might be possible and cannot be ruled out.
        </div>
      
      <div class="footnote">
        CPIC terms for allele function and phenotype are used for all CPIC genes. For non-CPIC genes, DPWG terms are used.
      </div>
      <div class="footnote">
        For a full list of disclaimers and limitations see <a href="#disclaimer">Section IV</a>.
      </div>

      
      
    
  </section>


  <section id="section-ii">
    <h2>Section II: Prescribing Recommendations</h2>

    
      
        <section class="guideline abrocitinib">
          <h3 id="abrocitinib">abrocitinib</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-label-abrocitinib">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166272961" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;In patients who are known or suspected to be CYP2C19 poor metabolizers, the recommended dosage of CIBINQO [abrocitinib] is 50 mg once daily. If an adequate response is not achieved with CIBINQO 50 mg orally daily after 12 weeks, consider increasing dosage to 100 mg orally once daily. Discontinue therapy if inadequate response is seen after dosage increase to 100 mg once daily.&quot; See label for more information.
                          <a href="#rx-ast-abrocitinib" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-abrocitinib">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329542" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations and may result in higher adverse reaction risk. Dosage adjustment is recommended. Refer to FDA labeling for specific dosing recommendations.&quot;
                          <a href="#rx-ast-abrocitinib" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-abrocitinib">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=213871" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Cibinqo (abrocitinib), NDA213871, Pfizer Laboratories Div Pfizer Inc</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline acenocoumarol">
          <h3 id="acenocoumarol">acenocoumarol</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-acenocoumarol">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104938" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 reference (C)/<br />rs9923231 reference (C)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">-1639 GG</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of the -1639 GG genotype on acenocoumarol.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for acenocoumarol in patients with the VKORC1 rs9923231 CC genotype (-1639 GG genotype).
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline allopurinol">
          <h3 id="allopurinol">allopurinol</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-allopurinol">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166264961" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#ABCG2">ABCG2</a>:<br />rs2231142 reference (G)/<br />rs2231142 reference (G)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of the ABCG2 rs2231142 GG genotype (c.421CC; p.141QQ) on allopurinol.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for allopurinol in patients with the the ABCG2 rs2231142 GG genotype (c.421CC; p.141QQ)
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10853275" target="_blank" rel="noopener noreferrer">Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.</a> <i>European journal of human genetics : EJHG</i>. 2024. PMID:36056234</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline amitriptyline">
          <h3 id="amitriptyline">amitriptyline</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-amitriptyline">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166105006" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>;<br /><span class="rx-dip">CYP2D6:Not called - no variant data provided</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CYP2C19"><dt>CYP2C19:</dt><dd>Poor Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C19"><dt>CYP2C19:</dt><dd>N/A</dd></div><div class="rx-activity rx-activity--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Greatly reduced metabolism of tertiary amines compared to normal metabolizers; Decreased conversion of tertiary amines to secondary amines may affect response or side effects</li><li>CYP2D6: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          Avoid tertiary amine use due to potential for sub-optimal response. Consider alternative drug not metabolized by CYP2C19. TCAs without major CYP2C19 metabolism include the secondary amines nortriptyline and desipramine. For tertiary amines, consider a 50% reduction of the recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects.
<h4 id="other-considerations">Other Considerations</h4>
Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689226" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478479" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:27997040</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline atazanavir">
          <h3 id="atazanavir">atazanavir</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-atazanavir">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166128738" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#UGT1A1">UGT1A1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>UGT1A1: Reference UGT1A1 activity; very low likelihood of bilirubin-related discontinuation of atazanavir.</td>
                        <td class="drugRecommendation">
                          There is no need to avoid prescribing of atazanavir based on UGT1A1 genetic test result. Inform the patient that some patients stop atazanavir because of jaundice (yellow eyes and skin), but that this patient’s genotype makes this unlikely (less than about a 1 in 20 chance of stopping atazanavir because of jaundice).
<h4 id="other-considerations">Other Considerations</h4>
All studies correlating UGT1A1 genotypes with atazanavir adverse events have involved ritonavir boosting. However, concentration-time profiles are equivalent when boosted with either cobicistat or ritonavir (PMID 23532097), and bilirubin-related adverse events including discontinuation of atazanavir occur in a similar percentage of patients prescribed atazanavir with cobicistat or ritonavir (PMID 23532097). Associations between UGT1A1 genotype, bilirubin elevations, and atazanavir/r discontinuation therefore almost certainly translate to atazanavir/cobicistat. &quot;reference&quot; function refers to the UGT1A1 allele to which other alleles are compared.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785051" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.</a> <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:26417955</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline atorvastatin">
          <h3 id="atorvastatin">atorvastatin</h3>



          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-atorvastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166262221" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">
                          Prescribe desired starting dose and adjust doses based on disease-specific guidelines.
<h4 id="other-considerations">Other Considerations</h4>
The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-atorvastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182843" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of the _SLCO1B1_ 521 TT genotype on atorvastatin.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for atorvastatin in patients with the <em>SLCO1B1</em> 521 TT genotype
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-assoc-atorvastatin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329629" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035072" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline azathioprine">
          <h3 id="azathioprine">azathioprine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-azathioprine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104933" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--NUDT15"><dt>NUDT15:</dt><dd>Normal Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--TPMT"><dt>TPMT:</dt><dd>Normal Metabolizer</dd></div></dl>
                        
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>NUDT15: Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression</li><li>TPMT: Lower concentrations of TGN metabolites, higher MeTIMP, this is the ‘normal’ pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.</li></ul></td>
                        <td class="drugRecommendation">
                          Start with normal starting dose (e.g., 2-3 mg/kg/day) and adjust doses of azathioprine based on disease-specific guidelines. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11302950, 15606506).
<h4 id="other-considerations">Other Considerations</h4>
Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-azathioprine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184614" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on azathioprine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for azathioprine in normal metabolizers
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-guideline-azathioprine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104934" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on azathioprine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for azathioprine in normal metabolizers.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-azathioprine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104782" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-azathioprine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329549" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098761" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21270794</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604643" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23422873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576267" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30447069</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=016324" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product IMURAN (azathioprine), NDA016324, Sebela Pharmaceuticals Inc.</a></li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline belzutifan">
          <h3 id="belzutifan">belzutifan</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-label-belzutifan">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166268882" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>"Patients who are dual UGT2B17 and CYP2C19 poor metabolizers have higher belzutifan exposures, which may increase the incidence and severity of adverse reactions of WELIREG [belzutifan]."</td>
                        <td class="drugRecommendation">
                          &quot;Closely monitor for adverse reactions in patients who are dual UGT2B17 and CYP2C19 poor metabolizers.&quot; See label for more information.
                          <a href="#rx-ast-belzutifan" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-belzutifan">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329551" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 and/or UGT2B17 poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations and may result in higher adverse reaction risk (anemia, hypoxia). Monitor patients who are poor metabolizers for both genes for adverse reactions.&quot;
                          <a href="#rx-ast-belzutifan" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-belzutifan">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=215383" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product WELIREG (belzutifan), NDA215383, Merck Sharp & Dohme Corp.</a></li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline brivaracetam">
          <h3 id="brivaracetam">brivaracetam</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-label-brivaracetam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166153492" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          The brivaracetam (BRIVIACT) label states: &quot;CYP2C19 poor metabolizers and patients using inhibitors of CYP2C19 may require dose reduction.&quot; See label for more information.
                          <a href="#rx-ast-brivaracetam" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-brivaracetam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329553" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations and higher adverse reaction risk. Consider dosage reductions in poor metabolizers.&quot;
                          <a href="#rx-ast-brivaracetam" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-brivaracetam">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205836" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Briviact (brivaracetam), NDA205836, UCB, Inc.</a></li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205836" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Briviact (brivaracetam), UCB, Inc. - NDA205836/SUPPL-14, 05/17/2023</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline capecitabine">
          <h3 id="capecitabine">capecitabine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-capecitabine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166109594" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>DPYD: Normal DPD activity and "normal" risk for fluoropyrimidine toxicity</td>
                        <td class="drugRecommendation">
                          Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-capecitabine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104963" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">2.0 (Normal Metabolizer)</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a DPYD activity score of 2 on capecitabine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for capecitabine in patients with a DPYD activity score of 2.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-capecitabine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104802" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#DPYD">DPYD</a>:Reference/Reference</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-capecitabine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329554" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#DPYD">DPYD</a>:Reference/Reference</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831181" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23988873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760397" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:29152729</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/31745289" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.</a> <i>European journal of human genetics : EJHG</i>. 2019. PMID:31745289</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020896" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Xeloda (capecitabine), NDA020896, Genentech, Inc.</a></li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline carisoprodol">
          <h3 id="carisoprodol">carisoprodol</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-label-carisoprodol">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166104832" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Patients with Reduced CYP2C19 Activity: SOMA [carisoprodol] should be used with caution in patients with reduced CYP2C19 activity.&quot; See label for more information.
                          <a href="#rx-ast-carisoprodol" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-carisoprodol">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329631" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations. Use with caution.&quot;
                          <a href="#rx-ast-carisoprodol" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-carisoprodol">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=011792" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Soma (Carisoprodol), NDA011792, Rebel Distributors Corp</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline celecoxib">
          <h3 id="celecoxib">celecoxib</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-celecoxib">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166191841" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Normal metabolism</td>
                        <td class="drugRecommendation">
                          Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-celecoxib">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104843" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-celecoxib">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329556" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080882" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020998" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product CELEBREX (Celecoxib), NDA020998, Aphena Pharma Solutions - Tennessee, LLC</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline citalopram">
          <h3 id="citalopram">citalopram</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-citalopram">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166127638" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Reduced metabolism of citalopram and escitalopram to less active compounds when compared to CYP2C19 normal and intermediate metabolizers. Higher plasma concentrations may increase the probability of side effects.</td>
                        <td class="drugRecommendation">
                          Consider a clinically appropriate antidepressant not predominantly metabolized by CYP2C19. If citalopram or escitalopram are clinically appropriate, consider a lower starting dose, slower titration schedule and 50% reduction of the standard maintenance dose as compared to normal metabolizers.
<h4 id="other-considerations">Other Considerations</h4>
Per the FDA warning, citalopram 20 mg/day is the maximum recommended dose in CYP2C19 poor metabolizers due to the risk of QT prolongation. FDA product labeling additionally cautions that citalopram dose should be limited to 20 mg/day in patients with hepatic impairment, those taking a CYP2C19 inhibitor, and patients greater than 60 years of age.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-citalopram">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104977" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The risk of QT prolongation and therefore also the theoretical risk of torsades de pointes is increased as the gene variation leads to an increased citalopram plasma concentration. If you follow the dose recommendation below, the increased plasma concentration and the increased risk of QT prolongation will be offset.</td>
                        <td class="drugRecommendation">
                          Do not exceed the following daily doses (50% of the standard maximum dose):
<ol>
<li>adults up to 65 years: 20mg as tablets or 16mg as drops,</li>
<li>Adults 65 years or older: 10mg as tablets or 8mg as drops</li>
</ol>
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-citalopram">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166104852" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19 poor metabolizers have higher systemic concentration and adverse reaction risk (QT prolongation).</td>
                        <td class="drugRecommendation">
                          &quot;Celexa [citalopram] 20 mg/day is the maximum recommended dose in CYP2C19 poor metabolizers due to the risk of QT prolongation.&quot; See label for more information.
                          <a href="#rx-ast-citalopram" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-citalopram">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329557" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations and adverse reaction risk (QT prolongation). The maximum recommended dose is 20 mg.&quot;
                          <a href="#rx-ast-citalopram" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-citalopram">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512908" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.</a> <i>Clinical pharmacology and therapeutics</i>. 2015. PMID:25974703</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34782755" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34782755</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020822" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Celexa (citalopram), NDA020822, Allergan, Inc.</a></li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline clobazam">
          <h3 id="clobazam">clobazam</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-label-clobazam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166104884" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;In CYP2C19 poor metabolizers ... the starting dose should be 5 mg/day and dose titration should proceed slowly according to weight, but to half the dose presented in Table 1 [of the drug label], as tolerated. If necessary and based upon clinical response, an additional titration to the maximum dose (20 mg/day or 40 mg/day, depending on the weight group) may be started on day 21.&quot; See label for more information.
                          <a href="#rx-ast-clobazam" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-clobazam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329558" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C9 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic active metabolite concentrations. Poor metabolism results in higher adverse reaction risk. Dosage adjustment is recommended. Refer to FDA labeling for specific dosing recommendations.&quot;
                          <a href="#rx-ast-clobazam" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-clobazam">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=202067" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Onfi (clobazam), NDA202067, Lundbeck Pharmaceuticals LLC</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline clomipramine">
          <h3 id="clomipramine">clomipramine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-clomipramine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166105007" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>;<br /><span class="rx-dip">CYP2D6:Not called - no variant data provided</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CYP2C19"><dt>CYP2C19:</dt><dd>Poor Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C19"><dt>CYP2C19:</dt><dd>N/A</dd></div><div class="rx-activity rx-activity--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Greatly reduced metabolism of tertiary amines compared to normal metabolizers; Decreased conversion of tertiary amines to secondary amines may affect response or side effects</li><li>CYP2D6: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          Avoid tertiary amine use due to potential for sub-optimal response. Consider alternative drug not metabolized by CYP2C19. TCAs without major CYP2C19 metabolism include the secondary amines nortriptyline and desipramine. For tertiary amines, consider a 50% reduction of the recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects.
<h4 id="other-considerations">Other Considerations</h4>
Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.
                          
                        </td>
                        <td>Optional</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-clomipramine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184528" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The gene variation increases the plasma concentration of clomipramine. However, there is insufficient evidence to substantiate an increase of the plasma concentration of clomipramine+desmethylclomipramine to such an extent that it increases the risk of side effects. The increase in the plasma concentration of clomipramine is favourable for the efficacy in anxiety and obsessive compulsive disorder.</td>
                        <td class="drugRecommendation">
                          NO action is required for this gene-drug interaction.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689226" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478479" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:27997040</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline clopidogrel">
          <h3 id="clopidogrel">clopidogrel</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-clopidogrel">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104948" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>CVI ACS PCI</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Significantly reduced clopidogrel active metabolite formation; increased on-treatment platelet reactivity; increased risk for adverse cardiac and cerebrovascular events</td>
                        <td class="drugRecommendation">
                          Avoid clopidogrel if possible. Use prasugrel or ticagrelor at standard dose if no contraindication.
<h4 id="other-considerations">Other Considerations</h4>
For cardiovascular indications of acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI). ACS and/or PCI includes patients undergoing PCI for an ACS or non-ACS (elective) indication.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                    <tr class="top-aligned cpic-guideline-clopidogrel">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104948" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>CVI non-ACS non-PCI</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Significantly reduced clopidogrel active metabolite formation; increased on-treatment platelet reactivity; increased risk for adverse cardiac and cerebrovascular events</td>
                        <td class="drugRecommendation">
                          Avoid clopidogrel if possible. Use prasugrel or ticagrelor at standard dose if no contraindication.
<h4 id="other-considerations">Other Considerations</h4>
For non-acute coronary syndrome (non-ACS) and non-percutaneous coronary intervention (non-PCI) cardiovascular indications. Non-ACS, non-PCI cardiovascular indications include peripheral arterial disease and stable coronary artery disease following a recent myocardial infarction outside the setting of PCI.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                    <tr class="top-aligned cpic-guideline-clopidogrel">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104948" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>NVI</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Significantly reduced clopidogrel active metabolite formation; increased on-treatment platelet reactivity; increased risk for adverse cardiac and cerebrovascular events</td>
                        <td class="drugRecommendation">
                          Avoid clopidogrel if possible. Consider an alternative P2Y12 inhibitor at standard dose if clinically indicated and no contraindication.
<h4 id="other-considerations">Other Considerations</h4>
For neurovascular indications. Neurovascular disease includes acute ischemic stroke or transient ischemic attack, secondary prevention of stroke, or prevention of thromboembolic events following neurointerventional procedures such as carotid artery stenting and stent-assisted coiling of intracranial aneurysms. Alternative P2Y12 inhibitors not impacted by CYP2C19 genetic variants include ticagrelor and ticlopidine. Prasugrel is contraindicated in patients with a history of stroke or TIA. Given limited outcomes data for genotype-guided anti-platelet therapy for neurovascular indications, selection of therapy should depend on individual patient treatment goals and risks for adverse events.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-clopidogrel">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104956" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The risk of serious cardiovascular and cerebrovascular events is increased in patients undergoing balloon angioplasty or stent placement (percutaneous coronary intervention) and in patients with a stroke or TIA, because the genetic variation reduces the activation of clopidogrel. No negative clinical consequences have been proved in other patients.</td>
                        <td class="drugRecommendation">
                          PERCUTANEOUS CORONARY INTERVENTION, STROKE or TIA: avoid clopidogrel. Prasugrel, ticagrelor and acetylsalicylic acid/dipyridamole are not metabolised by CYP2C19 (or to a lesser extent).
OTHER INDICATIONS: determine the level of inhibition of platelet aggregation by clopidogrel. Consider an alternative in poor responders. Prasugrel and ticagrelor are not metabolised by CYP2C19 (or to a lesser extent).
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-clopidogrel">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166104777" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          The clopidogrel (Plavix) label states: &quot;Consider use of another platelet P2Y12 inhibitor in patients identified as CYP2C19 poor metabolizers.&quot; See label for more information.
                          <a href="#rx-ast-clopidogrel" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-clopidogrel">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329559" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in lower systemic active metabolite concentrations, lower antiplatelet response, and may result in higher cardiovascular risk. Consider use of another platelet P2Y12 inhibitor.&quot;
                          <a href="#rx-ast-clopidogrel" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-clopidogrel">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234301" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21716271</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748366" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23698643</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287492" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35034351</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020839" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Plavix (clopidogrel bisulfate), NDA020839, Rebel Distributors Corp</a>.</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020839" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Plavix (clopidogrel), sanofi-aventis U.S. LLC - NDA020839/SUPPL-78, 09/16/2022</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline dapsone">
          <h3 id="dapsone">dapsone</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-dapsone">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166119846" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111801" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24787449</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline desflurane">
          <h3 id="desflurane">desflurane</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-desflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166303941" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td>These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</td>
                        <td class="drugRecommendation">
                          Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-desflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166129515" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;The use of SUPRANE [desflurane] is contraindicated in...[cases of k]nown or suspected genetic susceptibility to malignant hyperthermia...SUPRANE [desflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.  &quot; See label for more information.
                          <a href="#rx-ast-desflurane" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-desflurane">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513720" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30499100</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020118" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product SUPRANE (desflurane), NDA020118, Baxter Healthcare Corporation</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline dexlansoprazole">
          <h3 id="dexlansoprazole">dexlansoprazole</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-dexlansoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166219301" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Increased plasma concentration of PPI compared to CYP2C19 NMs; increased chance of efficacy and potentially toxicity</td>
                        <td class="drugRecommendation">
                          Initiate standard starting daily dose. For chronic therapy (&gt;12 weeks) and efficacy achieved, consider 50% reduction in daily dose and monitor for continued efficacy.
                          
                        </td>
                        <td>Optional</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-dexlansoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329635" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations.&quot;
                          <a href="#rx-ast-dexlansoprazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-dexlansoprazole">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868475" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:32770672</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline diazepam">
          <h3 id="diazepam">diazepam</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-assoc-diazepam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329636" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;May affect systemic concentrations.&quot;
                          <a href="#rx-ast-diazepam" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-diazepam">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline doxepin">
          <h3 id="doxepin">doxepin</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-doxepin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166105000" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>;<br /><span class="rx-dip">CYP2D6:Not called - no variant data provided</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CYP2C19"><dt>CYP2C19:</dt><dd>Poor Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C19"><dt>CYP2C19:</dt><dd>N/A</dd></div><div class="rx-activity rx-activity--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Greatly reduced metabolism of tertiary amines compared to normal metabolizers; Decreased conversion of tertiary amines to secondary amines may affect response or side effects</li><li>CYP2D6: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          Avoid tertiary amine use due to potential for sub-optimal response. Consider alternative drug not metabolized by CYP2C19. TCAs without major CYP2C19 metabolism include the secondary amines nortriptyline and desipramine. For tertiary amines, consider a 50% reduction of the recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects.
<h4 id="other-considerations">Other Considerations</h4>
Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.
                          
                        </td>
                        <td>Optional</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-doxepin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329639" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations.&quot;
                          <a href="#rx-ast-doxepin" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-doxepin">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689226" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478479" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:27997040</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline efavirenz">
          <h3 id="efavirenz">efavirenz</h3>



          
            <div class="alert alert-info CYP2B6-1-6-warning">The assigned genotype is *1/*6; however, *4/*9 cannot be ruled out without phased data.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-efavirenz">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182603" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>child >40kg_adult</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2B6">CYP2B6</a>:*1/*6</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Intermediate Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2B6: Higher dose-adjusted trough concentrations of efavirenz compared with normal metabolizers; increased risk of CNS adverse events</td>
                        <td class="drugRecommendation">
                          Consider initiating efavirenz with decreased dose of 400 mg/day
<h4 id="other-considerations">Other Considerations</h4>
If therapeutic drug monitoring is available and a decreased efavirenz dose is prescribed, consider obtaining steady-state plasma efavirenz concentrations to ensure concentrations are in the suggested therapeutic range (~1 to 4 μg/mL). To prescribe efavirenz at a decreased dose of 400 mg/day or 200 mg/day in a multidrug regimen may require prescribing more than one pill once daily. If so, the provider should weigh the potential benefit of reduced dose against the potential detrimental impact of increased pill number.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-efavirenz">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182846" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2B6">CYP2B6</a>:*1/*6</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Intermediate Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>Genetic variations increase the efavirenz plasma concentration and therefore the risk of side effects. However, the efavirenz plasma concentration remains within the therapeutic range for the majority of patients.</td>
                        <td class="drugRecommendation">
                          Determine the efavirenz plasma concentration if side effects occur and reduce the dose if needed. In 14 IM adults, a dose reduction to 400 mg/day (2/3rd of the standard dose) was sufficient to achieve therapeutic plasma concentrations and to reduce or resolve side effects. The therapeutic range established for efavirenz is 1000-4000 ng/ml.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-assoc-efavirenz">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329608" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2B6">CYP2B6</a>:*1/*6</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739160" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:31006110</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline enflurane">
          <h3 id="enflurane">enflurane</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-enflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166303941" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td>These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</td>
                        <td class="drugRecommendation">
                          Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513720" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline escitalopram">
          <h3 id="escitalopram">escitalopram</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-escitalopram">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166127638" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Reduced metabolism of citalopram and escitalopram to less active compounds when compared to CYP2C19 normal and intermediate metabolizers. Higher plasma concentrations may increase the probability of side effects.</td>
                        <td class="drugRecommendation">
                          Consider a clinically appropriate antidepressant not predominantly metabolized by CYP2C19. If citalopram or escitalopram are clinically appropriate, consider a lower starting dose, slower titration schedule and 50% reduction of the standard maintenance dose as compared to normal metabolizers.
<h4 id="other-considerations">Other Considerations</h4>
Per the FDA warning, citalopram 20 mg/day is the maximum recommended dose in CYP2C19 poor metabolizers due to the risk of QT prolongation. FDA product labeling additionally cautions that citalopram dose should be limited to 20 mg/day in patients with hepatic impairment, those taking a CYP2C19 inhibitor, and patients greater than 60 years of age.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-escitalopram">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104975" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The risk of switching to another antidepressant is increased. In addition, the risk of QT prolongation and torsades de pointes is theoretically increased because the gene variation leads to an increased escitalopram plasma concentration. If you follow the dose recommendation below, the increased plasma concentration, the theoretically increased risk of QT prolongation and the increased risk of switching to another antidepressant will be offset.</td>
                        <td class="drugRecommendation">
                          Do not exceed the following doses (50% of the standard maximum dose): adults &lt; 65 years 10 mg/day, =65 years 5 mg/day
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-escitalopram">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329642" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 ultrarapid, intermediate, or poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;May alter systemic concentrations.&quot;
                          <a href="#rx-ast-escitalopram" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-escitalopram">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512908" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.</a> <i>Clinical pharmacology and therapeutics</i>. 2015. PMID:25974703</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34782755" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34782755</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline esomeprazole">
          <h3 id="esomeprazole">esomeprazole</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-assoc-esomeprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329643" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations.&quot;
                          <a href="#rx-ast-esomeprazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-esomeprazole">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline flibanserin">
          <h3 id="flibanserin">flibanserin</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-label-flibanserin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166345022" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          The flibanserin (ADDYI) label states: &quot;[...]increase monitoring for adverse reactions (e.g., hypotension) in patients who are CYP2C19 poor metabolizers.&quot; See label for more information.
                          <a href="#rx-ast-flibanserin" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-flibanserin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329566" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;May result in higher systemic concentrations and higher adverse reaction risk. Monitor patients for adverse reactions.&quot;
                          <a href="#rx-ast-flibanserin" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-flibanserin">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=022526" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product ADDYI (flibanserin), Sprout Pharmaceuticals, Inc. - NDA022526/SUPPL-10, 09/29/2021</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline flucytosine">
          <h3 id="flucytosine">flucytosine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-flucytosine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166222801" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">2.0 (Normal Metabolizer)</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a DPYD activity score of 2 on flucytosine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for flucytosine in patients with a DPYD activity score of 2.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
        </section>
      
        <section class="guideline fluorouracil">
          <h3 id="fluorouracil">fluorouracil</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-fluorouracil">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166122686" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>DPYD: Normal DPD activity and "normal" risk for fluoropyrimidine toxicity</td>
                        <td class="drugRecommendation">
                          Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-fluorouracil">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104939" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">2.0 (Normal Metabolizer)</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a DPYD activity score of 2 on fluorouracil.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for fluorouracil in patients with a DPYD activity score of 2.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-fluorouracil">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104807" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#DPYD">DPYD</a>:Reference/Reference</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-fluorouracil">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329568" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#DPYD">DPYD</a>:Reference/Reference</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831181" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23988873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760397" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:29152729</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/31745289" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.</a> <i>European journal of human genetics : EJHG</i>. 2019. PMID:31745289</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020985" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Carac (fluorouracil), NDA020985, Valeant Pharmaceuticals North America LLC</a>.</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=210124" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Fluorouracil (Fluorouracil), BluePoint Laboratories - ANDA210124/SUPPL-9, 03/21/2024</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline flurbiprofen">
          <h3 id="flurbiprofen">flurbiprofen</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-flurbiprofen">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166191841" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Normal metabolism</td>
                        <td class="drugRecommendation">
                          Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-flurbiprofen">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104922" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-flurbiprofen">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329567" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080882" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=019404" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product FLURBIPROFEN SODIUM (flurbiprofen sodium), NDA019404, Rebel Distributors Corp</a>.</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=018766" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product flurbiprofen (NDA018766)</a></li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline fluvastatin">
          <h3 id="fluvastatin">fluvastatin</h3>



          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-fluvastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166262341" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CYP2C9"><dt>CYP2C9:</dt><dd>Normal Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--SLCO1B1"><dt>SLCO1B1:</dt><dd>Normal Function</dd></div></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C9"><dt>CYP2C9:</dt><dd>2.0</dd></div><div class="rx-activity rx-activity--SLCO1B1"><dt>SLCO1B1:</dt><dd>N/A</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C9: Normal exposure.</li><li>SLCO1B1: Typical myopathy risk and statin exposure.</li></ul></td>
                        <td class="drugRecommendation">
                          Prescribe desired starting dose and adjust doses of fluvastatin based on disease-specific guidelines.
<h4 id="other-considerations">Other Considerations</h4>
The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035072" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline fosphenytoin">
          <h3 id="fosphenytoin">fosphenytoin</h3>



          
            <div class="alert alert-info Phenytoin-HLA-B-warning">The displayed recommendation for CYP2C9 and phenytoin is ONLY valid for non-carriers of the HLA-B*15:02 high-risk allele. PharmCAT Named Allele Matcher does not determine HLA status. CPIC guidance: Fos-/Phenytoin is contraindicated in individuals with the HLA-B*15:02 variant allele ("HLA-B*15:02-positive") due to significantly increased risk of fos-/phenytoin-induced cutaneous adverse reactions of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). In HLA-B*15:02 carriers, carbamazepine should not be used as an alternative. Alternative medications such as oxcarbazepine, eslicarbazepine acetate, and lamotrigine have some evidence linking SJS/TEN with the HLA-B*15:02 allele, and thus caution should be used in choosing alternatives to phenytoin.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-fosphenytoin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166122806" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>PHT naive</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C9"><dt>CYP2C9:</dt><dd>2.0</dd></div><div class="rx-activity rx-activity--HLA-B"><dt>HLA-B:</dt><dd>N/A</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C9: Normal phenytoin metabolism</li><li>HLA-B: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          No adjustments needed from typical dosing strategies. Subsequent doses should be adjusted according to therapeutic drug monitoring, response, and side effects. An HLA-B*15:02 negative test does not eliminate the risk of phenytoin-induced SJS/TEN and patients should be carefully monitored according to a usual standard.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                    <tr class="top-aligned cpic-guideline-fosphenytoin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166122806" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>PHT use >3mos</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C9"><dt>CYP2C9:</dt><dd>2.0</dd></div><div class="rx-activity rx-activity--HLA-B"><dt>HLA-B:</dt><dd>N/A</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C9: Normal phenytoin metabolism</li><li>HLA-B: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          No adjustments needed from typical dosing strategies. Subsequent doses should be adjusted according to therapeutic drug monitoring, response, and side effects. An HLA-B*15:02 negative test does not eliminate the risk of phenytoin-induced SJS/TEN and patients should be carefully monitored according to a usual standard.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-fosphenytoin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166182766" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>;<br /><span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-fosphenytoin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329569" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329570" target="_blank" rel="noopener noreferrer">2</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206662" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:25099164</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831382" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:32779747</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020450" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product CEREBYX (Fosphenytoin Sodium), NDA020450, Pfizer Laboratories Div Pfizer Inc</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline halothane">
          <h3 id="halothane">halothane</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-halothane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166303941" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td>These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</td>
                        <td class="drugRecommendation">
                          Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513720" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ibuprofen">
          <h3 id="ibuprofen">ibuprofen</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-ibuprofen">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166191841" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Normal metabolism</td>
                        <td class="drugRecommendation">
                          Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-assoc-ibuprofen">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329648" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080882" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline imipramine">
          <h3 id="imipramine">imipramine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-imipramine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104999" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>;<br /><span class="rx-dip">CYP2D6:Not called - no variant data provided</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CYP2C19"><dt>CYP2C19:</dt><dd>Poor Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C19"><dt>CYP2C19:</dt><dd>N/A</dd></div><div class="rx-activity rx-activity--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Greatly reduced metabolism of tertiary amines compared to normal metabolizers; Decreased conversion of tertiary amines to secondary amines may affect response or side effects</li><li>CYP2D6: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          Avoid tertiary amine use due to potential for sub-optimal response. Consider alternative drug not metabolized by CYP2C19. TCAs without major CYP2C19 metabolism include the secondary amines nortriptyline and desipramine. For tertiary amines, consider a 50% reduction of the recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects.
<h4 id="other-considerations">Other Considerations</h4>
Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.
                          
                        </td>
                        <td>Optional</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-imipramine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104954" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The risk of side effects is increased. The gene variation results in an increase in the plasma concentration of imipramine+desipramine.</td>
                        <td class="drugRecommendation">
                          Use 70% of the standard dose and monitor the effect and side effects or the imipramine and desipramine plasma concentrations to determine the maintenance dose, or, avoid imipramine. Antidepressants that are not or to a lesser extent metabolised by CYP2C19 include, for example, nortriptyline, fluvoxamine and mirtazapine.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689226" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478479" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:27997040</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline irinotecan">
          <h3 id="irinotecan">irinotecan</h3>



          
            <div class="alert alert-info irinotecan-DPWG">Alleles determined based on the CPIC UGT1A1 allele definition file due to limited allele definition information in the DPWG UGT1A1 document</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-irinotecan">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104951" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#UGT1A1">UGT1A1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on irinotecan.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for irinotecan in normal metabolizers
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-irinotecan">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104831" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#UGT1A1">UGT1A1</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-irinotecan">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329573" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#UGT1A1">UGT1A1</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474017" target="_blank" rel="noopener noreferrer">Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.</a> <i>European journal of human genetics : EJHG</i>. 2023. PMID:36443464</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020571" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Camptosar (irinotecan hydrochloride), NDA020571, Pharmacia and Upjohn Company LLC</a>.</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=207793" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Onivyde (IRINOTECAN HYDROCHLORIDE), Ipsen Biopharmaceuticals, Inc. - NDA207793/ORIG-1, 10/22/2015</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline isoflurane">
          <h3 id="isoflurane">isoflurane</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-isoflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166303941" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td>These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</td>
                        <td class="drugRecommendation">
                          Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-isoflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166129517" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.
                          <a href="#rx-ast-isoflurane" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-isoflurane">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513720" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30499100</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=017624" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product FORANE (isoflurane), NDA017624, Baxter Healthcare Corporation</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ivacaftor">
          <h3 id="ivacaftor">ivacaftor</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-ivacaftor">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166114461" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CFTR">CFTR</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">ivacaftor non-responsive in CF patients</p>
                        
                        
                      </td>
                    
                        <td>CFTR: An individual diagnosed with cystic fibrosis (CF) and negative for a CFTR variant listed in the FDA-approved drug label as being responsive to ivacaftor.</td>
                        <td class="drugRecommendation">
                          Ivacaftor is not recommended
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-ivacaftor">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104890" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CFTR">CFTR</a>:Reference/Reference</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026598" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24598717</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=203188" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Kalydeco (ivacaftor), NDA203188, Vertex Pharmaceuticals Incorporated</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline lansoprazole">
          <h3 id="lansoprazole">lansoprazole</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-lansoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166219103" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Increased plasma concentration of PPI compared to CYP2C19 NMs; increased chance of efficacy and potentially toxicity</td>
                        <td class="drugRecommendation">
                          Initiate standard starting daily dose. For chronic therapy (&gt;12 weeks) and efficacy achieved, consider 50% reduction in daily dose and monitor for continued efficacy.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-lansoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104987" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The higher plasma concentration of lansoprazole results in an increase in the therapeutic effectiveness, without an increase in the incidence of side effects.</td>
                        <td class="drugRecommendation">
                          NO action is needed for this gene-drug interaction.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-lansoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329650" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations.&quot;
                          <a href="#rx-ast-lansoprazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-lansoprazole">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868475" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:32770672</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline lornoxicam">
          <h3 id="lornoxicam">lornoxicam</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-lornoxicam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166191841" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Normal metabolism</td>
                        <td class="drugRecommendation">
                          Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080882" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline lovastatin">
          <h3 id="lovastatin">lovastatin</h3>



          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-lovastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166262241" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">
                          Prescribe desired starting dose and adjust doses based on disease-specific guidelines.
<h4 id="other-considerations">Other Considerations</h4>
The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035072" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline mavacamten">
          <h3 id="mavacamten">mavacamten</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-assoc-mavacamten">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329612" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Indicate a Potential Impact on Safety or Response]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations and may have higher adverse reaction risk (heart failure). Dosage is based on individual response. The dose titration and monitoring schedule accounts for differences due to CYP2C19 genetic variation, so adjustments based on CYP2C19 genotype are not necessary. Refer to FDA labeling for specific dosing recommendations and monitoring.&quot;
                          <a href="#rx-ast-mavacamten" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-mavacamten">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline meloxicam">
          <h3 id="meloxicam">meloxicam</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-meloxicam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166192301" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Normal metabolism</td>
                        <td class="drugRecommendation">
                          Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-meloxicam">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166182753" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-meloxicam">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329576" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080882" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020938" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Mobic (meloxicam), NDA020938, REMEDYREPACK INC.</a></li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=211210" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product QMIIZ ODT (meloxicam), NDA211210, TerSera Therapeutics LLC</a>.</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=207233" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Vivlodex (meloxicam), NDA207233, Egalet US Inc.</a></li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline mercaptopurine">
          <h3 id="mercaptopurine">mercaptopurine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-mercaptopurine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104945" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--NUDT15"><dt>NUDT15:</dt><dd>Normal Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--TPMT"><dt>TPMT:</dt><dd>Normal Metabolizer</dd></div></dl>
                        
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>NUDT15: Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression</li><li>TPMT: Lower concentrations of TGN metabolites, higher MeTIMP, this is the ‘normal’ pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.</li></ul></td>
                        <td class="drugRecommendation">
                          Start with normal starting dose (e.g., 75 mg/m2/day or 1.5 mg/kg/day) and adjust doses of mercaptopurine (and of any other myelosuppressive therapy) without any special emphasis on mercaptopurine compared to other agents. Allow at least 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 16401827, 11302950).
<h4 id="other-considerations">Other Considerations</h4>
Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-mercaptopurine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184613" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on mercaptopurine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for mercaptopurine in normal metabolizers
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-guideline-mercaptopurine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104952" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on mercaptopurine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for mercaptopurine in normal metabolizers.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-mercaptopurine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104810" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-mercaptopurine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329578" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098761" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21270794</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604643" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23422873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576267" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30447069</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=009053" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product PURINETHOL (Mercaptopurine), Quinn Pharmaceuticals - NDA009053/SUPPL-40, 12/29/2020</a>.</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205919" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product PURIXAN (mercaptopurine), Nova Laboratories, Ltd - NDA205919/SUPPL-4, 04/07/2020</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline methoxyflurane">
          <h3 id="methoxyflurane">methoxyflurane</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-methoxyflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166303941" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td>These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</td>
                        <td class="drugRecommendation">
                          Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513720" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline methylene_blue">
          <h3 id="methylene_blue">methylene blue</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-methylene_blue">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166119846" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-methylene_blue">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104878" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#G6PD">G6PD</a>:B (reference)/B (reference)</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111801" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24787449</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204630" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product PROVAYBLUE (methylene blue), NDA204630, American Regent, Inc.</a></li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline nitrofurantoin">
          <h3 id="nitrofurantoin">nitrofurantoin</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-nitrofurantoin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166279721" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-nitrofurantoin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104903" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#G6PD">G6PD</a>:B (reference)/B (reference)</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=009175" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Furadantin (Nitrofurantoin), NDA009175, Casper Pharma LLC</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline omeprazole">
          <h3 id="omeprazole">omeprazole</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-omeprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166219103" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Increased plasma concentration of PPI compared to CYP2C19 NMs; increased chance of efficacy and potentially toxicity</td>
                        <td class="drugRecommendation">
                          Initiate standard starting daily dose. For chronic therapy (&gt;12 weeks) and efficacy achieved, consider 50% reduction in daily dose and monitor for continued efficacy.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-omeprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104957" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The higher plasma concentration of omeprazole results in an increase in the therapeutic effectiveness, without an increase in the side effects.</td>
                        <td class="drugRecommendation">
                          NO action is required for this gene-drug interaction.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-omeprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329655" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations.&quot;
                          <a href="#rx-ast-omeprazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-omeprazole">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868475" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:32770672</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pantoprazole">
          <h3 id="pantoprazole">pantoprazole</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-pantoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166219103" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Increased plasma concentration of PPI compared to CYP2C19 NMs; increased chance of efficacy and potentially toxicity</td>
                        <td class="drugRecommendation">
                          Initiate standard starting daily dose. For chronic therapy (&gt;12 weeks) and efficacy achieved, consider 50% reduction in daily dose and monitor for continued efficacy.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-pantoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104958" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The higher plasma concentration of pantoprazole results in an increase in the therapeutic effectiveness, without an increase in the side effects.</td>
                        <td class="drugRecommendation">
                          NO action is required for this gene-drug interaction.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-pantoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166104901" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;For adult patients who are CYP2C19 poor metabolizers, no dosage adjustment is needed...For known pediatric poor metabolizers, a dose reduction should be considered.&quot; See label for more information.
                          <a href="#rx-ast-pantoprazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-pantoprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329582" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Pediatrics; Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations. Consider dosage reduction in children who are poor metabolizers. No dosage adjustment is needed for adult patients who are intermediate or poor metabolizers.&quot;
                          <a href="#rx-ast-pantoprazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-pantoprazole">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868475" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:32770672</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020987" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Protonix Delayed-Release (PANTOPRAZOLE SODIUM), NDA020987, Avera McKennan Hospital</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pegloticase">
          <h3 id="pegloticase">pegloticase</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-pegloticase">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166119846" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-pegloticase">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104900" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#G6PD">G6PD</a>:B (reference)/B (reference)</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111801" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24787449</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=125293" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Krystexxa (pegloticase), BLA125293, Horizon Pharma Inc.</a></li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline phenprocoumon">
          <h3 id="phenprocoumon">phenprocoumon</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-phenprocoumon">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104940" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 reference (C)/<br />rs9923231 reference (C)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">-1639 GG</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of the VKORC1 rs9923231 CC genotype (-1639 GG genotype) on phenprocoumon.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for phenprocoumon in patients with the VKORC1 rs9923231 CC genotype (-1639 GG genotype).
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline phenytoin">
          <h3 id="phenytoin">phenytoin</h3>



          
            <div class="alert alert-info Phenytoin-HLA-B-warning">The displayed recommendation for CYP2C9 and phenytoin is ONLY valid for non-carriers of the HLA-B*15:02 high-risk allele. PharmCAT Named Allele Matcher does not determine HLA status. CPIC guidance: Fos-/Phenytoin is contraindicated in individuals with the HLA-B*15:02 variant allele ("HLA-B*15:02-positive") due to significantly increased risk of fos-/phenytoin-induced cutaneous adverse reactions of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). In HLA-B*15:02 carriers, carbamazepine should not be used as an alternative. Alternative medications such as oxcarbazepine, eslicarbazepine acetate, and lamotrigine have some evidence linking SJS/TEN with the HLA-B*15:02 allele, and thus caution should be used in choosing alternatives to phenytoin.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-phenytoin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166122806" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>PHT naive</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C9"><dt>CYP2C9:</dt><dd>2.0</dd></div><div class="rx-activity rx-activity--HLA-B"><dt>HLA-B:</dt><dd>N/A</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C9: Normal phenytoin metabolism</li><li>HLA-B: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          No adjustments needed from typical dosing strategies. Subsequent doses should be adjusted according to therapeutic drug monitoring, response, and side effects. An HLA-B*15:02 negative test does not eliminate the risk of phenytoin-induced SJS/TEN and patients should be carefully monitored according to a usual standard.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                    <tr class="top-aligned cpic-guideline-phenytoin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166122806" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>PHT use >3mos</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C9"><dt>CYP2C9:</dt><dd>2.0</dd></div><div class="rx-activity rx-activity--HLA-B"><dt>HLA-B:</dt><dd>N/A</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C9: Normal phenytoin metabolism</li><li>HLA-B: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          No adjustments needed from typical dosing strategies. Subsequent doses should be adjusted according to therapeutic drug monitoring, response, and side effects. An HLA-B*15:02 negative test does not eliminate the risk of phenytoin-induced SJS/TEN and patients should be carefully monitored according to a usual standard.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-phenytoin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104984" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on phenytoin.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for phenytoin in normal metabolizers.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
                  
                
              
            
              
                <tr class="top-aligned fda-label-phenytoin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104860" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>;<br /><span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-phenytoin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329583" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329584" target="_blank" rel="noopener noreferrer">2</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206662" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:25099164</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831382" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:32779747</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=008762" target="_blank" rel="noopener noreferrer">Drugs@FDA Drug Product: DILANTIN (phenytoin), NDA008762, Upjohn</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline piroxicam">
          <h3 id="piroxicam">piroxicam</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-piroxicam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166192321" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Normal metabolism</td>
                        <td class="drugRecommendation">
                          Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-piroxicam">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166105222" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-piroxicam">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329586" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080882" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=018147" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Feldene (piroxicam), NDA018147, Pfizer Laboratories Div Pfizer Inc</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pitavastatin">
          <h3 id="pitavastatin">pitavastatin</h3>



          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-pitavastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166262261" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">
                          Prescribe desired starting dose and adjust doses based on disease-specific guidelines.
<h4 id="other-considerations">Other Considerations</h4>
The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035072" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pravastatin">
          <h3 id="pravastatin">pravastatin</h3>



          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-pravastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166262281" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">
                          Prescribe desired starting dose and adjust doses based on disease-specific guidelines.
<h4 id="other-considerations">Other Considerations</h4>
The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035072" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline primaquine">
          <h3 id="primaquine">primaquine</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-primaquine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166279621" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-primaquine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104876" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#G6PD">G6PD</a>:B (reference)/B (reference)</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=008316" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Primaquine Phosphate (Primaquine Phosphate), NDA008316, PD-Rx Pharmaceuticals, Inc.</a></li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline quetiapine">
          <h3 id="quetiapine">quetiapine</h3>



          
            <div class="alert alert-info CYP3A4">The CYP3A4 alleles are determined based on PharmVar CYP3A4 allele definitions. See PharmCAT disclaimer for further information.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-quetiapine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166265421" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP3A4">CYP3A4</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on quetiapine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for quetiapine in normal metabolizers.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923774" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.</a> <i>European journal of human genetics : EJHG</i>. 2024. PMID:37002327</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline rabeprazole">
          <h3 id="rabeprazole">rabeprazole</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned fda-assoc-rabeprazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329657" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Demonstrate a Potential Impact on Pharmacokinetic Properties Only]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations.&quot;
                          <a href="#rx-ast-rabeprazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-rabeprazole">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline rasburicase">
          <h3 id="rasburicase">rasburicase</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-rasburicase">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166119846" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-rasburicase">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166151881" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#G6PD">G6PD</a>:B (reference)/B (reference)</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111801" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24787449</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=103946" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Elitek (rasburicase), BLA103946, sanofi-aventis U.S. LLC</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline rosuvastatin">
          <h3 id="rosuvastatin">rosuvastatin</h3>



          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-rosuvastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166262321" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#ABCG2">ABCG2</a>:<br />rs2231142 reference (G)/<br />rs2231142 reference (G)</span>;<br /><span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--ABCG2"><dt>ABCG2:</dt><dd>Normal Function</dd></div><div class="rx-phenotype rx-phenotype--SLCO1B1"><dt>SLCO1B1:</dt><dd>Normal Function</dd></div></dl>
                        
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>ABCG2: Typical myopathy risk and rosuvastatin exposure</li><li>SLCO1B1: Typical myopathy risk and statin exposure</li></ul></td>
                        <td class="drugRecommendation">
                          Prescribe desired starting dose and adjust doses of rosuvastatin based on disease-specific and specific population guidelines.
<h4 id="other-considerations">Other Considerations</h4>
The potential for drug-drug interactions and dose limits based on renal and hepatic function and Asian ancestry should be evaluated prior to initiating rosuvastatin.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-assoc-rosuvastatin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329660" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035072" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sertraline">
          <h3 id="sertraline">sertraline</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-sertraline">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166127639" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2B6">CYP2B6</a>:*1/*6</span>;<br /><span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CYP2B6"><dt>CYP2B6:</dt><dd>Intermediate Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--CYP2C19"><dt>CYP2C19:</dt><dd>Poor Metabolizer</dd></div></dl>
                        
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2B6: Reduced metabolism of sertraline to less active compounds when compared to CYP2B6 normal metabolizers.</li><li>CYP2C19: Greatly reduced metabolism of sertraline to less active compounds when compared to CYP2C19 normal metabolizers. Higher plasma concentrations may increase the probability of side effects.</li></ul></td>
                        <td class="drugRecommendation">
                          Consider a lower starting dose, slower titration schedule and 50% reduction of standard maintenance dose as compared to CYP2C19 normal metabolizers or select a clinically appropriate alternative antidepressant not predominantly metabolized by CYP2C19.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-sertraline">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104980" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The risk of side effects is increased. The gene variation leads to increased plasma concentrations of sertraline.</td>
                        <td class="drugRecommendation">
                          Do not give doses exceeding 75 mg/day. Guide the dose by response and side effects and/or sertraline plasma concentration.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512908" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.</a> <i>Clinical pharmacology and therapeutics</i>. 2015. PMID:25974703</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34782755" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34782755</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sevoflurane">
          <h3 id="sevoflurane">sevoflurane</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-sevoflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166303941" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td>These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</td>
                        <td class="drugRecommendation">
                          Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-sevoflurane">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166129519" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Alternate Drug</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;CONTRAINDICATIONS: Known or suspected genetic susceptibility to malignant hyperthermia...ULTANE [sevoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.
                          <a href="#rx-ast-sevoflurane" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-sevoflurane">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513720" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30499100</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020478" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Ultane (Sevoflurane), NDA020478, AbbVie Inc.</a></li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline simvastatin">
          <h3 id="simvastatin">simvastatin</h3>



          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-simvastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166105005" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">
                          Prescribe desired starting dose and adjust doses based on disease-specific guidelines.
<h4 id="other-considerations">Other Considerations</h4>
The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-simvastatin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182844" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Function</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of the SLCO1B1 521 TT genotype on simvastatin.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for atorvastatin in patients with the <em>SLCO1B1</em> 521 TT genotype.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-assoc-simvastatin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329621" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#SLCO1B1">SLCO1B1</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384438" target="_blank" rel="noopener noreferrer">The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.</a> <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169720" target="_blank" rel="noopener noreferrer">The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035072" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline siponimod">
          <h3 id="siponimod">siponimod</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-siponimod">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166211021" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on siponimod.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for siponimod in normal metabolizers.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-siponimod">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166182738" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          The MAYZENT (siponimod) label states: &quot;Recommended Dosage in Patients With CYP2C9 Genotypes *1/*1, *1/*2, or *2/*2&quot; &quot;Initiate MAYZENT with a 5-day titration, as shown in Table 1... A starter pack should be used for patients who will be titrated to the 2-mg maintenance dosage&quot; &quot;After treatment titration (see Treatment Initiation), the recommended maintenance dosage of MAYZENT is 2 mg taken orally once daily starting on Day 6.&quot; See label for more information.
                          <a href="#rx-ast-siponimod" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-assoc-siponimod">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329590" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-siponimod">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=209884" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product MAYZENT (siponimod), NDA209884, Novartis Pharmaceuticals Corporation</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline succinylcholine">
          <h3 id="succinylcholine">succinylcholine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-succinylcholine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166303941" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td>These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</td>
                        <td class="drugRecommendation">
                          Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-succinylcholine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166122970" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:Reference/<br />Reference</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CACNA1S"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd></div><div class="rx-phenotype rx-phenotype--RYR1"><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></div></dl>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;ANECTINE [succinylcholine] is contraindicated in patients with...[k]nown or suspected genetic susceptibility to malignant hyperthermia...Anectine [succinylcholine] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants...Succinylcholine is metabolized by plasma cholinesterase and should be used with caution, if at all, in patients known to be or suspected of being homozygous for the atypical plasma cholinesterase gene [BCHE] .&quot; See label for more information.
                          <a href="#rx-ast-succinylcholine" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-succinylcholine">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513720" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30499100</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=008453" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Anectine (Succinylcholine Chloride), NDA008453, Sandoz Inc</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tacrolimus">
          <h3 id="tacrolimus">tacrolimus</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-tacrolimus">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166124619" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP3A5">CYP3A5</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP3A5: Lower dose-adjusted trough concentrations of tacrolimus and decreased chance of achieving target tacrolimus concentrations.</td>
                        <td class="drugRecommendation">
                          Increase starting dose 1.5 to 2 times recommended starting dose. Total starting dose should not exceed 0.3 mg/kg/day. Use therapeutic drug monitoring to guide dose adjustments.
<h4 id="other-considerations">Other Considerations</h4>
This recommendation includes the use of tacrolimus in kidney, heart, lung and hematopoietic stem cell transplant patients, and liver transplant patients where the donor and recipient genotypes are identical. Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors (e.g., medication interactions, or hepatic function). Typically with other CYP enzymes, a normal metabolizer would be classified as having normal metabolism, and therefore, the drug dose would not change based on the patient’s genotype. However, in the case of CYP3A5 and tacrolimus, a CYP3A5 expresser (i.e., CYP3A5 normal metabolizer or intermediate metabolizer) would require a higher recommended starting dose, and the CYP3A5 non-expresser (i.e., poor metabolizer) would require the standard recommended starting dose.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-tacrolimus">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104983" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP3A5">CYP3A5</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>An increase of the initial dose can result in an increased chance of reaching a tacrolimus concentration within the target range before the start of therapeutic drug monitoring. However, there is no direct evidence that this results in improved clinical results. The genetic variation results in an increased conversion of tacrolimus to inactive metabolites and therefore a higher required dose.</td>
                        <td class="drugRecommendation">
                          LIVER TRANSPLANTATION
In addition to the patient’s genotype, the metabolism of tacrolimus is also determined by the genotype of the transplanted liver.
LIVER is also of the genotype HOMOZYGOUS EXPRESSOR: Use 2.5 times the normal initial dose. Adjustment of the dose should then be based on therapeutic drug monitoring.
LIVER has a DIFFERENT genotype: There is insufficient evidence in the literature to support a dose recommendation.
OTHER TRANSPLANTATION
Use 2.5 times the initial dose that would yield the desired result in non-expressers. Adjustment of the dose should then be based on therapeutic drug monitoring. For example: One Dutch study found a median trough concentration for tacrolimus after three days of 9.4 ng/mL at an initial dose of 0.15 mg/kg twice daily for 5 homozygous kidney transplant patients. Their target value was 10 - 15 ng/mL.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-tacrolimus">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329592" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]</a></b>
                        </p>
                        <p>Affected subgroup: CYP3A5 intermediate or normal metabolizers</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP3A5">CYP3A5</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in lower systemic concentrations, lower probability of achieving target concentrations and may result in higher rejection risk. Measure drug concentrations and adjust dosage based on trough whole blood tacrolimus concentrations.&quot;
                          <a href="#rx-ast-tacrolimus" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-tacrolimus">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481158" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2015. PMID:25801146</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tafenoquine">
          <h3 id="tafenoquine">tafenoquine</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-tafenoquine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166119846" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
<h4 id="other-considerations">Other Considerations</h4>
Tafenoquine’s safety has been established for a G6PD enzyme activity ≥70% of normal. (Inclusion criteria for clinical trials involving tafenoquine included G6PD activity ≥70%.)
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-tafenoquine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166182739" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotype</div>
                      <span class="rx-unmatched-dip"><a href="#G6PD">G6PD</a>:B (reference)/B (reference)</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111801" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24787449</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=210607" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product Arakoda (Tafenoquine), NDA210607, 60 Degrees Pharmaceuticals, LLC</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tegafur">
          <h3 id="tegafur">tegafur</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-tegafur">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104944" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:Reference/<br />Reference</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">2.0 (Normal Metabolizer)</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a DPYD activity score of 2 on tegafur.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for tegafur in patients with a DPYD activity score of 2.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/31745289" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.</a> <i>European journal of human genetics : EJHG</i>. 2019. PMID:31745289</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tenoxicam">
          <h3 id="tenoxicam">tenoxicam</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-tenoxicam">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166192341" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p class="rx-activity">2.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Normal metabolism</td>
                        <td class="drugRecommendation">
                          Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080882" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline thioguanine">
          <h3 id="thioguanine">thioguanine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-thioguanine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104965" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--NUDT15"><dt>NUDT15:</dt><dd>Normal Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--TPMT"><dt>TPMT:</dt><dd>Normal Metabolizer</dd></div></dl>
                        
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>NUDT15: Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression</li><li>TPMT: Lower concentrations of TGN metabolites, but note that TGN after thioguanine are 5-10X higher than TGN after mercaptopurine or azathioprine. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.</li></ul></td>
                        <td class="drugRecommendation">
                          Start with normal starting dose (e.g., 40-60 mg/m2/day) and adjust doses of thioguanine and of other myelosuppressive therapy without any special emphasis on thioguanine. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11037857).
<h4 id="other-considerations">Other Considerations</h4>
Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-thioguanine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184612" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on thioguanine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for thioguanine in normal metabolizers
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-guideline-thioguanine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104960" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on thioguanine.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for thioguanine in normal metabolizers.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-label-thioguanine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA Label Annotation</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/labelAnnotation/PA166104838" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA Label Annotation provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
              
                <tr class="top-aligned fda-assoc-thioguanine">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329594" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098761" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21270794</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604643" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23422873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576267" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30447069</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=012429" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product TABLOID (thioguanine), NDA012429, Aspen Global Inc.</a></li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline toluidine_blue">
          <h3 id="toluidine_blue">toluidine blue</h3>



          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-toluidine_blue">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166119846" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">
                          No reason to avoid based on G6PD status
<h4 id="other-considerations">Other Considerations</h4>
Toluidine blue classification strength is based on extrapolation from methylene blue data
                          
                        </td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111801" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24787449</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline trimipramine">
          <h3 id="trimipramine">trimipramine</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-trimipramine">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166105001" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>general</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>;<br /><span class="rx-dip">CYP2D6:Not called - no variant data provided</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><div class="rx-phenotype rx-phenotype--CYP2C19"><dt>CYP2C19:</dt><dd>Poor Metabolizer</dd></div><div class="rx-phenotype rx-phenotype--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C19"><dt>CYP2C19:</dt><dd>N/A</dd></div><div class="rx-activity rx-activity--CYP2D6"><dt>CYP2D6:</dt><dd>No Result</dd></div></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Greatly reduced metabolism of tertiary amines compared to normal metabolizers; Decreased conversion of tertiary amines to secondary amines may affect response or side effects</li><li>CYP2D6: n/a</li></ul></td>
                        <td class="drugRecommendation">
                          Avoid tertiary amine use due to potential for sub-optimal response. Consider alternative drug not metabolized by CYP2C19. TCAs without major CYP2C19 metabolism include the secondary amines nortriptyline and desipramine. For tertiary amines, consider a 50% reduction of the recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects.
<h4 id="other-considerations">Other Considerations</h4>
Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.
                          
                        </td>
                        <td>Optional</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689226" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478479" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:27997040</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline voriconazole">
          <h3 id="voriconazole">voriconazole</h3>



          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-voriconazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166161537" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>adults</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Higher dose-adjusted trough concentrations of voriconazole and may increase probability of adverse events</td>
                        <td class="drugRecommendation">
                          Choose an alternative agent that is not dependent on CYP2C19 metabolism as primary therapy in lieu of voriconazole. Such agents include isavuconazole, liposomal amphotericin B, and posaconazole. In the event that voriconazole is considered to be the most appropriate agent, based on clinical advice, for a patient with poor metabolizer genotype, voriconazole should be administered at a preferably lower than standard dosage with careful therapeutic drug monitoring.
<h4 id="other-considerations">Other Considerations</h4>
Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                    <tr class="top-aligned cpic-guideline-voriconazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166161537" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>pediatrics</p>
                        
                          <div class="tag">Alternate Drug</div>
<div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Higher dose-adjusted trough concentrations of voriconazole and may increase probability of adverse events</td>
                        <td class="drugRecommendation">
                          Choose an alternative agent that is not dependent on CYP2C19 metabolism as primary therapy in lieu of voriconazole. Such agents include liposomal amphotericin B and posaconazole. In the event that voriconazole is considered to be the most appropriate agent, based on clinical advice, for a patient with poor metabolizer genotype, voriconazole should be administered at a preferably lower than standard dosage with careful therapeutic drug monitoring.
<h4 id="other-considerations">Other Considerations</h4>
Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities. Recommendation based upon data extrapolated from adults.
                          
                        </td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-voriconazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104990" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The gene variation can reduce the conversion of voriconazole and consequently increase the plasma concentration. This could result in improved efficacy or an increase in the risk of side effects. Initially, the risk of side effects is of particular interest.</td>
                        <td class="drugRecommendation">
                          Use 50% of the standard dose and monitor the plasma concentration.
                          
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-assoc-voriconazole">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329626" target="_blank">FDA PGx Association [Pharmacogenetic Associations for which the Data Indicate a Potential Impact on Safety or Response]</a></b>
                        </p>
                        <p>Affected subgroup: CYP2C19 intermediate or poor metabolizers</p>
                        
                          <div class="tag">Other Guidance</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*2/*2</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          &quot;Results in higher systemic concentrations and may result in higher adverse reaction risk.&quot;
                          <a href="#rx-ast-voriconazole" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-voriconazole">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474211" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:27981572</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline warfarin">
          <h3 id="warfarin">warfarin</h3>



          
            <div class="alert alert-info pcat-cpic-warfarin-1-flowchart">Please follow the flow chart in figure 2 of the <a href="https://www.pharmgkb.org/guideline/PA166104949">CPIC warfarin guideline</a> to determine the appropriate dosing recommendation.</div>
          
            <div class="alert alert-info pcat-cpic-warfarin-2-vkorc1">The CPIC warfarin guideline only considers a single SNV in VKORC1 (rs9923231), which has varying frequency among different ancestral populations, and largely explains the differences in average dose requirements between people of European, African, and Asian descents. While other functional variants in VKORC1 have been associated with warfarin resistance (high dose requirements), there are currently no CPIC recommendations for how to use these other variants in warfarin dosing. An alternate name for rs9923231 is -1639G>A (note that VKORC1 is on the negative chromosomal strand, so displayed alleles are complemented). </div>
          

          <table>
            <thead>
            <tr>
              <th>Source</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-guideline-warfarin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104949" target="_blank">CPIC Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>N/A</p>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#CYP4F2">CYP4F2</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 reference (C)/<br />rs9923231 reference (C)</span>;<br /><span class="rx-hl-var">rs12777823:G/G</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td colspan="4">
                          
                          <div class="warfarinFlowchart">
                            <img src="https://files.cpicpgx.org/images/warfarin/warfarin_recommendation_diagram.png"
                                alt="Figure 2 from the CPIC guideline for warfarin"/>
                          </div>
                        </td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-guideline-warfarin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182842" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of a normal metabolizer phenotype on warfarin.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for warfarin in normal metabolizers.
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-guideline-warfarin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182841" target="_blank">DPWG Guideline Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag noAction">No Action</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 reference (C)/<br />rs9923231 reference (C)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">-1639 GG</p>
                        
                        
                      </td>
                    
                        <td>The guideline does not provide a description of the impact of the VKORC1 rs9923231 CC genotype (-1639 GG genotype) on warfarin.</td>
                        <td class="drugRecommendation">
                          The guideline does not provide a recommendation for warfarin in patients with the VKORC1 rs9923231 CC genotype (-1639 GG genotype).
                          
                        </td>
                        <td>No recommendation</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned fda-label-warfarin">
                      <td>
                        <p>
                          <b><a href="https://www.pharmgkb.org/labelAnnotation/PA166104776" target="_blank">FDA Label Annotation</a></b>
                        </p>
                        <p>Population:<br/>Unspecified</p>
                        
                          <div class="tag">Dosing Info</div>
                        
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 reference (C)/<br />rs9923231 reference (C)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p class="rx-phenotype">Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><div class="rx-activity rx-activity--CYP2C9"><dt>CYP2C9:</dt><dd>2.0</dd></div><div class="rx-activity rx-activity--VKORC1"><dt>VKORC1:</dt><dd>N/A</dd></div></dl>
                        
                      </td>
                    
                        <td></td>
                        <td class="drugRecommendation">
                          Table 1 in the drug label provides ranges of expected maintenance daily doses of warfarin (COUMADIN) based on CYP2C9*2, CYP2C9*3 and VKORC1−1639G&gt;A (rs9923231) genotypes. For CYP2C9*1/*1, VKORC1 GG (rs9923231CC), the range of expected maintenance daily dose is 5-7 mg.
                          <a href="#rx-ast-warfarin" style="text-decoration: none">&ast;</a>
                        </td>
                        <td>Unspecified</td>
                    
                  
                
              
            
              
                <tr class="top-aligned fda-assoc-warfarin">
                  <td class="top-aligned">
                    <p>
                      <b>FDA PGx Association</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329600" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/fdaPgxAssociations#PA166329602" target="_blank" rel="noopener noreferrer">2</a>
                        </sup>
                      
                    </p>
                  </td>
                  
                    <td class="top-aligned">
                      <div class="hint">Genotypes</div>
                      <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*1/*1</span>;<br /><span class="rx-unmatched-dip"><a href="#VKORC1">VKORC1</a>:rs9923231 reference (C)/rs9923231 reference (C)</span>
                      
                      
                    </td>
                    <td colspan="4" class="top-aligned">
                      <div class="hint">&nbsp;</div>
                      FDA PGx Association provides no genotype-based recommendations for this genotype, after evaluating the evidence.
                    </td>
                  
                </tr>
              
            
            </tbody>
          </table>

          
          
          
            <div class="footnote" id="rx-ast-warfarin">
              <sup>&ast;</sup> Text in quotation is taken directly from the FDA Label or FDA PGx Association table. For
              a label PDF with highlighted PGx content use the link in the Source column or go to
              <a href="https://www.pharmgkb.org/fda">PharmGKB</a>.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187550" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21900891</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546947" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:28198005</li>
                
                  <li><a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=009218" target="_blank" rel="noopener noreferrer">Drugs@FDA: Drug Product COUMADIN (warfarin sodium), NDA009218, Bristol-Myers Squibb Pharma Company</a>.</li>
                
                  <li><a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations" target="_blank" rel="noopener noreferrer">FDA Table of Pharmacogenetic Associations</a>.</li>
                
              </ul>
            </div>
          
        </section>
      
    

    
      <div>
        <h3>Drugs With No Guidance</h3>
        <p>The following drugs are known to be associated with the given genes but have no guidance for their genotypes.</p>
        <ul>
          
            <li>Ascorbic acid (vitamin C), combinations</li>
          
            <li>Ascorbic acid (vitamin C), plain</li>
          
            <li>articaine / epinephrine</li>
          
            <li>avatrombopag</li>
          
            <li>belinostat</li>
          
            <li>bupivacaine</li>
          
            <li>ceftriaxone</li>
          
            <li>chloroquine</li>
          
            <li>chlorpropamide</li>
          
            <li>dabrafenib</li>
          
            <li>dolutegravir</li>
          
            <li>dronabinol</li>
          
            <li>elagolix</li>
          
            <li>erdafitinib</li>
          
            <li>flutamide</li>
          
            <li>glimepiride</li>
          
            <li>glipizide</li>
          
            <li>glyburide</li>
          
            <li>hydroxychloroquine</li>
          
            <li>lesinurad</li>
          
            <li>lidocaine / prilocaine</li>
          
            <li>lidocaine and tetracaine</li>
          
            <li>mepivacaine</li>
          
            <li>moviprep</li>
          
            <li>nalidixic acid</li>
          
            <li>nateglinide</li>
          
            <li>nilotinib</li>
          
            <li>oxymetazoline and tetracaine</li>
          
            <li>pazopanib</li>
          
            <li>peginterferon alfa-2a</li>
          
            <li>peginterferon alfa-2b</li>
          
            <li>raltegravir</li>
          
            <li>ribavirin</li>
          
            <li>sacituzumab govitecan</li>
          
            <li>sodium ascorbate</li>
          
            <li>sodium nitrite</li>
          
            <li>sulfasalazine</li>
          
            <li>tolazamide</li>
          
            <li>tolbutamide</li>
          
        </ul>
      </div>
    
  </section>


  <section id="section-iii">
    <h2>Section III: Allele Matching Details</h2>

    
      <ol>
        
          <li><a href="#ABCG2">ABCG2 allele match data</a></li>
        
          <li><a href="#CACNA1S">CACNA1S allele match data</a></li>
        
          <li><a href="#CFTR">CFTR allele match data</a></li>
        
          <li><a href="#CYP2B6">CYP2B6 allele match data</a></li>
        
          <li><a href="#CYP2C19">CYP2C19 allele match data</a></li>
        
          <li><a href="#CYP2C9">CYP2C9 allele match data</a></li>
        
          <li><a href="#CYP3A4">CYP3A4 allele match data</a></li>
        
          <li><a href="#CYP3A5">CYP3A5 allele match data</a></li>
        
          <li><a href="#CYP4F2">CYP4F2 allele match data</a></li>
        
          <li><a href="#DPYD">DPYD allele match data</a></li>
        
          <li><a href="#G6PD">G6PD allele match data</a></li>
        
          <li><a href="#IFNL3_4">IFNL3/4 allele match data</a></li>
        
          <li><a href="#NUDT15">NUDT15 allele match data</a></li>
        
          <li><a href="#RYR1">RYR1 allele match data</a></li>
        
          <li><a href="#SLCO1B1">SLCO1B1 allele match data</a></li>
        
          <li><a href="#TPMT">TPMT allele match data</a></li>
        
          <li><a href="#UGT1A1">UGT1A1 allele match data</a></li>
        
          <li><a href="#VKORC1">VKORC1 allele match data</a></li>
        
      </ol>
    
    
      <p class="noGeneData">No data provided for <span class="gene cyp2d6"><span class="no-data">CYP2D6</span></span>.</p>
    


    
      <section class="gene ABCG2">
        <h3 id="ABCG2">ABCG2 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Variant Matched:</th>
              <td class="top-aligned genotype-result">
                
                  rs2231142 reference (G)/rs2231142 reference (G)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr4_88131171" style="vertical-align: initial;">
                  <td>chr4:88131171</td>
                  <td id="rs2231142">rs2231142</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>rs2231142 variant (T) - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CACNA1S">
        <h3 id="CACNA1S">CACNA1S allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Variant Matched:</th>
              <td class="top-aligned genotype-result">
                
                  Reference/Reference
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The CACNA1S Reference allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr1_201060815" style="vertical-align: initial;">
                  <td>chr1:201060815</td>
                  <td id="rs1800559">rs1800559</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3257G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_201091993" style="vertical-align: initial;">
                  <td>chr1:201091993</td>
                  <td id="rs772226819">rs772226819</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.520C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CFTR">
        <h3 id="CFTR">CFTR allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Variant Matched:</th>
              <td class="top-aligned genotype-result">
                
                  Reference/Reference
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr7_117509035" style="vertical-align: initial;">
                  <td>chr7:117509035</td>
                  <td id="rs397508256">rs397508256</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>E56K - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117509069" style="vertical-align: initial;">
                  <td>chr7:117509069</td>
                  <td id="rs368505753">rs368505753</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>P67L - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117509089" style="vertical-align: initial;">
                  <td>chr7:117509089</td>
                  <td id="rs115545701">rs115545701</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>R74W - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117530953" style="vertical-align: initial;">
                  <td>chr7:117530953</td>
                  <td id="rs113993958">rs113993958</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>D110H - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117530955" style="vertical-align: initial;">
                  <td>chr7:117530955</td>
                  <td id="rs397508537">rs397508537</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>D110E - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117530974" style="vertical-align: initial;">
                  <td>chr7:117530974</td>
                  <td id="rs77834169">rs77834169</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>R117C - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117530975" style="vertical-align: initial;">
                  <td>chr7:117530975</td>
                  <td id="rs78655421">rs78655421</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>R117H - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117534318" style="vertical-align: initial;">
                  <td>chr7:117534318</td>
                  <td id="rs80282562">rs80282562</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>G178R - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117534363" style="vertical-align: initial;">
                  <td>chr7:117534363</td>
                  <td id="rs397508759">rs397508759</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>E193K - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117534368" style="vertical-align: initial;">
                  <td>chr7:117534368</td>
                  <td id="rs397508761">rs397508761</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>711+3A->G - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117535285" style="vertical-align: initial;">
                  <td>chr7:117535285</td>
                  <td id="rs121908752">rs121908752</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>L206W - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117540270" style="vertical-align: initial;">
                  <td>chr7:117540270</td>
                  <td id="rs77932196">rs77932196</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>R347H - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117540285" style="vertical-align: initial;">
                  <td>chr7:117540285</td>
                  <td id="rs121908753">rs121908753</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>R352Q - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117548795" style="vertical-align: initial;">
                  <td>chr7:117548795</td>
                  <td id="rs74551128">rs74551128</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>A455E - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117587799" style="vertical-align: initial;">
                  <td>chr7:117587799</td>
                  <td id="rs121908757">rs121908757</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S549R(A>C) - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117587800" style="vertical-align: initial;">
                  <td>chr7:117587800</td>
                  <td id="rs121908755">rs121908755</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S549N - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117587801" style="vertical-align: initial;">
                  <td>chr7:117587801</td>
                  <td id="rs121909005">rs121909005</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S549R(T>G) - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117587805" style="vertical-align: initial;">
                  <td>chr7:117587805</td>
                  <td id="rs121909013">rs121909013</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>G551S - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117587806" style="vertical-align: initial;">
                  <td>chr7:117587806</td>
                  <td id="rs75527207">rs75527207</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>G551D - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117590409" style="vertical-align: initial;">
                  <td>chr7:117590409</td>
                  <td id="rs397508288">rs397508288</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>D579G - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117594930" style="vertical-align: initial;">
                  <td>chr7:117594930</td>
                  <td id="rs397508387">rs397508387</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>E831X - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117602868" style="vertical-align: initial;">
                  <td>chr7:117602868</td>
                  <td id="rs80224560">rs80224560</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>2789+5G->A - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117603708" style="vertical-align: initial;">
                  <td>chr7:117603708</td>
                  <td id="rs397508442">rs397508442</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S945L - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117606695" style="vertical-align: initial;">
                  <td>chr7:117606695</td>
                  <td id="rs141033578">rs141033578</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S977F - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611555" style="vertical-align: initial;">
                  <td>chr7:117611555</td>
                  <td id="rs76151804">rs76151804</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>3272-26A->G - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611595" style="vertical-align: initial;">
                  <td>chr7:117611595</td>
                  <td id="rs150212784">rs150212784</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>F1052V - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611620" style="vertical-align: initial;">
                  <td>chr7:117611620</td>
                  <td id="rs397508513">rs397508513</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>K1060T - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611640" style="vertical-align: initial;">
                  <td>chr7:117611640</td>
                  <td id="rs121909020">rs121909020</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>A1067T - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611646" style="vertical-align: initial;">
                  <td>chr7:117611646</td>
                  <td id="rs200321110">rs200321110</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>G1069R - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611649" style="vertical-align: initial;">
                  <td>chr7:117611649</td>
                  <td id="rs202179988">rs202179988</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>R1070W - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611650" style="vertical-align: initial;">
                  <td>chr7:117611650</td>
                  <td id="rs78769542">rs78769542</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>R1070Q - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117611663" style="vertical-align: initial;">
                  <td>chr7:117611663</td>
                  <td id="rs186045772">rs186045772</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>F1074L - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117614699" style="vertical-align: initial;">
                  <td>chr7:117614699</td>
                  <td id="rs75541969">rs75541969</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>D1152H - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117639961" style="vertical-align: initial;">
                  <td>chr7:117639961</td>
                  <td id="rs75039782">rs75039782</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>3849+10kbC->T - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117642451" style="vertical-align: initial;">
                  <td>chr7:117642451</td>
                  <td id="rs267606723">rs267606723</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>G1244E - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117642472" style="vertical-align: initial;">
                  <td>chr7:117642472</td>
                  <td id="rs74503330">rs74503330</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S1251N - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117642483" style="vertical-align: initial;">
                  <td>chr7:117642483</td>
                  <td id="rs121909041">rs121909041</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S1255P - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117642528" style="vertical-align: initial;">
                  <td>chr7:117642528</td>
                  <td id="rs11971167">rs11971167</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>D1270N - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_117664770" style="vertical-align: initial;">
                  <td>chr7:117664770</td>
                  <td id="rs193922525">rs193922525</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>G1349D - ivacaftor responsive</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP2B6">
        <h3 id="CYP2B6">CYP2B6 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*6
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning CYP2B6-1-6-warning">The assigned genotype is *1/*6; however, *4/*9 cannot be ruled out without phased data.</div>
        
          <div class="alert alert-warning reference-allele">The CYP2B6 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr19_40991224" style="vertical-align: initial;">
                  <td>chr19:40991224</td>
                  <td id="rs34223104">rs34223104</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*22 - Uncertain function</li>
                        
                          <li>*34 - Decreased function</li>
                        
                          <li>*35 - Uncertain function</li>
                        
                          <li>*36 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_40991367" style="vertical-align: initial;">
                  <td>chr19:40991367</td>
                  <td id="rs34883432">rs34883432</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*10 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_40991369" style="vertical-align: initial;">
                  <td>chr19:40991369</td>
                  <td id="rs8192709">rs8192709</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - Normal function</li>
                        
                          <li>*10 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_40991381" style="vertical-align: initial;">
                  <td>chr19:40991381</td>
                  <td id="rs33973337">rs33973337</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_40991388" style="vertical-align: initial;">
                  <td>chr19:40991388</td>
                  <td id="rs33980385">rs33980385</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_40991390" style="vertical-align: initial;">
                  <td>chr19:40991390</td>
                  <td id="rs33926104">rs33926104</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_40991391" style="vertical-align: initial;">
                  <td>chr19:40991391</td>
                  <td id="rs34284776">rs34284776</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_40991441" style="vertical-align: initial;">
                  <td>chr19:40991441</td>
                  <td id="rs35303484">rs35303484</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*11 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004015" style="vertical-align: initial;">
                  <td>chr19:41004015</td>
                  <td id="rs281864907">rs281864907</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*38 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004125" style="vertical-align: initial;">
                  <td>chr19:41004125</td>
                  <td id="rs36060847">rs36060847</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*12 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004133" style="vertical-align: initial;">
                  <td>chr19:41004133</td>
                  <td id="rs148009906">rs148009906</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*44 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004158" style="vertical-align: initial;">
                  <td>chr19:41004158</td>
                  <td id="rs186335453">rs186335453</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*35 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004303" style="vertical-align: initial;">
                  <td>chr19:41004303</td>
                  <td id="rs139801276">rs139801276</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*35 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004377" style="vertical-align: initial;">
                  <td>chr19:41004377</td>
                  <td id="rs12721655">rs12721655</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - No function</li>
                        
                          <li>*13 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004380" style="vertical-align: initial;">
                  <td>chr19:41004380</td>
                  <td id="rs535039125">rs535039125</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*39 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004381" style="vertical-align: initial;">
                  <td>chr19:41004381</td>
                  <td id="rs35773040">rs35773040</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*14 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41004406" style="vertical-align: initial;">
                  <td>chr19:41004406</td>
                  <td id="rs145884402">rs145884402</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*35 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41006919" style="vertical-align: initial;">
                  <td>chr19:41006919</td>
                  <td id="rs3826711">rs3826711</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*26 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41006923" style="vertical-align: initial;">
                  <td>chr19:41006923</td>
                  <td id="rs36056539">rs36056539</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*20 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41006936" style="vertical-align: initial;">
                  <td>chr19:41006936</td>
                  <td id="rs3745274">rs3745274</td>
                  
                  
                    <td class="nonwild">G/T</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - Decreased function</li>
                        
                          <li>*7 - Decreased function</li>
                        
                          <li>*9 - Decreased function</li>
                        
                          <li>*13 - No function</li>
                        
                          <li>*19 - Decreased function</li>
                        
                          <li>*20 - Decreased function</li>
                        
                          <li>*26 - Decreased function</li>
                        
                          <li>*34 - Decreased function</li>
                        
                          <li>*36 - Decreased function</li>
                        
                          <li>*37 - Decreased function</li>
                        
                          <li>*38 - No function</li>
                        
                          <li>*39 - Decreased function</li>
                        
                          <li>*40 - Decreased function</li>
                        
                          <li>*41 - Decreased function</li>
                        
                          <li>*42 - Decreased function</li>
                        
                          <li>*43 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41006967" style="vertical-align: initial;">
                  <td>chr19:41006967</td>
                  <td id="rs58871670">rs58871670</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*45 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41006968" style="vertical-align: initial;">
                  <td>chr19:41006968</td>
                  <td id="rs373489637">rs373489637</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*37 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41007013" style="vertical-align: initial;">
                  <td>chr19:41007013</td>
                  <td id="rs36079186">rs36079186</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*27 - Uncertain function</li>
                        
                          <li>*35 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41009313" style="vertical-align: initial;">
                  <td>chr19:41009313</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*46 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41009350" style="vertical-align: initial;">
                  <td>chr19:41009350</td>
                  <td id="rs45482602">rs45482602</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41009358" style="vertical-align: initial;">
                  <td>chr19:41009358</td>
                  <td id="rs2279343">rs2279343</td>
                  
                  
                    <td class="nonwild">A/G</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*4 - Increased function</li>
                        
                          <li>*6 - Decreased function</li>
                        
                          <li>*7 - Decreased function</li>
                        
                          <li>*13 - No function</li>
                        
                          <li>*18 - No function</li>
                        
                          <li>*19 - Decreased function</li>
                        
                          <li>*20 - Decreased function</li>
                        
                          <li>*26 - Decreased function</li>
                        
                          <li>*34 - Decreased function</li>
                        
                          <li>*36 - Decreased function</li>
                        
                          <li>*37 - Decreased function</li>
                        
                          <li>*38 - No function</li>
                        
                          <li>*39 - Decreased function</li>
                        
                          <li>*40 - Decreased function</li>
                        
                          <li>*41 - Decreased function</li>
                        
                          <li>*42 - Decreased function</li>
                        
                          <li>*43 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41010006" style="vertical-align: initial;">
                  <td>chr19:41010006</td>
                  <td id="rs139029625">rs139029625</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*35 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41010088" style="vertical-align: initial;">
                  <td>chr19:41010088</td>
                  <td id="rs34698757">rs34698757</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*28 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41010108" style="vertical-align: initial;">
                  <td>chr19:41010108</td>
                  <td id="rs193922917">rs193922917</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*31 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012316" style="vertical-align: initial;">
                  <td>chr19:41012316</td>
                  <td id="rs28399499">rs28399499</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*18 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012339" style="vertical-align: initial;">
                  <td>chr19:41012339</td>
                  <td id="rs34826503">rs34826503</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*19 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012393" style="vertical-align: initial;">
                  <td>chr19:41012393</td>
                  <td id="rs754621576">rs754621576</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*47 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012394" style="vertical-align: initial;">
                  <td>chr19:41012394</td>
                  <td id="rs780991919">rs780991919</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*47 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012465" style="vertical-align: initial;">
                  <td>chr19:41012465</td>
                  <td id="rs34097093">rs34097093</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*28 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012466" style="vertical-align: initial;">
                  <td>chr19:41012466</td>
                  <td id="rs200458614">rs200458614</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*40 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012471" style="vertical-align: initial;">
                  <td>chr19:41012471</td>
                  <td id="rs201500445">rs201500445</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*41 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012478" style="vertical-align: initial;">
                  <td>chr19:41012478</td>
                  <td id="rs200238771">rs200238771</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*48 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012693" style="vertical-align: initial;">
                  <td>chr19:41012693</td>
                  <td id="rs35979566">rs35979566</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*15 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012740" style="vertical-align: initial;">
                  <td>chr19:41012740</td>
                  <td id="rs193922918">rs193922918</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*32 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41012803" style="vertical-align: initial;">
                  <td>chr19:41012803</td>
                  <td id="rs35010098">rs35010098</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*21 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41016652" style="vertical-align: initial;">
                  <td>chr19:41016652</td>
                  <td id="rs764288403">rs764288403</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*49 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41016679" style="vertical-align: initial;">
                  <td>chr19:41016679</td>
                  <td id="rs374099483">rs374099483</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*42 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41016726" style="vertical-align: initial;">
                  <td>chr19:41016726</td>
                  <td id="rs3211369">rs3211369</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*23 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41016741" style="vertical-align: initial;">
                  <td>chr19:41016741</td>
                  <td id="rs117872433">rs117872433</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*43 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41016778" style="vertical-align: initial;">
                  <td>chr19:41016778</td>
                  <td id="rs564083989">rs564083989</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*24 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41016805" style="vertical-align: initial;">
                  <td>chr19:41016805</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*25 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_41016810" style="vertical-align: initial;">
                  <td>chr19:41016810</td>
                  <td id="rs3211371">rs3211371</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*5 - Normal function</li>
                        
                          <li>*7 - Decreased function</li>
                        
                          <li>*33 - Uncertain function</li>
                        
                          <li>*34 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP2C19">
        <h3 id="CYP2C19">CYP2C19 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *2/*2
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr10_94761900" style="vertical-align: initial;">
                  <td>chr10:94761900</td>
                  <td id="rs12248560">rs12248560</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*4 - No function</li>
                        
                          <li>*17 - Increased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94762706" style="vertical-align: initial;">
                  <td>chr10:94762706</td>
                  <td id="rs28399504">rs28399504</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*4 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94762712" style="vertical-align: initial;">
                  <td>chr10:94762712</td>
                  <td id="rs367543002">rs367543002</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*34 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94762715" style="vertical-align: initial;">
                  <td>chr10:94762715</td>
                  <td id="rs367543003">rs367543003</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*34 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94762755" style="vertical-align: initial;">
                  <td>chr10:94762755</td>
                  <td id="rs55752064">rs55752064</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*14 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94762760" style="vertical-align: initial;">
                  <td>chr10:94762760</td>
                  <td id="rs17882687">rs17882687</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*15 - Normal function</li>
                        
                          <li>*28 - Normal function</li>
                        
                          <li>*35 - No function</li>
                        
                          <li>*39 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94762788" style="vertical-align: initial;">
                  <td>chr10:94762788</td>
                  <td id="rs1564656981">rs1564656981</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*29 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94762856" style="vertical-align: initial;">
                  <td>chr10:94762856</td>
                  <td id="rs1564657013">rs1564657013</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*19 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775106" style="vertical-align: initial;">
                  <td>chr10:94775106</td>
                  <td id="rs145328984">rs145328984</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*30 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775121" style="vertical-align: initial;">
                  <td>chr10:94775121</td>
                  <td id="rs1564660997">rs1564660997</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*31 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775160" style="vertical-align: initial;">
                  <td>chr10:94775160</td>
                  <td id="rs118203756">rs118203756</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*23 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775185" style="vertical-align: initial;">
                  <td>chr10:94775185</td>
                  <td id="rs1288601658">rs1288601658</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*32 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775367" style="vertical-align: initial;">
                  <td>chr10:94775367</td>
                  <td id="rs12769205">rs12769205</td>
                  
                  
                    <td class="nonwild">G/G</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*2 - No function</li>
                        
                          <li>*35 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775416" style="vertical-align: initial;">
                  <td>chr10:94775416</td>
                  <td id="rs41291556">rs41291556</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*8 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775423" style="vertical-align: initial;">
                  <td>chr10:94775423</td>
                  <td id="rs17885179">rs17885179</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*39 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775453" style="vertical-align: initial;">
                  <td>chr10:94775453</td>
                  <td id="rs72552267">rs72552267</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*6 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775489" style="vertical-align: initial;">
                  <td>chr10:94775489</td>
                  <td id="rs17884712">rs17884712</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*9 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94775507" style="vertical-align: initial;">
                  <td>chr10:94775507</td>
                  <td id="rs58973490">rs58973490</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*2 - No function</li>
                        
                          <li>*11 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94780574" style="vertical-align: initial;">
                  <td>chr10:94780574</td>
                  <td id="rs140278421">rs140278421</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*22 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94780579" style="vertical-align: initial;">
                  <td>chr10:94780579</td>
                  <td id="rs370803989">rs370803989</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*33 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94780653" style="vertical-align: initial;">
                  <td>chr10:94780653</td>
                  <td id="rs4986893">rs4986893</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*3 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94781858" style="vertical-align: initial;">
                  <td>chr10:94781858</td>
                  <td id="rs6413438">rs6413438</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*10 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94781859" style="vertical-align: initial;">
                  <td>chr10:94781859</td>
                  <td id="rs4244285">rs4244285</td>
                  
                  
                    <td class="nonwild">A/A</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*2 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94781944" style="vertical-align: initial;">
                  <td>chr10:94781944</td>
                  <td id="rs375781227">rs375781227</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*26 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94781999" style="vertical-align: initial;">
                  <td>chr10:94781999</td>
                  <td id="rs72558186">rs72558186</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*7 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94842861" style="vertical-align: initial;">
                  <td>chr10:94842861</td>
                  <td id="rs138142612">rs138142612</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*18 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94842866" style="vertical-align: initial;">
                  <td>chr10:94842866</td>
                  <td id="rs3758581">rs3758581</td>
                  
                  
                    <td class="nonwild">G/G</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*1 - Normal function</li>
                        
                          <li>*2 - No function</li>
                        
                          <li>*3 - No function</li>
                        
                          <li>*4 - No function</li>
                        
                          <li>*5 - No function</li>
                        
                          <li>*6 - No function</li>
                        
                          <li>*7 - No function</li>
                        
                          <li>*8 - No function</li>
                        
                          <li>*9 - Decreased function</li>
                        
                          <li>*10 - Decreased function</li>
                        
                          <li>*11 - Normal function</li>
                        
                          <li>*12 - Uncertain function</li>
                        
                          <li>*13 - Normal function</li>
                        
                          <li>*14 - Uncertain function</li>
                        
                          <li>*15 - Normal function</li>
                        
                          <li>*17 - Increased function</li>
                        
                          <li>*18 - Normal function</li>
                        
                          <li>*19 - Decreased function</li>
                        
                          <li>*22 - No function</li>
                        
                          <li>*23 - Uncertain function</li>
                        
                          <li>*24 - No function</li>
                        
                          <li>*25 - Decreased function</li>
                        
                          <li>*26 - Decreased function</li>
                        
                          <li>*28 - Normal function</li>
                        
                          <li>*29 - Uncertain function</li>
                        
                          <li>*31 - Uncertain function</li>
                        
                          <li>*32 - Uncertain function</li>
                        
                          <li>*33 - Uncertain function</li>
                        
                          <li>*35 - No function</li>
                        
                          <li>*39 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94842879" style="vertical-align: initial;">
                  <td>chr10:94842879</td>
                  <td id="rs118203757">rs118203757</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*24 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94842995" style="vertical-align: initial;">
                  <td>chr10:94842995</td>
                  <td id="rs113934938">rs113934938</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*28 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94849995" style="vertical-align: initial;">
                  <td>chr10:94849995</td>
                  <td id="rs17879685">rs17879685</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*13 - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94852738" style="vertical-align: initial;">
                  <td>chr10:94852738</td>
                  <td id="rs56337013">rs56337013</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*5 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94852765" style="vertical-align: initial;">
                  <td>chr10:94852765</td>
                  <td id="rs192154563">rs192154563</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*16 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94852785" style="vertical-align: initial;">
                  <td>chr10:94852785</td>
                  <td id="rs118203759">rs118203759</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*25 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94852914" style="vertical-align: initial;">
                  <td>chr10:94852914</td>
                  <td id="rs55640102">rs55640102</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          
                        
                          <li>*12 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP2C9">
        <h3 id="CYP2C9">CYP2C9 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The CYP2C9 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr10_94938683" style="vertical-align: initial;">
                  <td>chr10:94938683</td>
                  <td id="rs114071557">rs114071557</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*36 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94938719" style="vertical-align: initial;">
                  <td>chr10:94938719</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*80 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94938737" style="vertical-align: initial;">
                  <td>chr10:94938737</td>
                  <td id="rs67807361">rs67807361</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*7 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94938771" style="vertical-align: initial;">
                  <td>chr10:94938771</td>
                  <td id="rs142240658">rs142240658</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*21 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94938788" style="vertical-align: initial;">
                  <td>chr10:94938788</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*83 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94938800" style="vertical-align: initial;">
                  <td>chr10:94938800</td>
                  <td id="rs1364419386">rs1364419386</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*76 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94938803" style="vertical-align: initial;">
                  <td>chr10:94938803</td>
                  <td id="rs2031308986">rs2031308986</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*22 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94938828" style="vertical-align: initial;">
                  <td>chr10:94938828</td>
                  <td id="rs564813580">rs564813580</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*37 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94941897" style="vertical-align: initial;">
                  <td>chr10:94941897</td>
                  <td id="rs371055887">rs371055887</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*20 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94941915" style="vertical-align: initial;">
                  <td>chr10:94941915</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*23 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94941958" style="vertical-align: initial;">
                  <td>chr10:94941958</td>
                  <td id="rs72558187">rs72558187</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*13 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94941975" style="vertical-align: initial;">
                  <td>chr10:94941975</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*77 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94941976" style="vertical-align: initial;">
                  <td>chr10:94941976</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*38 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94941982" style="vertical-align: initial;">
                  <td>chr10:94941982</td>
                  <td id="rs762239445">rs762239445</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*39 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942018" style="vertical-align: initial;">
                  <td>chr10:94942018</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*40 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942205" style="vertical-align: initial;">
                  <td>chr10:94942205</td>
                  <td id="rs1304490498">rs1304490498</td>
                  
                  
                    <td class="">CAATGGAAA<br />GA/<br />CAATGGAAA<br />GA</td>
                  
                  <td>
                    CAATGGAAA<br />GA
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*25 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942216" style="vertical-align: initial;">
                  <td>chr10:94942216</td>
                  <td id="rs774607211">rs774607211</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*41 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942230" style="vertical-align: initial;">
                  <td>chr10:94942230</td>
                  <td id="rs767576260">rs767576260</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*43 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942231" style="vertical-align: initial;">
                  <td>chr10:94942231</td>
                  <td id="rs12414460">rs12414460</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*42 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942233" style="vertical-align: initial;">
                  <td>chr10:94942233</td>
                  <td id="rs375805362">rs375805362</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*62 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942234" style="vertical-align: initial;">
                  <td>chr10:94942234</td>
                  <td id="rs72558189">rs72558189</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*14 - Activity Value 0.5 (Decreased function)</li>
                        
                          <li>*35 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942243" style="vertical-align: initial;">
                  <td>chr10:94942243</td>
                  <td id="rs1375956433">rs1375956433</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*78 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942249" style="vertical-align: initial;">
                  <td>chr10:94942249</td>
                  <td id="rs200965026">rs200965026</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*26 - Activity Value 0.5 (Decreased function)</li>
                        
                          <li>*44 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942254" style="vertical-align: initial;">
                  <td>chr10:94942254</td>
                  <td id="rs199523631">rs199523631</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*45 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942255" style="vertical-align: initial;">
                  <td>chr10:94942255</td>
                  <td id="rs200183364">rs200183364</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*33 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942290" style="vertical-align: initial;">
                  <td>chr10:94942290</td>
                  <td id="rs1799853">rs1799853</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - Activity Value 0.5 (Decreased function)</li>
                        
                          <li>*35 - Activity Value 0.0 (No function)</li>
                        
                          <li>*61 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942291" style="vertical-align: initial;">
                  <td>chr10:94942291</td>
                  <td id="rs141489852">rs141489852</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*63 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942305" style="vertical-align: initial;">
                  <td>chr10:94942305</td>
                  <td id="rs754487195">rs754487195</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*46 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942306" style="vertical-align: initial;">
                  <td>chr10:94942306</td>
                  <td id="rs1289704600">rs1289704600</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*72 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942308" style="vertical-align: initial;">
                  <td>chr10:94942308</td>
                  <td id="rs17847037">rs17847037</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*73 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94942309" style="vertical-align: initial;">
                  <td>chr10:94942309</td>
                  <td id="rs7900194">rs7900194</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - Activity Value 0.5 (Decreased function)</li>
                        
                          <li>*27 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94947782" style="vertical-align: initial;">
                  <td>chr10:94947782</td>
                  <td id="rs72558190">rs72558190</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*15 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94947785" style="vertical-align: initial;">
                  <td>chr10:94947785</td>
                  <td id="rs774550549">rs774550549</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*47 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94947869" style="vertical-align: initial;">
                  <td>chr10:94947869</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*69 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94947907" style="vertical-align: initial;">
                  <td>chr10:94947907</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*57 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94947917" style="vertical-align: initial;">
                  <td>chr10:94947917</td>
                  <td id="rs1326630788">rs1326630788</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*48 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94947938" style="vertical-align: initial;">
                  <td>chr10:94947938</td>
                  <td id="rs2031531005">rs2031531005</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*28 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94947939" style="vertical-align: initial;">
                  <td>chr10:94947939</td>
                  <td id="rs370100007">rs370100007</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*74 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94949129" style="vertical-align: initial;">
                  <td>chr10:94949129</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*49 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94949144" style="vertical-align: initial;">
                  <td>chr10:94949144</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*50 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94949145" style="vertical-align: initial;">
                  <td>chr10:94949145</td>
                  <td id="rs772782449">rs772782449</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*82 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94949161" style="vertical-align: initial;">
                  <td>chr10:94949161</td>
                  <td ></td>
                  
                  
                    <td class="">AT/AT</td>
                  
                  <td>
                    AT
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*85 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94949217" style="vertical-align: initial;">
                  <td>chr10:94949217</td>
                  <td id="rs2256871">rs2256871</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*9 - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94949280" style="vertical-align: initial;">
                  <td>chr10:94949280</td>
                  <td id="rs9332130">rs9332130</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*10 - Uncertain function</li>
                        
                          <li>*71 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94949281" style="vertical-align: initial;">
                  <td>chr10:94949281</td>
                  <td id="rs9332131">rs9332131</td>
                  
                  
                    <td class="">GA/GA</td>
                  
                  <td>
                    GA
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94972119" style="vertical-align: initial;">
                  <td>chr10:94972119</td>
                  <td id="rs182132442">rs182132442</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*29 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94972123" style="vertical-align: initial;">
                  <td>chr10:94972123</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*64 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94972134" style="vertical-align: initial;">
                  <td>chr10:94972134</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*51 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94972179" style="vertical-align: initial;">
                  <td>chr10:94972179</td>
                  <td id="rs72558192">rs72558192</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*16 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94972180" style="vertical-align: initial;">
                  <td>chr10:94972180</td>
                  <td id="rs988617574">rs988617574</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*52 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94972183" style="vertical-align: initial;">
                  <td>chr10:94972183</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*81 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94972233" style="vertical-align: initial;">
                  <td>chr10:94972233</td>
                  <td id="rs1237225311">rs1237225311</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*53 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981199" style="vertical-align: initial;">
                  <td>chr10:94981199</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*65 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981201" style="vertical-align: initial;">
                  <td>chr10:94981201</td>
                  <td id="rs57505750">rs57505750</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*31 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981224" style="vertical-align: initial;">
                  <td>chr10:94981224</td>
                  <td id="rs28371685">rs28371685</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*11 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981225" style="vertical-align: initial;">
                  <td>chr10:94981225</td>
                  <td id="rs367826293">rs367826293</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*34 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981230" style="vertical-align: initial;">
                  <td>chr10:94981230</td>
                  <td id="rs1274535931">rs1274535931</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*58 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981250" style="vertical-align: initial;">
                  <td>chr10:94981250</td>
                  <td id="rs750820937">rs750820937</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*54 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981258" style="vertical-align: initial;">
                  <td>chr10:94981258</td>
                  <td id="rs1297714792">rs1297714792</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*79 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981281" style="vertical-align: initial;">
                  <td>chr10:94981281</td>
                  <td id="rs749060448">rs749060448</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*24 - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981296" style="vertical-align: initial;">
                  <td>chr10:94981296</td>
                  <td id="rs1057910">rs1057910</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3 - Activity Value 0.0 (No function)</li>
                        
                          <li>*18 - Uncertain function</li>
                        
                          <li>*68 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981297" style="vertical-align: initial;">
                  <td>chr10:94981297</td>
                  <td id="rs56165452">rs56165452</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*4 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981301" style="vertical-align: initial;">
                  <td>chr10:94981301</td>
                  <td id="rs28371686">rs28371686</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*5 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981302" style="vertical-align: initial;">
                  <td>chr10:94981302</td>
                  <td id="rs1250577724">rs1250577724</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*55 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981305" style="vertical-align: initial;">
                  <td>chr10:94981305</td>
                  <td id="rs578144976">rs578144976</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*66 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981365" style="vertical-align: initial;">
                  <td>chr10:94981365</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94981371" style="vertical-align: initial;">
                  <td>chr10:94981371</td>
                  <td id="rs542577750">rs542577750</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*68 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94986042" style="vertical-align: initial;">
                  <td>chr10:94986042</td>
                  <td id="rs764211126">rs764211126</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*56 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94986073" style="vertical-align: initial;">
                  <td>chr10:94986073</td>
                  <td id="rs72558193">rs72558193</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*18 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94986136" style="vertical-align: initial;">
                  <td>chr10:94986136</td>
                  <td id="rs1254213342">rs1254213342</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*75 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94986174" style="vertical-align: initial;">
                  <td>chr10:94986174</td>
                  <td id="rs1441296358">rs1441296358</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*84 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94988852" style="vertical-align: initial;">
                  <td>chr10:94988852</td>
                  <td id="rs776908257">rs776908257</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*67 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94988855" style="vertical-align: initial;">
                  <td>chr10:94988855</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*59 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94988880" style="vertical-align: initial;">
                  <td>chr10:94988880</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*70 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94988917" style="vertical-align: initial;">
                  <td>chr10:94988917</td>
                  <td id="rs769942899">rs769942899</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*19 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94988925" style="vertical-align: initial;">
                  <td>chr10:94988925</td>
                  <td id="rs202201137">rs202201137</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*61 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94988955" style="vertical-align: initial;">
                  <td>chr10:94988955</td>
                  <td id="rs767284820">rs767284820</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*60 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94988984" style="vertical-align: initial;">
                  <td>chr10:94988984</td>
                  <td id="rs781583846">rs781583846</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*30 - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94989020" style="vertical-align: initial;">
                  <td>chr10:94989020</td>
                  <td id="rs9332239">rs9332239</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*12 - Activity Value 0.5 (Decreased function)</li>
                        
                          <li>*71 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr10_94989023" style="vertical-align: initial;">
                  <td>chr10:94989023</td>
                  <td id="rs868182778">rs868182778</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*32 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          
            <h4>Other Positions of Interest</h4>
            
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr10_94645745">chr10:94645745</td>
                  <td id="rs12777823">rs12777823</td>
                  
                  
                    <td class="">G/G</td>
                  
                </tr>
              
              </tbody>
            </table>
          

        

      </section>
    
      <section class="gene CYP3A4">
        <h3 id="CYP3A4">CYP3A4 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning CYP3A4">The CYP3A4 alleles are determined based on PharmVar CYP3A4 allele definitions. See PharmCAT disclaimer for further information.</div>
        
          <div class="alert alert-warning reference-allele">The CYP3A4 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr7_99758183" style="vertical-align: initial;">
                  <td>chr7:99758183</td>
                  <td id="rs67666821">rs67666821</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*20 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99758228" style="vertical-align: initial;">
                  <td>chr7:99758228</td>
                  <td id="rs1584538410">rs1584538410</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*46 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99760836" style="vertical-align: initial;">
                  <td>chr7:99760836</td>
                  <td id="rs4986913">rs4986913</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*19 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99760901" style="vertical-align: initial;">
                  <td>chr7:99760901</td>
                  <td id="rs4986910">rs4986910</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3 - Unassigned</li>
                        
                          <li>*37 - Unassigned</li>
                        
                          <li>*38 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99760956" style="vertical-align: initial;">
                  <td>chr7:99760956</td>
                  <td id="rs774109750">rs774109750</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*34 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99762047" style="vertical-align: initial;">
                  <td>chr7:99762047</td>
                  <td id="rs4986909">rs4986909</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*13 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99762054" style="vertical-align: initial;">
                  <td>chr7:99762054</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*45 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99762069" style="vertical-align: initial;">
                  <td>chr7:99762069</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*47 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99762177" style="vertical-align: initial;">
                  <td>chr7:99762177</td>
                  <td id="rs12721629">rs12721629</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*12 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99762186" style="vertical-align: initial;">
                  <td>chr7:99762186</td>
                  <td id="rs756833413">rs756833413</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*33 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99762206" style="vertical-align: initial;">
                  <td>chr7:99762206</td>
                  <td id="rs67784355">rs67784355</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*11 - Decreased function</li>
                        
                          <li>*38 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99762234" style="vertical-align: initial;">
                  <td>chr7:99762234</td>
                  <td id="rs1318364992">rs1318364992</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*48 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99763877" style="vertical-align: initial;">
                  <td>chr7:99763877</td>
                  <td id="rs368296206">rs368296206</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*32 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99763909" style="vertical-align: initial;">
                  <td>chr7:99763909</td>
                  <td id="rs1303250043">rs1303250043</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*31 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99763925" style="vertical-align: initial;">
                  <td>chr7:99763925</td>
                  <td id="rs201821708">rs201821708</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*21 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99764003" style="vertical-align: initial;">
                  <td>chr7:99764003</td>
                  <td id="rs28371759">rs28371759</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*18 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99766411" style="vertical-align: initial;">
                  <td>chr7:99766411</td>
                  <td id="rs4646438">rs4646438</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99766424" style="vertical-align: initial;">
                  <td>chr7:99766424</td>
                  <td id="rs1429705359">rs1429705359</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*44 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99766439" style="vertical-align: initial;">
                  <td>chr7:99766439</td>
                  <td id="rs145582851">rs145582851</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*43 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99766440" style="vertical-align: initial;">
                  <td>chr7:99766440</td>
                  <td id="rs138105638">rs138105638</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*26 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99768360" style="vertical-align: initial;">
                  <td>chr7:99768360</td>
                  <td id="rs55785340">rs55785340</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99768371" style="vertical-align: initial;">
                  <td>chr7:99768371</td>
                  <td id="rs55901263">rs55901263</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*5 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99768424" style="vertical-align: initial;">
                  <td>chr7:99768424</td>
                  <td id="rs113667357">rs113667357</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*24 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99768447" style="vertical-align: initial;">
                  <td>chr7:99768447</td>
                  <td id="rs3208361">rs3208361</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*42 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99768458" style="vertical-align: initial;">
                  <td>chr7:99768458</td>
                  <td id="rs4987161">rs4987161</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99768470" style="vertical-align: initial;">
                  <td>chr7:99768470</td>
                  <td id="rs12721627">rs12721627</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*16 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99768693" style="vertical-align: initial;">
                  <td>chr7:99768693</td>
                  <td id="rs35599367">rs35599367</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*22 - Decreased function</li>
                        
                          <li>*37 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99769769" style="vertical-align: initial;">
                  <td>chr7:99769769</td>
                  <td id="rs4986908">rs4986908</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*10 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99769781" style="vertical-align: initial;">
                  <td>chr7:99769781</td>
                  <td id="rs72552798">rs72552798</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*9 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99769804" style="vertical-align: initial;">
                  <td>chr7:99769804</td>
                  <td id="rs4986907">rs4986907</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*15 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99769805" style="vertical-align: initial;">
                  <td>chr7:99769805</td>
                  <td id="rs57409622">rs57409622</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*23 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99770165" style="vertical-align: initial;">
                  <td>chr7:99770165</td>
                  <td id="rs72552799">rs72552799</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99770166" style="vertical-align: initial;">
                  <td>chr7:99770166</td>
                  <td id="rs778013004">rs778013004</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*30 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99770196" style="vertical-align: initial;">
                  <td>chr7:99770196</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*41 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99770202" style="vertical-align: initial;">
                  <td>chr7:99770202</td>
                  <td id="rs55951658">rs55951658</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*4 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99770217" style="vertical-align: initial;">
                  <td>chr7:99770217</td>
                  <td id="rs1449865051">rs1449865051</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*29 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99778079" style="vertical-align: initial;">
                  <td>chr7:99778079</td>
                  <td id="rs56324128">rs56324128</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*7 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99780036" style="vertical-align: initial;">
                  <td>chr7:99780036</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*40 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99784018" style="vertical-align: initial;">
                  <td>chr7:99784018</td>
                  <td id="rs570051168">rs570051168</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*28 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99784038" style="vertical-align: initial;">
                  <td>chr7:99784038</td>
                  <td id="rs12721634">rs12721634</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*14 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99784075" style="vertical-align: initial;">
                  <td>chr7:99784075</td>
                  <td id="rs188389063">rs188389063</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*35 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99784078" style="vertical-align: initial;">
                  <td>chr7:99784078</td>
                  <td id="rs1226205448">rs1226205448</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*39 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP3A5">
        <h3 id="CYP3A5">CYP3A5 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The CYP3A5 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr7_99652770" style="vertical-align: initial;">
                  <td>chr7:99652770</td>
                  <td id="rs41303343">rs41303343</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*7 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99660516" style="vertical-align: initial;">
                  <td>chr7:99660516</td>
                  <td id="rs28383479">rs28383479</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*9 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99665212" style="vertical-align: initial;">
                  <td>chr7:99665212</td>
                  <td id="rs10264272">rs10264272</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99672916" style="vertical-align: initial;">
                  <td>chr7:99672916</td>
                  <td id="rs776746">rs776746</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr7_99676198" style="vertical-align: initial;">
                  <td>chr7:99676198</td>
                  <td id="rs55817950">rs55817950</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP4F2">
        <h3 id="CYP4F2">CYP4F2 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The CYP4F2 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr19_15878779" style="vertical-align: initial;">
                  <td>chr19:15878779</td>
                  <td id="rs3093200">rs3093200</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*5 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15878920" style="vertical-align: initial;">
                  <td>chr19:15878920</td>
                  <td id="rs4020346">rs4020346</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15879412" style="vertical-align: initial;">
                  <td>chr19:15879412</td>
                  <td id="rs138971789">rs138971789</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*15 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15879621" style="vertical-align: initial;">
                  <td>chr19:15879621</td>
                  <td id="rs2108622">rs2108622</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3 - Unassigned</li>
                        
                          <li>*4 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15886018" style="vertical-align: initial;">
                  <td>chr19:15886018</td>
                  <td id="rs145174239">rs145174239</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*14 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15889671" style="vertical-align: initial;">
                  <td>chr19:15889671</td>
                  <td id="rs144233412">rs144233412</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*13 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15890405" style="vertical-align: initial;">
                  <td>chr19:15890405</td>
                  <td id="rs3093153">rs3093153</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15892541" style="vertical-align: initial;">
                  <td>chr19:15892541</td>
                  <td id="rs145875499">rs145875499</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*12 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15895527" style="vertical-align: initial;">
                  <td>chr19:15895527</td>
                  <td id="rs114396708">rs114396708</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*11 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15895560" style="vertical-align: initial;">
                  <td>chr19:15895560</td>
                  <td id="rs144455532">rs144455532</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*10 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15897466" style="vertical-align: initial;">
                  <td>chr19:15897466</td>
                  <td id="rs201380574">rs201380574</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*9 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15897473" style="vertical-align: initial;">
                  <td>chr19:15897473</td>
                  <td id="rs115517770">rs115517770</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15897566" style="vertical-align: initial;">
                  <td>chr19:15897566</td>
                  <td id="rs114099324">rs114099324</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*7 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_15897578" style="vertical-align: initial;">
                  <td>chr19:15897578</td>
                  <td id="rs3093105">rs3093105</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - Unassigned</li>
                        
                          <li>*4 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene DPYD">
        <h3 id="DPYD">DPYD allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  Reference/Reference
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning DPYD-lowest-activity-score-note">The two lowest activity values (variant activity scores, see CPIC guideline <a href="https://pubmed.ncbi.nlm.nih.gov/29152729" target="_blank" rel="noopener noreferrer">PMID:29152729</a>) are used for unphased data and the lowest activity value per allele is used for phased data to determine the gene activity score and phenotype to retrieve prescribing recommendations. </div>
        
          <div class="alert alert-warning reference-allele">The DPYD Reference allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr1_97078987" style="vertical-align: initial;">
                  <td>chr1:97078987</td>
                  <td id="rs114096998">rs114096998</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3067C>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97078993" style="vertical-align: initial;">
                  <td>chr1:97078993</td>
                  <td id="rs148799944">rs148799944</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3061G>C - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97079005" style="vertical-align: initial;">
                  <td>chr1:97079005</td>
                  <td id="rs140114515">rs140114515</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3049G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97079071" style="vertical-align: initial;">
                  <td>chr1:97079071</td>
                  <td id="rs1801268">rs1801268</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2983G>T (*10) - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97079076" style="vertical-align: initial;">
                  <td>chr1:97079076</td>
                  <td id="rs139459586">rs139459586</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2978T>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97079077" style="vertical-align: initial;">
                  <td>chr1:97079077</td>
                  <td id="rs202144771">rs202144771</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2977C>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97079121" style="vertical-align: initial;">
                  <td>chr1:97079121</td>
                  <td id="rs72547601">rs72547601</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2933A>G - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97079133" style="vertical-align: initial;">
                  <td>chr1:97079133</td>
                  <td id="rs72547602">rs72547602</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2921A>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97079139" style="vertical-align: initial;">
                  <td>chr1:97079139</td>
                  <td id="rs145529148">rs145529148</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2915A>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97082365" style="vertical-align: initial;">
                  <td>chr1:97082365</td>
                  <td id="rs141044036">rs141044036</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2872A>G - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97082391" style="vertical-align: initial;">
                  <td>chr1:97082391</td>
                  <td id="rs67376798">rs67376798</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2846A>T - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97098598" style="vertical-align: initial;">
                  <td>chr1:97098598</td>
                  <td id="rs1801267">rs1801267</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2657G>A (*9B) - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97098599" style="vertical-align: initial;">
                  <td>chr1:97098599</td>
                  <td id="rs147545709">rs147545709</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2656C>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97098616" style="vertical-align: initial;">
                  <td>chr1:97098616</td>
                  <td id="rs55674432">rs55674432</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2639G>T - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97098632" style="vertical-align: initial;">
                  <td>chr1:97098632</td>
                  <td id="rs201035051">rs201035051</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2623A>C - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97193109" style="vertical-align: initial;">
                  <td>chr1:97193109</td>
                  <td id="rs60139309">rs60139309</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2582A>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97193209" style="vertical-align: initial;">
                  <td>chr1:97193209</td>
                  <td id="rs200687447">rs200687447</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2482G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97234958" style="vertical-align: initial;">
                  <td>chr1:97234958</td>
                  <td id="rs199634007">rs199634007</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2336C>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97234991" style="vertical-align: initial;">
                  <td>chr1:97234991</td>
                  <td id="rs56005131">rs56005131</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2303C>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97305279" style="vertical-align: initial;">
                  <td>chr1:97305279</td>
                  <td id="rs112766203">rs112766203</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2279C>T - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97305363" style="vertical-align: initial;">
                  <td>chr1:97305363</td>
                  <td id="rs60511679">rs60511679</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2195T>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97305364" style="vertical-align: initial;">
                  <td>chr1:97305364</td>
                  <td id="rs1801160">rs1801160</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2194G>A (*6) - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97305372" style="vertical-align: initial;">
                  <td>chr1:97305372</td>
                  <td id="rs146529561">rs146529561</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2186C>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97306195" style="vertical-align: initial;">
                  <td>chr1:97306195</td>
                  <td id="rs145548112">rs145548112</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2161G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97373598" style="vertical-align: initial;">
                  <td>chr1:97373598</td>
                  <td id="rs137999090">rs137999090</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2021G>A - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97373629" style="vertical-align: initial;">
                  <td>chr1:97373629</td>
                  <td id="rs138545885">rs138545885</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1990G>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97382461" style="vertical-align: initial;">
                  <td>chr1:97382461</td>
                  <td id="rs55971861">rs55971861</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1906A>C - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450058" style="vertical-align: initial;">
                  <td>chr1:97450058</td>
                  <td id="rs3918290">rs3918290</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1905+1G>A (*2A) - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450059" style="vertical-align: initial;">
                  <td>chr1:97450059</td>
                  <td id="rs3918289">rs3918289</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1905C>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450065" style="vertical-align: initial;">
                  <td>chr1:97450065</td>
                  <td id="rs72549303">rs72549303</td>
                  
                  
                    <td class="">TG/TG</td>
                  
                  <td>
                    TG
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1898delC (*3) - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450068" style="vertical-align: initial;">
                  <td>chr1:97450068</td>
                  <td id="rs17376848">rs17376848</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1896T>C - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450168" style="vertical-align: initial;">
                  <td>chr1:97450168</td>
                  <td id="rs147601618">rs147601618</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1796T>C - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450187" style="vertical-align: initial;">
                  <td>chr1:97450187</td>
                  <td id="rs145773863">rs145773863</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1777G>A - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450189" style="vertical-align: initial;">
                  <td>chr1:97450189</td>
                  <td id="rs138616379">rs138616379</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1775G>A - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97450190" style="vertical-align: initial;">
                  <td>chr1:97450190</td>
                  <td id="rs59086055">rs59086055</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1774C>T - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97515784" style="vertical-align: initial;">
                  <td>chr1:97515784</td>
                  <td id="rs201615754">rs201615754</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1682G>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97515787" style="vertical-align: initial;">
                  <td>chr1:97515787</td>
                  <td id="rs55886062">rs55886062</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1679T>G (*13) - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97515839" style="vertical-align: initial;">
                  <td>chr1:97515839</td>
                  <td id="rs1801159">rs1801159</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1627A>G (*5) - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97515851" style="vertical-align: initial;">
                  <td>chr1:97515851</td>
                  <td id="rs142619737">rs142619737</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1615G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97515865" style="vertical-align: initial;">
                  <td>chr1:97515865</td>
                  <td id="rs1801158">rs1801158</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1601G>A (*4) - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97515889" style="vertical-align: initial;">
                  <td>chr1:97515889</td>
                  <td id="rs190951787">rs190951787</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1577C>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97515923" style="vertical-align: initial;">
                  <td>chr1:97515923</td>
                  <td id="rs148994843">rs148994843</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1543G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97549565" style="vertical-align: initial;">
                  <td>chr1:97549565</td>
                  <td id="rs138391898">rs138391898</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1519G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97549600" style="vertical-align: initial;">
                  <td>chr1:97549600</td>
                  <td id="rs111858276">rs111858276</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1484A>G - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97549609" style="vertical-align: initial;">
                  <td>chr1:97549609</td>
                  <td id="rs72549304">rs72549304</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1475C>T - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97549681" style="vertical-align: initial;">
                  <td>chr1:97549681</td>
                  <td id="rs199549923">rs199549923</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1403C>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97549713" style="vertical-align: initial;">
                  <td>chr1:97549713</td>
                  <td id="rs57918000">rs57918000</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1371C>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97549726" style="vertical-align: initial;">
                  <td>chr1:97549726</td>
                  <td id="rs144395748">rs144395748</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1358C>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97549735" style="vertical-align: initial;">
                  <td>chr1:97549735</td>
                  <td id="rs72975710">rs72975710</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1349C>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573785" style="vertical-align: initial;">
                  <td>chr1:97573785</td>
                  <td id="rs186169810">rs186169810</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1314T>G - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573805" style="vertical-align: initial;">
                  <td>chr1:97573805</td>
                  <td id="rs142512579">rs142512579</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1294G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573821" style="vertical-align: initial;">
                  <td>chr1:97573821</td>
                  <td id="rs764666241">rs764666241</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1278G>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573839" style="vertical-align: initial;">
                  <td>chr1:97573839</td>
                  <td id="rs200064537">rs200064537</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1260T>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573863" style="vertical-align: initial;">
                  <td>chr1:97573863</td>
                  <td id="rs56038477">rs56038477</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1129-5923C>G, c.1236G>A (HapB3) - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573881" style="vertical-align: initial;">
                  <td>chr1:97573881</td>
                  <td id="rs61622928">rs61622928</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1218G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573918" style="vertical-align: initial;">
                  <td>chr1:97573918</td>
                  <td id="rs143815742">rs143815742</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1181G>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573919" style="vertical-align: initial;">
                  <td>chr1:97573919</td>
                  <td id="rs140602333">rs140602333</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1180C>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97573943" style="vertical-align: initial;">
                  <td>chr1:97573943</td>
                  <td id="rs78060119">rs78060119</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1156G>T (*12) - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97579893" style="vertical-align: initial;">
                  <td>chr1:97579893</td>
                  <td id="rs75017182">rs75017182</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1129-5923C>G - Activity Value 0.5 (Decreased function)</li>
                        
                          <li>c.1129-5923C>G, c.1236G>A (HapB3) - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97593238" style="vertical-align: initial;">
                  <td>chr1:97593238</td>
                  <td id="rs72549305">rs72549305</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1108A>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97593289" style="vertical-align: initial;">
                  <td>chr1:97593289</td>
                  <td id="rs143154602">rs143154602</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1057C>T - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97593322" style="vertical-align: initial;">
                  <td>chr1:97593322</td>
                  <td id="rs183385770">rs183385770</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1024G>A - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97593343" style="vertical-align: initial;">
                  <td>chr1:97593343</td>
                  <td id="rs72549306">rs72549306</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1003G>T (*11) - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97593379" style="vertical-align: initial;">
                  <td>chr1:97593379</td>
                  <td id="rs201018345">rs201018345</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.967G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97595083" style="vertical-align: initial;">
                  <td>chr1:97595083</td>
                  <td id="rs145112791">rs145112791</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.934C>T - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97595088" style="vertical-align: initial;">
                  <td>chr1:97595088</td>
                  <td id="rs150437414">rs150437414</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.929T>C - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97595149" style="vertical-align: initial;">
                  <td>chr1:97595149</td>
                  <td id="rs146356975">rs146356975</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.868A>G - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97679170" style="vertical-align: initial;">
                  <td>chr1:97679170</td>
                  <td id="rs45589337">rs45589337</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.775A>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97691776" style="vertical-align: initial;">
                  <td>chr1:97691776</td>
                  <td id="rs1801266">rs1801266</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.703C>T (*8) - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97699399" style="vertical-align: initial;">
                  <td>chr1:97699399</td>
                  <td id="rs72549307">rs72549307</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.632A>G - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97699430" style="vertical-align: initial;">
                  <td>chr1:97699430</td>
                  <td id="rs72549308">rs72549308</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.601A>C - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97699474" style="vertical-align: initial;">
                  <td>chr1:97699474</td>
                  <td id="rs115232898">rs115232898</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.557A>G - Activity Value 0.5 (Decreased function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97699506" style="vertical-align: initial;">
                  <td>chr1:97699506</td>
                  <td id="rs6670886">rs6670886</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.525G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97699533" style="vertical-align: initial;">
                  <td>chr1:97699533</td>
                  <td id="rs139834141">rs139834141</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.498G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97699535" style="vertical-align: initial;">
                  <td>chr1:97699535</td>
                  <td id="rs2297595">rs2297595</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.496A>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97721542" style="vertical-align: initial;">
                  <td>chr1:97721542</td>
                  <td id="rs200562975">rs200562975</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.451A>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97721650" style="vertical-align: initial;">
                  <td>chr1:97721650</td>
                  <td id="rs141462178">rs141462178</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.343A>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97740400" style="vertical-align: initial;">
                  <td>chr1:97740400</td>
                  <td id="rs150385342">rs150385342</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.313G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97740410" style="vertical-align: initial;">
                  <td>chr1:97740410</td>
                  <td id="rs72549309">rs72549309</td>
                  
                  
                    <td class="">GATGA/<br />GATGA</td>
                  
                  <td>
                    GATGA
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.295_298delTCAT (*7) - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97883329" style="vertical-align: initial;">
                  <td>chr1:97883329</td>
                  <td id="rs1801265">rs1801265</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.85T>C (*9A) - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97883352" style="vertical-align: initial;">
                  <td>chr1:97883352</td>
                  <td id="rs80081766">rs80081766</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.62G>A - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97883353" style="vertical-align: initial;">
                  <td>chr1:97883353</td>
                  <td id="rs72549310">rs72549310</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.61C>T - Activity Value 0.0 (No function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr1_97883368" style="vertical-align: initial;">
                  <td>chr1:97883368</td>
                  <td id="rs150036960">rs150036960</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.46C>G - Activity Value 1.0 (Normal function)</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene G6PD">
        <h3 id="G6PD">G6PD allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Variant Matched:</th>
              <td class="top-aligned genotype-result">
                
                  B (reference)/B (reference)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
        
          <div class="alert alert-warning reference-allele">The G6PD B (reference) allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chrX_154532046" style="vertical-align: initial;">
                  <td>chrX:154532046</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Bangkok Noi - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532055" style="vertical-align: initial;">
                  <td>chrX:154532055</td>
                  <td ></td>
                  
                  
                    <td class="">CTCT/CTCT</td>
                  
                  <td>
                    CTCT
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Brighton - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532082" style="vertical-align: initial;">
                  <td>chrX:154532082</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Arakawa - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532083" style="vertical-align: initial;">
                  <td>chrX:154532083</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Buenos Aires - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532085" style="vertical-align: initial;">
                  <td>chrX:154532085</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Campinas - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532086" style="vertical-align: initial;">
                  <td>chrX:154532086</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Fukaya - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532203" style="vertical-align: initial;">
                  <td>chrX:154532203</td>
                  <td id="rs137852348">rs137852348</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Split - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532231" style="vertical-align: initial;">
                  <td>chrX:154532231</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Laibin - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532245" style="vertical-align: initial;">
                  <td>chrX:154532245</td>
                  <td id="rs137852344">rs137852344</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Neapolis - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532257" style="vertical-align: initial;">
                  <td>chrX:154532257</td>
                  <td id="rs72554664">rs72554664</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Kaiping, Anant, Dhon, Sapporo-like, Wosera - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532258" style="vertical-align: initial;">
                  <td>chrX:154532258</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Flores - II/Deficient</li>
                        
                          <li>Kamiube, Keelung - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532264" style="vertical-align: initial;">
                  <td>chrX:154532264</td>
                  <td id="rs782608284">rs782608284</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Yunan - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532265" style="vertical-align: initial;">
                  <td>chrX:154532265</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Nice - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532269" style="vertical-align: initial;">
                  <td>chrX:154532269</td>
                  <td id="rs72554665">rs72554665</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Bangkok Noi - I/Deficient with CNSHA</li>
                        
                          <li>Canton, Taiwan-Hakka, Gifu-like, Agrigento-like - II/Deficient</li>
                        
                          <li>Cosenza - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532278" style="vertical-align: initial;">
                  <td>chrX:154532278</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Amiens - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532279" style="vertical-align: initial;">
                  <td>chrX:154532279</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Figuera da Foz - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532389" style="vertical-align: initial;">
                  <td>chrX:154532389</td>
                  <td id="rs137852324">rs137852324</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Andalus - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532390" style="vertical-align: initial;">
                  <td>chrX:154532390</td>
                  <td id="rs398123546">rs398123546</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Hermoupolis - II/Deficient</li>
                        
                          <li>Honiara - I/Deficient with CNSHA</li>
                        
                          <li>Union,Maewo, Chinese-2, Kalo - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532392" style="vertical-align: initial;">
                  <td>chrX:154532392</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Harima - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532403" style="vertical-align: initial;">
                  <td>chrX:154532403</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Cassano - II/Deficient</li>
                        
                          <li>Hermoupolis - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532408" style="vertical-align: initial;">
                  <td>chrX:154532408</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>S. Antioco - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532411" style="vertical-align: initial;">
                  <td>chrX:154532411</td>
                  <td id="rs137852317">rs137852317</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Santiago de Cuba, Morioka - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532432" style="vertical-align: initial;">
                  <td>chrX:154532432</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Telti, Kobe - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532434" style="vertical-align: initial;">
                  <td>chrX:154532434</td>
                  <td id="rs137852337">rs137852337</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Pawnee - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532458" style="vertical-align: initial;">
                  <td>chrX:154532458</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Sumare - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532459" style="vertical-align: initial;">
                  <td>chrX:154532459</td>
                  <td id="rs782098548">rs782098548</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Surabaya - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532570" style="vertical-align: initial;">
                  <td>chrX:154532570</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Georgia - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532590" style="vertical-align: initial;">
                  <td>chrX:154532590</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>202G>A_376A>G_1264C>G - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532608" style="vertical-align: initial;">
                  <td>chrX:154532608</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Tokyo, Fukushima - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532623" style="vertical-align: initial;">
                  <td>chrX:154532623</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Munich - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532625" style="vertical-align: initial;">
                  <td>chrX:154532625</td>
                  <td id="rs137852336">rs137852336</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Japan, Shinagawa - I/Deficient with CNSHA</li>
                        
                          <li>Kawasaki - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532626" style="vertical-align: initial;">
                  <td>chrX:154532626</td>
                  <td id="rs137852323">rs137852323</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Riverside - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532628" style="vertical-align: initial;">
                  <td>chrX:154532628</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Suwalki - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532629" style="vertical-align: initial;">
                  <td>chrX:154532629</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Utrecht - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532634" style="vertical-align: initial;">
                  <td>chrX:154532634</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Abeno - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532639" style="vertical-align: initial;">
                  <td>chrX:154532639</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Clinic - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532649" style="vertical-align: initial;">
                  <td>chrX:154532649</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Covao do Lobo - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532661" style="vertical-align: initial;">
                  <td>chrX:154532661</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Anadia - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532662" style="vertical-align: initial;">
                  <td>chrX:154532662</td>
                  <td id="rs137852325">rs137852325</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Puerto Limon - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532667" style="vertical-align: initial;">
                  <td>chrX:154532667</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Bari - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532674" style="vertical-align: initial;">
                  <td>chrX:154532674</td>
                  <td id="rs137852335">rs137852335</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Alhambra - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532676" style="vertical-align: initial;">
                  <td>chrX:154532676</td>
                  <td id="rs137852316">rs137852316</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Nashville, Anaheim, Portici - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532677" style="vertical-align: initial;">
                  <td>chrX:154532677</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Wisconsin - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532679" style="vertical-align: initial;">
                  <td>chrX:154532679</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Krakow - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532688" style="vertical-align: initial;">
                  <td>chrX:154532688</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Praha - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532692" style="vertical-align: initial;">
                  <td>chrX:154532692</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Hartford - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532694" style="vertical-align: initial;">
                  <td>chrX:154532694</td>
                  <td id="rs137852321">rs137852321</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Beverly Hills, Genova, Iwate, Niigata, Yamaguchi - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532695" style="vertical-align: initial;">
                  <td>chrX:154532695</td>
                  <td id="rs137852334">rs137852334</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Guadalajara - I/Deficient with CNSHA</li>
                        
                          <li>Mt Sinai - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532698" style="vertical-align: initial;">
                  <td>chrX:154532698</td>
                  <td id="rs137852320">rs137852320</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Iowa, Walter Reed, Springfield - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532699" style="vertical-align: initial;">
                  <td>chrX:154532699</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Madrid - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532700" style="vertical-align: initial;">
                  <td>chrX:154532700</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Lynwood - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532701" style="vertical-align: initial;">
                  <td>chrX:154532701</td>
                  <td id="rs137852322">rs137852322</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Tomah - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532713" style="vertical-align: initial;">
                  <td>chrX:154532713</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Olomouc - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532715" style="vertical-align: initial;">
                  <td>chrX:154532715</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Riley - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532716" style="vertical-align: initial;">
                  <td>chrX:154532716</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Calvo Mackenna - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532722" style="vertical-align: initial;">
                  <td>chrX:154532722</td>
                  <td id="rs371489738">rs371489738</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Montpellier - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532752" style="vertical-align: initial;">
                  <td>chrX:154532752</td>
                  <td ></td>
                  
                  
                    <td class="">CGGCCTTGC<br />GCTCGTTCA<br />G/<br />CGGCCTTGC<br />GCTCGTTCA<br />G</td>
                  
                  <td>
                    CGGCCTTGC<br />GCTCGTTCA<br />G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Tondela - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532758" style="vertical-align: initial;">
                  <td>chrX:154532758</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Tenri - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532765" style="vertical-align: initial;">
                  <td>chrX:154532765</td>
                  <td id="rs137852329">rs137852329</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Aachen - I/Deficient with CNSHA</li>
                        
                          <li>Loma Linda - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532772" style="vertical-align: initial;">
                  <td>chrX:154532772</td>
                  <td id="rs137852345">rs137852345</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Serres - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532773" style="vertical-align: initial;">
                  <td>chrX:154532773</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Iwatsuki - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532797" style="vertical-align: initial;">
                  <td>chrX:154532797</td>
                  <td id="rs137852333">rs137852333</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Ierapetra - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532802" style="vertical-align: initial;">
                  <td>chrX:154532802</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Partenope - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532945" style="vertical-align: initial;">
                  <td>chrX:154532945</td>
                  <td id="rs34193178">rs34193178</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Mira d'Aire - IV/Normal</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532956" style="vertical-align: initial;">
                  <td>chrX:154532956</td>
                  <td id="rs398123544">rs398123544</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Cincinnati - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532969" style="vertical-align: initial;">
                  <td>chrX:154532969</td>
                  <td id="rs137852342">rs137852342</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Chinese-5 - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532987" style="vertical-align: initial;">
                  <td>chrX:154532987</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Torun - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532989" style="vertical-align: initial;">
                  <td>chrX:154532989</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Fushan - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154532990" style="vertical-align: initial;">
                  <td>chrX:154532990</td>
                  <td id="rs5030869">rs5030869</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Chatham - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533004" style="vertical-align: initial;">
                  <td>chrX:154533004</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Insuli - IV/Normal</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533012" style="vertical-align: initial;">
                  <td>chrX:154533012</td>
                  <td ></td>
                  
                  
                    <td class="">CGTGGGGTC<br />GTCCAGGTA<br />CCCTTTG/<br />CGTGGGGTC<br />GTCCAGGTA<br />CCCTTTG</td>
                  
                  <td>
                    CGTGGGGTC<br />GTCCAGGTA<br />CCCTTTG
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Nara - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533016" style="vertical-align: initial;">
                  <td>chrX:154533016</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Farroupilha - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533025" style="vertical-align: initial;">
                  <td>chrX:154533025</td>
                  <td id="rs76723693">rs76723693</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>A- 968C_376G - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533029" style="vertical-align: initial;">
                  <td>chrX:154533029</td>
                  <td id="rs137852347">rs137852347</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Rehevot - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533031" style="vertical-align: initial;">
                  <td>chrX:154533031</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Manhattan - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533044" style="vertical-align: initial;">
                  <td>chrX:154533044</td>
                  <td id="rs137852339">rs137852339</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Kalyan-Kerala, Jamnaga, Rohini - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533064" style="vertical-align: initial;">
                  <td>chrX:154533064</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Ludhiana - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533072" style="vertical-align: initial;">
                  <td>chrX:154533072</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Omiya - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533077" style="vertical-align: initial;">
                  <td>chrX:154533077</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Seoul - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533083" style="vertical-align: initial;">
                  <td>chrX:154533083</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>West Virginia - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533122" style="vertical-align: initial;">
                  <td>chrX:154533122</td>
                  <td id="rs137852327">rs137852327</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Ananindeua - II/Deficient</li>
                        
                          <li>Hechi - II/Deficient</li>
                        
                          <li>Viangchan, Jammu - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533586" style="vertical-align: initial;">
                  <td>chrX:154533586</td>
                  <td id="rs74575103">rs74575103</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Montalbano - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533587" style="vertical-align: initial;">
                  <td>chrX:154533587</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Osaka - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533589" style="vertical-align: initial;">
                  <td>chrX:154533589</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Piotrkow - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533591" style="vertical-align: initial;">
                  <td>chrX:154533591</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Papua - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533592" style="vertical-align: initial;">
                  <td>chrX:154533592</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Mizushima - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533596" style="vertical-align: initial;">
                  <td>chrX:154533596</td>
                  <td id="rs137852318">rs137852318</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Bajo Maumere - III/Deficient</li>
                        
                          <li>Seattle, Lodi, Modena, Ferrara II, Athens-like - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533605" style="vertical-align: initial;">
                  <td>chrX:154533605</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Chinese-1 - II/Deficient</li>
                        
                          <li>Haikou - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533607" style="vertical-align: initial;">
                  <td>chrX:154533607</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Wexham - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533608" style="vertical-align: initial;">
                  <td>chrX:154533608</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>La Jolla - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533614" style="vertical-align: initial;">
                  <td>chrX:154533614</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Sugao - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533615" style="vertical-align: initial;">
                  <td>chrX:154533615</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Bangkok - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533619" style="vertical-align: initial;">
                  <td>chrX:154533619</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Lille - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533620" style="vertical-align: initial;">
                  <td>chrX:154533620</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Cleveland Corum - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533629" style="vertical-align: initial;">
                  <td>chrX:154533629</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Roubaix - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154533634" style="vertical-align: initial;">
                  <td>chrX:154533634</td>
                  <td id="rs137852346">rs137852346</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Aveiro - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534036" style="vertical-align: initial;">
                  <td>chrX:154534036</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Wayne - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534074" style="vertical-align: initial;">
                  <td>chrX:154534074</td>
                  <td ></td>
                  
                  
                    <td class="">TCAGTGC/<br />TCAGTGC</td>
                  
                  <td>
                    TCAGTGC
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Stonybrook - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534092" style="vertical-align: initial;">
                  <td>chrX:154534092</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Durham - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534102" style="vertical-align: initial;">
                  <td>chrX:154534102</td>
                  <td id="rs782757170">rs782757170</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Nanning - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534110" style="vertical-align: initial;">
                  <td>chrX:154534110</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Asahikawa - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534116" style="vertical-align: initial;">
                  <td>chrX:154534116</td>
                  <td ></td>
                  
                  
                    <td class="">ATGT/ATGT</td>
                  
                  <td>
                    ATGT
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>North Dallas - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534125" style="vertical-align: initial;">
                  <td>chrX:154534125</td>
                  <td id="rs137852328">rs137852328</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>A- 680T_376G - III/Deficient</li>
                        
                          <li>Mexico City - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534126" style="vertical-align: initial;">
                  <td>chrX:154534126</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Radlowo - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534157" style="vertical-align: initial;">
                  <td>chrX:154534157</td>
                  <td id="rs137852319">rs137852319</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Harilaou - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534345" style="vertical-align: initial;">
                  <td>chrX:154534345</td>
                  <td id="rs137852326">rs137852326</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Cincinnati - I/Deficient with CNSHA</li>
                        
                          <li>Minnesota, Marion, Gastonia, LeJeune - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534348" style="vertical-align: initial;">
                  <td>chrX:154534348</td>
                  <td id="rs782754619">rs782754619</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Sibari - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534387" style="vertical-align: initial;">
                  <td>chrX:154534387</td>
                  <td id="rs781865768">rs781865768</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Dagua - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534389" style="vertical-align: initial;">
                  <td>chrX:154534389</td>
                  <td id="rs137852332">rs137852332</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Nilgiri - II/Deficient</li>
                        
                          <li>Santiago - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534390" style="vertical-align: initial;">
                  <td>chrX:154534390</td>
                  <td id="rs137852330">rs137852330</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Coimbra Shunde - II/Deficient</li>
                        
                          <li>Vancouver - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534409" style="vertical-align: initial;">
                  <td>chrX:154534409</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Pedoplis-Ckaro - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534414" style="vertical-align: initial;">
                  <td>chrX:154534414</td>
                  <td ></td>
                  
                  
                    <td class="">GGGA/GGGA</td>
                  
                  <td>
                    GGGA
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Tsukui - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534419" style="vertical-align: initial;">
                  <td>chrX:154534419</td>
                  <td id="rs5030868">rs5030868</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534438" style="vertical-align: initial;">
                  <td>chrX:154534438</td>
                  <td id="rs267606836">rs267606836</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Vancouver - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534440" style="vertical-align: initial;">
                  <td>chrX:154534440</td>
                  <td id="rs5030872">rs5030872</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Malaga - III/Deficient</li>
                        
                          <li>Santa Maria - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534447" style="vertical-align: initial;">
                  <td>chrX:154534447</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Chikugo - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534455" style="vertical-align: initial;">
                  <td>chrX:154534455</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Shinshu - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534463" style="vertical-align: initial;">
                  <td>chrX:154534463</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Miaoli - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534465" style="vertical-align: initial;">
                  <td>chrX:154534465</td>
                  <td id="rs137852343">rs137852343</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Nankang - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534468" style="vertical-align: initial;">
                  <td>chrX:154534468</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Volendam - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534485" style="vertical-align: initial;">
                  <td>chrX:154534485</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Naone - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534486" style="vertical-align: initial;">
                  <td>chrX:154534486</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Toledo - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534489" style="vertical-align: initial;">
                  <td>chrX:154534489</td>
                  <td id="rs137852331">rs137852331</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Taipei, Chinese-3 - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534494" style="vertical-align: initial;">
                  <td>chrX:154534494</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Plymouth - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154534495" style="vertical-align: initial;">
                  <td>chrX:154534495</td>
                  <td id="rs137852314">rs137852314</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Mahidol - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535176" style="vertical-align: initial;">
                  <td>chrX:154535176</td>
                  <td id="rs370918918">rs370918918</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Gond - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535180" style="vertical-align: initial;">
                  <td>chrX:154535180</td>
                  <td id="rs782487723">rs782487723</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Shenzen - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535187" style="vertical-align: initial;">
                  <td>chrX:154535187</td>
                  <td id="rs137852313">rs137852313</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Ilesha - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535190" style="vertical-align: initial;">
                  <td>chrX:154535190</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Acrokorinthos - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535211" style="vertical-align: initial;">
                  <td>chrX:154535211</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Liuzhou - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535244" style="vertical-align: initial;">
                  <td>chrX:154535244</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Belem - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535247" style="vertical-align: initial;">
                  <td>chrX:154535247</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Valladolid - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535249" style="vertical-align: initial;">
                  <td>chrX:154535249</td>
                  <td id="rs782322505">rs782322505</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Cairo - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535261" style="vertical-align: initial;">
                  <td>chrX:154535261</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Quing Yan - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535269" style="vertical-align: initial;">
                  <td>chrX:154535269</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Crispim - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535270" style="vertical-align: initial;">
                  <td>chrX:154535270</td>
                  <td id="rs78365220">rs78365220</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Crispim - II/Deficient</li>
                        
                          <li>Salerno Pyrgos - III/Deficient</li>
                        
                          <li>Vanua Lava - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535274" style="vertical-align: initial;">
                  <td>chrX:154535274</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Crispim - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535277" style="vertical-align: initial;">
                  <td>chrX:154535277</td>
                  <td id="rs1050829">rs1050829</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>202G>A_376A>G_1264C>G - I/Deficient with CNSHA</li>
                        
                          <li>A - IV/Normal</li>
                        
                          <li>A- 202A_376G - III/Deficient</li>
                        
                          <li>A- 680T_376G - III/Deficient</li>
                        
                          <li>A- 968C_376G - III/Deficient</li>
                        
                          <li>Acrokorinthos - II/Deficient</li>
                        
                          <li>Ananindeua - II/Deficient</li>
                        
                          <li>Mt Sinai - I/Deficient with CNSHA</li>
                        
                          <li>Santa Maria - II/Deficient</li>
                        
                          <li>Sierra Leone - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535278" style="vertical-align: initial;">
                  <td>chrX:154535278</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Crispim - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535301" style="vertical-align: initial;">
                  <td>chrX:154535301</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Bao Loc - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535316" style="vertical-align: initial;">
                  <td>chrX:154535316</td>
                  <td id="rs5030870">rs5030870</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Sao Borja - IV/Normal</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535330" style="vertical-align: initial;">
                  <td>chrX:154535330</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Hammersmith - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535336" style="vertical-align: initial;">
                  <td>chrX:154535336</td>
                  <td id="rs267606835">rs267606835</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Vancouver - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535342" style="vertical-align: initial;">
                  <td>chrX:154535342</td>
                  <td id="rs181277621">rs181277621</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Sierra Leone - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535367" style="vertical-align: initial;">
                  <td>chrX:154535367</td>
                  <td ></td>
                  
                  
                    <td class="">GCTT/GCTT</td>
                  
                  <td>
                    GCTT
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Urayasu - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535379" style="vertical-align: initial;">
                  <td>chrX:154535379</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Guangzhou - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535962" style="vertical-align: initial;">
                  <td>chrX:154535962</td>
                  <td id="rs782308266">rs782308266</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Lagosanto - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535963" style="vertical-align: initial;">
                  <td>chrX:154535963</td>
                  <td id="rs138687036">rs138687036</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Ube Konan - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535980" style="vertical-align: initial;">
                  <td>chrX:154535980</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Swansea - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535995" style="vertical-align: initial;">
                  <td>chrX:154535995</td>
                  <td id="rs782090947">rs782090947</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Murcia Oristano - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154535996" style="vertical-align: initial;">
                  <td>chrX:154535996</td>
                  <td id="rs137852349">rs137852349</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Namouru - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536002" style="vertical-align: initial;">
                  <td>chrX:154536002</td>
                  <td id="rs1050828">rs1050828</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>202G>A_376A>G_1264C>G - I/Deficient with CNSHA</li>
                        
                          <li>A- 202A_376G - III/Deficient</li>
                        
                          <li>Asahi - III/Deficient</li>
                        
                          <li>Hechi - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536008" style="vertical-align: initial;">
                  <td>chrX:154536008</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Songklanagarind - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536019" style="vertical-align: initial;">
                  <td>chrX:154536019</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Amazonia - II/Deficient</li>
                        
                          <li>Musashino - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536021" style="vertical-align: initial;">
                  <td>chrX:154536021</td>
                  <td ></td>
                  
                  
                    <td class="">CAGA/CAGA</td>
                  
                  <td>
                    CAGA
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Amsterdam - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536025" style="vertical-align: initial;">
                  <td>chrX:154536025</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Costanzo - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536032" style="vertical-align: initial;">
                  <td>chrX:154536032</td>
                  <td id="rs137852315">rs137852315</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Metaponto - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536034" style="vertical-align: initial;">
                  <td>chrX:154536034</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Palestrina - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536035" style="vertical-align: initial;">
                  <td>chrX:154536035</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Kamogawa - II/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536045" style="vertical-align: initial;">
                  <td>chrX:154536045</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Kozukata - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536151" style="vertical-align: initial;">
                  <td>chrX:154536151</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Kambos - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536156" style="vertical-align: initial;">
                  <td>chrX:154536156</td>
                  <td id="rs76645461">rs76645461</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Aures - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536168" style="vertical-align: initial;">
                  <td>chrX:154536168</td>
                  <td id="rs78478128">rs78478128</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Orissa - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154536169" style="vertical-align: initial;">
                  <td>chrX:154536169</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Rignano - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154546045" style="vertical-align: initial;">
                  <td>chrX:154546045</td>
                  <td id="rs137852338">rs137852338</td>
                  
                  
                    <td class="">CATG/CATG</td>
                  
                  <td>
                    CATG
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Sunderland - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154546046" style="vertical-align: initial;">
                  <td>chrX:154546046</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Gidra - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154546057" style="vertical-align: initial;">
                  <td>chrX:154546057</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Honiara - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154546061" style="vertical-align: initial;">
                  <td>chrX:154546061</td>
                  <td id="rs137852340">rs137852340</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Gaohe - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154546116" style="vertical-align: initial;">
                  <td>chrX:154546116</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Lages - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154546122" style="vertical-align: initial;">
                  <td>chrX:154546122</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>Sinnai - III/Deficient</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chrX_154546131" style="vertical-align: initial;">
                  <td>chrX:154546131</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>No name - I/Deficient with CNSHA</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene IFNL3_4">
        <h3 id="IFNL3_4">IFNL3/4 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  rs12979860 reference (C)/rs12979860 reference (C)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr19_39248147" style="vertical-align: initial;">
                  <td>chr19:39248147</td>
                  <td id="rs12979860">rs12979860</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>rs12979860 variant (T) - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene NUDT15">
        <h3 id="NUDT15">NUDT15 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The NUDT15 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr13_48037748" style="vertical-align: initial;">
                  <td>chr13:48037748</td>
                  <td id="rs769369441">rs769369441</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*10 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037749" style="vertical-align: initial;">
                  <td>chr13:48037749</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*19 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037782" style="vertical-align: initial;">
                  <td>chr13:48037782</td>
                  <td id="rs746071566">rs746071566</td>
                  
                  
                    <td class="">AGGAGTC/<br />AGGAGTC</td>
                  
                  <td>
                    AGGAGTC
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - No function</li>
                        
                          <li>*6 - Uncertain function</li>
                        
                          <li>*9 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037798" style="vertical-align: initial;">
                  <td>chr13:48037798</td>
                  <td id="rs186364861">rs186364861</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*5 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037825" style="vertical-align: initial;">
                  <td>chr13:48037825</td>
                  <td id="rs777311140">rs777311140</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*14 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037834" style="vertical-align: initial;">
                  <td>chr13:48037834</td>
                  <td id="rs1202487323">rs1202487323</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*16 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037847" style="vertical-align: initial;">
                  <td>chr13:48037847</td>
                  <td id="rs766023281">rs766023281</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*7 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037849" style="vertical-align: initial;">
                  <td>chr13:48037849</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037885" style="vertical-align: initial;">
                  <td>chr13:48037885</td>
                  <td id="rs1950545307">rs1950545307</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*11 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48037902" style="vertical-align: initial;">
                  <td>chr13:48037902</td>
                  <td id="rs149436418">rs149436418</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*12 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48040977" style="vertical-align: initial;">
                  <td>chr13:48040977</td>
                  <td id="rs1457579126">rs1457579126</td>
                  
                  
                    <td class="">GA/GA</td>
                  
                  <td>
                    GA
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*18 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48041103" style="vertical-align: initial;">
                  <td>chr13:48041103</td>
                  <td id="rs761191455">rs761191455</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*13 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48041113" style="vertical-align: initial;">
                  <td>chr13:48041113</td>
                  <td id="rs1368252918">rs1368252918</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48045690" style="vertical-align: initial;">
                  <td>chr13:48045690</td>
                  <td id="rs768324690">rs768324690</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*20 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48045719" style="vertical-align: initial;">
                  <td>chr13:48045719</td>
                  <td id="rs116855232">rs116855232</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - No function</li>
                        
                          <li>*3 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48045720" style="vertical-align: initial;">
                  <td>chr13:48045720</td>
                  <td id="rs147390019">rs147390019</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*4 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr13_48045771" style="vertical-align: initial;">
                  <td>chr13:48045771</td>
                  <td id="rs139551410">rs139551410</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*15 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene RYR1">
        <h3 id="RYR1">RYR1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  Reference/Reference
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The RYR1 Reference allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr19_38433867" style="vertical-align: initial;">
                  <td>chr19:38433867</td>
                  <td id="rs193922744">rs193922744</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.38T>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38440747" style="vertical-align: initial;">
                  <td>chr19:38440747</td>
                  <td id="rs193922745">rs193922745</td>
                  
                  
                    <td class="">CGAT/CGAT</td>
                  
                  <td>
                    CGAT
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.51_53del - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38440796" style="vertical-align: initial;">
                  <td>chr19:38440796</td>
                  <td id="rs193922746">rs193922746</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.97A>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38440802" style="vertical-align: initial;">
                  <td>chr19:38440802</td>
                  <td id="rs193922747">rs193922747</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.103T>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38440818" style="vertical-align: initial;">
                  <td>chr19:38440818</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.119G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38440829" style="vertical-align: initial;">
                  <td>chr19:38440829</td>
                  <td id="rs193922748">rs193922748</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.130C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38440830" style="vertical-align: initial;">
                  <td>chr19:38440830</td>
                  <td id="rs139161723">rs139161723</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.131G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38440851" style="vertical-align: initial;">
                  <td>chr19:38440851</td>
                  <td id="rs193922749">rs193922749</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.152C>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38442361" style="vertical-align: initial;">
                  <td>chr19:38442361</td>
                  <td id="rs118192160">rs118192160</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.178G>A - Uncertain function</li>
                        
                          <li>c.178G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38442373" style="vertical-align: initial;">
                  <td>chr19:38442373</td>
                  <td id="rs995399438">rs995399438</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.190T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38442395" style="vertical-align: initial;">
                  <td>chr19:38442395</td>
                  <td id="rs118192113">rs118192113</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.212C>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38442434" style="vertical-align: initial;">
                  <td>chr19:38442434</td>
                  <td id="rs186983396">rs186983396</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.251C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38443790" style="vertical-align: initial;">
                  <td>chr19:38443790</td>
                  <td id="rs142474192">rs142474192</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.418G>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444179" style="vertical-align: initial;">
                  <td>chr19:38444179</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.455C>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444187" style="vertical-align: initial;">
                  <td>chr19:38444187</td>
                  <td id="rs193922750">rs193922750</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.463C>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444191" style="vertical-align: initial;">
                  <td>chr19:38444191</td>
                  <td id="rs193922751">rs193922751</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.467G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444203" style="vertical-align: initial;">
                  <td>chr19:38444203</td>
                  <td id="rs193922752">rs193922752</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.479A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444211" style="vertical-align: initial;">
                  <td>chr19:38444211</td>
                  <td id="rs118192161">rs118192161</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.487C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444212" style="vertical-align: initial;">
                  <td>chr19:38444212</td>
                  <td id="rs193922753">rs193922753</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.488G>A - Uncertain function</li>
                        
                          <li>c.488G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444217" style="vertical-align: initial;">
                  <td>chr19:38444217</td>
                  <td id="rs193922754">rs193922754</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.493G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444220" style="vertical-align: initial;">
                  <td>chr19:38444220</td>
                  <td id="rs193922755">rs193922755</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.496G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444221" style="vertical-align: initial;">
                  <td>chr19:38444221</td>
                  <td id="rs193922756">rs193922756</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.497A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444250" style="vertical-align: initial;">
                  <td>chr19:38444250</td>
                  <td id="rs761616815">rs761616815</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.526G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444252" style="vertical-align: initial;">
                  <td>chr19:38444252</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.528G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444253" style="vertical-align: initial;">
                  <td>chr19:38444253</td>
                  <td id="rs193922757">rs193922757</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.529C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444257" style="vertical-align: initial;">
                  <td>chr19:38444257</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.533A>C - Uncertain function</li>
                        
                          <li>c.533A>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38444671" style="vertical-align: initial;">
                  <td>chr19:38444671</td>
                  <td id="rs771058055">rs771058055</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.625G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38446481" style="vertical-align: initial;">
                  <td>chr19:38446481</td>
                  <td id="rs727504129">rs727504129</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.641C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38446492" style="vertical-align: initial;">
                  <td>chr19:38446492</td>
                  <td id="rs193922759">rs193922759</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.652G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38446517" style="vertical-align: initial;">
                  <td>chr19:38446517</td>
                  <td id="rs112596687">rs112596687</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.677T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38446520" style="vertical-align: initial;">
                  <td>chr19:38446520</td>
                  <td id="rs193922760">rs193922760</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.680A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38446710" style="vertical-align: initial;">
                  <td>chr19:38446710</td>
                  <td id="rs1801086">rs1801086</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.742G>A - Malignant Hyperthermia associated</li>
                        
                          <li>c.742G>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38448500" style="vertical-align: initial;">
                  <td>chr19:38448500</td>
                  <td id="rs752652072">rs752652072</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.946C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38448501" style="vertical-align: initial;">
                  <td>chr19:38448501</td>
                  <td id="rs193922761">rs193922761</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.947G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38448673" style="vertical-align: initial;">
                  <td>chr19:38448673</td>
                  <td id="rs193922762">rs193922762</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.982C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38448680" style="vertical-align: initial;">
                  <td>chr19:38448680</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.992_994dup - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38448712" style="vertical-align: initial;">
                  <td>chr19:38448712</td>
                  <td id="rs121918592">rs121918592</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1021G>A - Malignant Hyperthermia associated</li>
                        
                          <li>c.1021G>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38448715" style="vertical-align: initial;">
                  <td>chr19:38448715</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1024G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38448791" style="vertical-align: initial;">
                  <td>chr19:38448791</td>
                  <td id="rs113332073">rs113332073</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1100G>A - Uncertain function</li>
                        
                          <li>c.1100G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38451785" style="vertical-align: initial;">
                  <td>chr19:38451785</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1144C>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38451842" style="vertical-align: initial;">
                  <td>chr19:38451842</td>
                  <td id="rs193922764">rs193922764</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1201C>A - Uncertain function</li>
                        
                          <li>c.1201C>G - Uncertain function</li>
                        
                          <li>c.1201C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38451843" style="vertical-align: initial;">
                  <td>chr19:38451843</td>
                  <td id="rs193922766">rs193922766</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1202G>A - Malignant Hyperthermia associated</li>
                        
                          <li>c.1202G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38451850" style="vertical-align: initial;">
                  <td>chr19:38451850</td>
                  <td id="rs118192116">rs118192116</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1209C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38452985" style="vertical-align: initial;">
                  <td>chr19:38452985</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1411C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38452996" style="vertical-align: initial;">
                  <td>chr19:38452996</td>
                  <td id="rs193922767">rs193922767</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1422G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455247" style="vertical-align: initial;">
                  <td>chr19:38455247</td>
                  <td id="rs147723844">rs147723844</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1453A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455253" style="vertical-align: initial;">
                  <td>chr19:38455253</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1459C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455254" style="vertical-align: initial;">
                  <td>chr19:38455254</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1460T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455269" style="vertical-align: initial;">
                  <td>chr19:38455269</td>
                  <td id="rs901087791">rs901087791</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1475G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455347" style="vertical-align: initial;">
                  <td>chr19:38455347</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1553T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455359" style="vertical-align: initial;">
                  <td>chr19:38455359</td>
                  <td id="rs118192162">rs118192162</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1565A>C - Malignant Hyperthermia associated</li>
                        
                          <li>c.1565A>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455463" style="vertical-align: initial;">
                  <td>chr19:38455463</td>
                  <td id="rs111888148">rs111888148</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1589G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455471" style="vertical-align: initial;">
                  <td>chr19:38455471</td>
                  <td id="rs193922768">rs193922768</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1597C>A - Uncertain function</li>
                        
                          <li>c.1597C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455472" style="vertical-align: initial;">
                  <td>chr19:38455472</td>
                  <td id="rs144336148">rs144336148</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1598G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455489" style="vertical-align: initial;">
                  <td>chr19:38455489</td>
                  <td id="rs193922769">rs193922769</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1615T>C - Malignant Hyperthermia associated</li>
                        
                          <li>c.1615T>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455504" style="vertical-align: initial;">
                  <td>chr19:38455504</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1630G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38455528" style="vertical-align: initial;">
                  <td>chr19:38455528</td>
                  <td id="rs193922770">rs193922770</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1654C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38457539" style="vertical-align: initial;">
                  <td>chr19:38457539</td>
                  <td id="rs118204423">rs118204423</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1834G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38457545" style="vertical-align: initial;">
                  <td>chr19:38457545</td>
                  <td id="rs118192172">rs118192172</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1840C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38457546" style="vertical-align: initial;">
                  <td>chr19:38457546</td>
                  <td id="rs193922772">rs193922772</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.1841G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38458175" style="vertical-align: initial;">
                  <td>chr19:38458175</td>
                  <td id="rs747177274">rs747177274</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2050G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38458247" style="vertical-align: initial;">
                  <td>chr19:38458247</td>
                  <td id="rs138874610">rs138874610</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2122G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38460461" style="vertical-align: initial;">
                  <td>chr19:38460461</td>
                  <td id="rs376149732">rs376149732</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2447C>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38460551" style="vertical-align: initial;">
                  <td>chr19:38460551</td>
                  <td id="rs193922775">rs193922775</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2537C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38463499" style="vertical-align: initial;">
                  <td>chr19:38463499</td>
                  <td id="rs370634440">rs370634440</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2654G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38464649" style="vertical-align: initial;">
                  <td>chr19:38464649</td>
                  <td id="rs148623597">rs148623597</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2797G>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38466144" style="vertical-align: initial;">
                  <td>chr19:38466144</td>
                  <td id="rs778241277">rs778241277</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2924G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38466216" style="vertical-align: initial;">
                  <td>chr19:38466216</td>
                  <td id="rs180714609">rs180714609</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.2996G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38466315" style="vertical-align: initial;">
                  <td>chr19:38466315</td>
                  <td id="rs141942845">rs141942845</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3095G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38466347" style="vertical-align: initial;">
                  <td>chr19:38466347</td>
                  <td id="rs111272095">rs111272095</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3127C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38466386" style="vertical-align: initial;">
                  <td>chr19:38466386</td>
                  <td id="rs2145447772">rs2145447772</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3166G>A - Uncertain function</li>
                        
                          <li>c.3166G>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38466392" style="vertical-align: initial;">
                  <td>chr19:38466392</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3172G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38467655" style="vertical-align: initial;">
                  <td>chr19:38467655</td>
                  <td id="rs749040743">rs749040743</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3224G>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38469002" style="vertical-align: initial;">
                  <td>chr19:38469002</td>
                  <td id="rs193922776">rs193922776</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3418C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38469111" style="vertical-align: initial;">
                  <td>chr19:38469111</td>
                  <td id="rs549201486">rs549201486</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3527C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38469404" style="vertical-align: initial;">
                  <td>chr19:38469404</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3656A>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38469415" style="vertical-align: initial;">
                  <td>chr19:38469415</td>
                  <td id="rs936513262">rs936513262</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.3667G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38473635" style="vertical-align: initial;">
                  <td>chr19:38473635</td>
                  <td id="rs34694816">rs34694816</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.4024A>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38475335" style="vertical-align: initial;">
                  <td>chr19:38475335</td>
                  <td id="rs137933390">rs137933390</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.4178A>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38477816" style="vertical-align: initial;">
                  <td>chr19:38477816</td>
                  <td id="rs145573319">rs145573319</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.4400A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38483293" style="vertical-align: initial;">
                  <td>chr19:38483293</td>
                  <td id="rs146429605">rs146429605</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.4711A>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38483329" style="vertical-align: initial;">
                  <td>chr19:38483329</td>
                  <td id="rs754476250">rs754476250</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.4747C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38483345" style="vertical-align: initial;">
                  <td>chr19:38483345</td>
                  <td id="rs151029675">rs151029675</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.4763C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38483357" style="vertical-align: initial;">
                  <td>chr19:38483357</td>
                  <td id="rs193922777">rs193922777</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.4775C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485679" style="vertical-align: initial;">
                  <td>chr19:38485679</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5024T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485688" style="vertical-align: initial;">
                  <td>chr19:38485688</td>
                  <td id="rs781104539">rs781104539</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5033A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485691" style="vertical-align: initial;">
                  <td>chr19:38485691</td>
                  <td id="rs146504767">rs146504767</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5036G>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485787" style="vertical-align: initial;">
                  <td>chr19:38485787</td>
                  <td id="rs754785770">rs754785770</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5132A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485838" style="vertical-align: initial;">
                  <td>chr19:38485838</td>
                  <td id="rs193922781">rs193922781</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5183C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485841" style="vertical-align: initial;">
                  <td>chr19:38485841</td>
                  <td id="rs193922782">rs193922782</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5186T>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485972" style="vertical-align: initial;">
                  <td>chr19:38485972</td>
                  <td id="rs192863857">rs192863857</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5317C>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38485996" style="vertical-align: initial;">
                  <td>chr19:38485996</td>
                  <td id="rs372958050">rs372958050</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5341T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38486015" style="vertical-align: initial;">
                  <td>chr19:38486015</td>
                  <td id="rs34934920">rs34934920</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5360C>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38486095" style="vertical-align: initial;">
                  <td>chr19:38486095</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5440A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38486096" style="vertical-align: initial;">
                  <td>chr19:38486096</td>
                  <td id="rs193922783">rs193922783</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5441T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38490151" style="vertical-align: initial;">
                  <td>chr19:38490151</td>
                  <td id="rs145801146">rs145801146</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.5890C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38490642" style="vertical-align: initial;">
                  <td>chr19:38490642</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6037A>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38492540" style="vertical-align: initial;">
                  <td>chr19:38492540</td>
                  <td id="rs35364374">rs35364374</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6178G>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494379" style="vertical-align: initial;">
                  <td>chr19:38494379</td>
                  <td id="rs746818096">rs746818096</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6302T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494381" style="vertical-align: initial;">
                  <td>chr19:38494381</td>
                  <td id="rs770593660">rs770593660</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6304G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494426" style="vertical-align: initial;">
                  <td>chr19:38494426</td>
                  <td id="rs193922788">rs193922788</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6349G>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494454" style="vertical-align: initial;">
                  <td>chr19:38494454</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6377G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494464" style="vertical-align: initial;">
                  <td>chr19:38494464</td>
                  <td id="rs117886618">rs117886618</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6387C>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494465" style="vertical-align: initial;">
                  <td>chr19:38494465</td>
                  <td id="rs193922789">rs193922789</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6388G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494555" style="vertical-align: initial;">
                  <td>chr19:38494555</td>
                  <td id="rs143398211">rs143398211</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6478G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494564" style="vertical-align: initial;">
                  <td>chr19:38494564</td>
                  <td id="rs118192175">rs118192175</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6487C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494565" style="vertical-align: initial;">
                  <td>chr19:38494565</td>
                  <td id="rs118192163">rs118192163</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6488G>A - Malignant Hyperthermia associated</li>
                        
                          <li>c.6488G>C - Malignant Hyperthermia associated</li>
                        
                          <li>c.6488G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494579" style="vertical-align: initial;">
                  <td>chr19:38494579</td>
                  <td id="rs118192176">rs118192176</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6502G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494621" style="vertical-align: initial;">
                  <td>chr19:38494621</td>
                  <td id="rs193922790">rs193922790</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6544A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38494625" style="vertical-align: initial;">
                  <td>chr19:38494625</td>
                  <td id="rs959170123">rs959170123</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6548G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496265" style="vertical-align: initial;">
                  <td>chr19:38496265</td>
                  <td id="rs193922791">rs193922791</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6599C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496278" style="vertical-align: initial;">
                  <td>chr19:38496278</td>
                  <td id="rs141646642">rs141646642</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6612C>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496283" style="vertical-align: initial;">
                  <td>chr19:38496283</td>
                  <td id="rs118192177">rs118192177</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6617C>G - Malignant Hyperthermia associated</li>
                        
                          <li>c.6617C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496294" style="vertical-align: initial;">
                  <td>chr19:38496294</td>
                  <td id="rs193922792">rs193922792</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6628G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496301" style="vertical-align: initial;">
                  <td>chr19:38496301</td>
                  <td id="rs193922793">rs193922793</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6635T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496306" style="vertical-align: initial;">
                  <td>chr19:38496306</td>
                  <td id="rs193922795">rs193922795</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6640G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496415" style="vertical-align: initial;">
                  <td>chr19:38496415</td>
                  <td id="rs199870223">rs199870223</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6670C>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496416" style="vertical-align: initial;">
                  <td>chr19:38496416</td>
                  <td id="rs537994744">rs537994744</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6671G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496455" style="vertical-align: initial;">
                  <td>chr19:38496455</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6710G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496487" style="vertical-align: initial;">
                  <td>chr19:38496487</td>
                  <td id="rs763352221">rs763352221</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6742C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496488" style="vertical-align: initial;">
                  <td>chr19:38496488</td>
                  <td id="rs140152019">rs140152019</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6743G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496502" style="vertical-align: initial;">
                  <td>chr19:38496502</td>
                  <td id="rs917523269">rs917523269</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6757C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496901" style="vertical-align: initial;">
                  <td>chr19:38496901</td>
                  <td id="rs193922797">rs193922797</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6838G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38496910" style="vertical-align: initial;">
                  <td>chr19:38496910</td>
                  <td id="rs118192121">rs118192121</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6847A>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499177" style="vertical-align: initial;">
                  <td>chr19:38499177</td>
                  <td id="rs34390345">rs34390345</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.6961A>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499223" style="vertical-align: initial;">
                  <td>chr19:38499223</td>
                  <td id="rs112563513">rs112563513</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7007G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499234" style="vertical-align: initial;">
                  <td>chr19:38499234</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7018T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499241" style="vertical-align: initial;">
                  <td>chr19:38499241</td>
                  <td id="rs147213895">rs147213895</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7025A>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499639" style="vertical-align: initial;">
                  <td>chr19:38499639</td>
                  <td id="rs193922798">rs193922798</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7032G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499642" style="vertical-align: initial;">
                  <td>chr19:38499642</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7035C>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499643" style="vertical-align: initial;">
                  <td>chr19:38499643</td>
                  <td id="rs193922799">rs193922799</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7036G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499644" style="vertical-align: initial;">
                  <td>chr19:38499644</td>
                  <td id="rs121918596">rs121918596</td>
                  
                  
                    <td class="">TGGA/TGGA</td>
                  
                  <td>
                    TGGA
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7042_7044delGAG - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499650" style="vertical-align: initial;">
                  <td>chr19:38499650</td>
                  <td id="rs193922801">rs193922801</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7043A>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499655" style="vertical-align: initial;">
                  <td>chr19:38499655</td>
                  <td id="rs193922802">rs193922802</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7048G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499667" style="vertical-align: initial;">
                  <td>chr19:38499667</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7060G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499670" style="vertical-align: initial;">
                  <td>chr19:38499670</td>
                  <td id="rs193922803">rs193922803</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7063C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499680" style="vertical-align: initial;">
                  <td>chr19:38499680</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7073T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499682" style="vertical-align: initial;">
                  <td>chr19:38499682</td>
                  <td id="rs769482889">rs769482889</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7075C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499683" style="vertical-align: initial;">
                  <td>chr19:38499683</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7076G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499691" style="vertical-align: initial;">
                  <td>chr19:38499691</td>
                  <td id="rs762401851">rs762401851</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7084G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499692" style="vertical-align: initial;">
                  <td>chr19:38499692</td>
                  <td id="rs193922804">rs193922804</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7085A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499696" style="vertical-align: initial;">
                  <td>chr19:38499696</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7089C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499697" style="vertical-align: initial;">
                  <td>chr19:38499697</td>
                  <td id="rs193922805">rs193922805</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7090T>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499704" style="vertical-align: initial;">
                  <td>chr19:38499704</td>
                  <td id="rs193922806">rs193922806</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7097C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499706" style="vertical-align: initial;">
                  <td>chr19:38499706</td>
                  <td id="rs146306934">rs146306934</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7099G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499719" style="vertical-align: initial;">
                  <td>chr19:38499719</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7112A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499730" style="vertical-align: initial;">
                  <td>chr19:38499730</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7123G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499731" style="vertical-align: initial;">
                  <td>chr19:38499731</td>
                  <td id="rs193922807">rs193922807</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7124G>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499806" style="vertical-align: initial;">
                  <td>chr19:38499806</td>
                  <td id="rs976108591">rs976108591</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7199A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499817" style="vertical-align: initial;">
                  <td>chr19:38499817</td>
                  <td id="rs111364296">rs111364296</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7210G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499975" style="vertical-align: initial;">
                  <td>chr19:38499975</td>
                  <td id="rs193922809">rs193922809</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7282G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499984" style="vertical-align: initial;">
                  <td>chr19:38499984</td>
                  <td id="rs193922810">rs193922810</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7291G>A - Malignant Hyperthermia associated</li>
                        
                          <li>c.7291G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499985" style="vertical-align: initial;">
                  <td>chr19:38499985</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7292A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499993" style="vertical-align: initial;">
                  <td>chr19:38499993</td>
                  <td id="rs121918593">rs121918593</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7300G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38499997" style="vertical-align: initial;">
                  <td>chr19:38499997</td>
                  <td id="rs28933396">rs28933396</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7304G>A - Malignant Hyperthermia associated</li>
                        
                          <li>c.7304G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500000" style="vertical-align: initial;">
                  <td>chr19:38500000</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7307G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500003" style="vertical-align: initial;">
                  <td>chr19:38500003</td>
                  <td id="rs193922812">rs193922812</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7310C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500010" style="vertical-align: initial;">
                  <td>chr19:38500010</td>
                  <td id="rs193922813">rs193922813</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7317G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500636" style="vertical-align: initial;">
                  <td>chr19:38500636</td>
                  <td id="rs118192124">rs118192124</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7354C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500637" style="vertical-align: initial;">
                  <td>chr19:38500637</td>
                  <td id="rs193922815">rs193922815</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7355G>A - Uncertain function</li>
                        
                          <li>c.7355G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500640" style="vertical-align: initial;">
                  <td>chr19:38500640</td>
                  <td id="rs118192123">rs118192123</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7358T>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500642" style="vertical-align: initial;">
                  <td>chr19:38500642</td>
                  <td id="rs193922816">rs193922816</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7360C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500643" style="vertical-align: initial;">
                  <td>chr19:38500643</td>
                  <td id="rs118192122">rs118192122</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7361G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500654" style="vertical-align: initial;">
                  <td>chr19:38500654</td>
                  <td id="rs28933397">rs28933397</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7372C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500655" style="vertical-align: initial;">
                  <td>chr19:38500655</td>
                  <td id="rs121918594">rs121918594</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7373G>A - Malignant Hyperthermia associated</li>
                        
                          <li>c.7373G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500667" style="vertical-align: initial;">
                  <td>chr19:38500667</td>
                  <td id="rs551223467">rs551223467</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7385C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500863" style="vertical-align: initial;">
                  <td>chr19:38500863</td>
                  <td id="rs193922817">rs193922817</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7487C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500898" style="vertical-align: initial;">
                  <td>chr19:38500898</td>
                  <td id="rs118192178">rs118192178</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7522C>G - Uncertain function</li>
                        
                          <li>c.7522C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500899" style="vertical-align: initial;">
                  <td>chr19:38500899</td>
                  <td id="rs193922818">rs193922818</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7523G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38500904" style="vertical-align: initial;">
                  <td>chr19:38500904</td>
                  <td id="rs193922819">rs193922819</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7528T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38502652" style="vertical-align: initial;">
                  <td>chr19:38502652</td>
                  <td id="rs767553612">rs767553612</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7760A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38502663" style="vertical-align: initial;">
                  <td>chr19:38502663</td>
                  <td id="rs193922822">rs193922822</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7771C>G - Uncertain function</li>
                        
                          <li>c.7771C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38502669" style="vertical-align: initial;">
                  <td>chr19:38502669</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7777C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38502670" style="vertical-align: initial;">
                  <td>chr19:38502670</td>
                  <td id="rs751180702">rs751180702</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7778G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38502679" style="vertical-align: initial;">
                  <td>chr19:38502679</td>
                  <td id="rs193922824">rs193922824</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7787C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38502708" style="vertical-align: initial;">
                  <td>chr19:38502708</td>
                  <td id="rs748575133">rs748575133</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7816T>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38502923" style="vertical-align: initial;">
                  <td>chr19:38502923</td>
                  <td id="rs914804033">rs914804033</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.7879G>A - Uncertain function</li>
                        
                          <li>c.7879G>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38504298" style="vertical-align: initial;">
                  <td>chr19:38504298</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8005G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38504319" style="vertical-align: initial;">
                  <td>chr19:38504319</td>
                  <td id="rs193922826">rs193922826</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8026C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38504347" style="vertical-align: initial;">
                  <td>chr19:38504347</td>
                  <td id="rs781126470">rs781126470</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8054C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38504868" style="vertical-align: initial;">
                  <td>chr19:38504868</td>
                  <td id="rs193922827">rs193922827</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8188G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38504869" style="vertical-align: initial;">
                  <td>chr19:38504869</td>
                  <td id="rs112196644">rs112196644</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8189A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38504878" style="vertical-align: initial;">
                  <td>chr19:38504878</td>
                  <td id="rs193922828">rs193922828</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8198G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38505061" style="vertical-align: initial;">
                  <td>chr19:38505061</td>
                  <td id="rs193922829">rs193922829</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8290G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38505325" style="vertical-align: initial;">
                  <td>chr19:38505325</td>
                  <td id="rs147707463">rs147707463</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8327C>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38505358" style="vertical-align: initial;">
                  <td>chr19:38505358</td>
                  <td id="rs35180584">rs35180584</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8360C>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38505923" style="vertical-align: initial;">
                  <td>chr19:38505923</td>
                  <td id="rs193922830">rs193922830</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8518C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38505932" style="vertical-align: initial;">
                  <td>chr19:38505932</td>
                  <td id="rs768535909">rs768535909</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8527T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38506361" style="vertical-align: initial;">
                  <td>chr19:38506361</td>
                  <td id="rs193922831">rs193922831</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8600T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38506492" style="vertical-align: initial;">
                  <td>chr19:38506492</td>
                  <td id="rs112772310">rs112772310</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8638G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38506508" style="vertical-align: initial;">
                  <td>chr19:38506508</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8654C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38506865" style="vertical-align: initial;">
                  <td>chr19:38506865</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8729C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38507821" style="vertical-align: initial;">
                  <td>chr19:38507821</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.8926C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38511590" style="vertical-align: initial;">
                  <td>chr19:38511590</td>
                  <td id="rs147303895">rs147303895</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9152G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38512279" style="vertical-align: initial;">
                  <td>chr19:38512279</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9268G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38512321" style="vertical-align: initial;">
                  <td>chr19:38512321</td>
                  <td id="rs193922832">rs193922832</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9310G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38512367" style="vertical-align: initial;">
                  <td>chr19:38512367</td>
                  <td id="rs193922833">rs193922833</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9356G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38515052" style="vertical-align: initial;">
                  <td>chr19:38515052</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9499C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38516167" style="vertical-align: initial;">
                  <td>chr19:38516167</td>
                  <td id="rs199738299">rs199738299</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9635A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38516181" style="vertical-align: initial;">
                  <td>chr19:38516181</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9649T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38516184" style="vertical-align: initial;">
                  <td>chr19:38516184</td>
                  <td id="rs553055844">rs553055844</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9652G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38516208" style="vertical-align: initial;">
                  <td>chr19:38516208</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9676G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38517431" style="vertical-align: initial;">
                  <td>chr19:38517431</td>
                  <td id="rs375626634">rs375626634</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9758T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38517470" style="vertical-align: initial;">
                  <td>chr19:38517470</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9797T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38517521" style="vertical-align: initial;">
                  <td>chr19:38517521</td>
                  <td id="rs757753317">rs757753317</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9848G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38517523" style="vertical-align: initial;">
                  <td>chr19:38517523</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9850T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38517541" style="vertical-align: initial;">
                  <td>chr19:38517541</td>
                  <td id="rs112151058">rs112151058</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.9868G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38519237" style="vertical-align: initial;">
                  <td>chr19:38519237</td>
                  <td id="rs118204421">rs118204421</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10042C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38519238" style="vertical-align: initial;">
                  <td>chr19:38519238</td>
                  <td id="rs193922834">rs193922834</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10043G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38519292" style="vertical-align: initial;">
                  <td>chr19:38519292</td>
                  <td id="rs137932199">rs137932199</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10097G>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38519295" style="vertical-align: initial;">
                  <td>chr19:38519295</td>
                  <td id="rs118192126">rs118192126</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10100A>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38519424" style="vertical-align: initial;">
                  <td>chr19:38519424</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10229C>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38519432" style="vertical-align: initial;">
                  <td>chr19:38519432</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10237A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38519447" style="vertical-align: initial;">
                  <td>chr19:38519447</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10252A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38525432" style="vertical-align: initial;">
                  <td>chr19:38525432</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10556C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38525492" style="vertical-align: initial;">
                  <td>chr19:38525492</td>
                  <td id="rs143987857">rs143987857</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10616G>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38527707" style="vertical-align: initial;">
                  <td>chr19:38527707</td>
                  <td id="rs55876273">rs55876273</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10747G>C - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38527710" style="vertical-align: initial;">
                  <td>chr19:38527710</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10750G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38528372" style="vertical-align: initial;">
                  <td>chr19:38528372</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.10891G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38529002" style="vertical-align: initial;">
                  <td>chr19:38529002</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11086G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38529036" style="vertical-align: initial;">
                  <td>chr19:38529036</td>
                  <td id="rs193922838">rs193922838</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11120G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38529042" style="vertical-align: initial;">
                  <td>chr19:38529042</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11126C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38529048" style="vertical-align: initial;">
                  <td>chr19:38529048</td>
                  <td id="rs375915752">rs375915752</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11132C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38534726" style="vertical-align: initial;">
                  <td>chr19:38534726</td>
                  <td id="rs4802584">rs4802584</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11266C>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38534774" style="vertical-align: initial;">
                  <td>chr19:38534774</td>
                  <td id="rs763112609">rs763112609</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11314C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38534775" style="vertical-align: initial;">
                  <td>chr19:38534775</td>
                  <td id="rs193922839">rs193922839</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11315G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38535197" style="vertical-align: initial;">
                  <td>chr19:38535197</td>
                  <td id="rs111565359">rs111565359</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11416G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38535998" style="vertical-align: initial;">
                  <td>chr19:38535998</td>
                  <td id="rs140616359">rs140616359</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11518G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543365" style="vertical-align: initial;">
                  <td>chr19:38543365</td>
                  <td id="rs148399313">rs148399313</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11708G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543380" style="vertical-align: initial;">
                  <td>chr19:38543380</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11723A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543405" style="vertical-align: initial;">
                  <td>chr19:38543405</td>
                  <td id="rs193922840">rs193922840</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11748T>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543551" style="vertical-align: initial;">
                  <td>chr19:38543551</td>
                  <td id="rs147136339">rs147136339</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11798A>G - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543566" style="vertical-align: initial;">
                  <td>chr19:38543566</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11813G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543810" style="vertical-align: initial;">
                  <td>chr19:38543810</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11947C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543816" style="vertical-align: initial;">
                  <td>chr19:38543816</td>
                  <td id="rs118204422">rs118204422</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11953T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543821" style="vertical-align: initial;">
                  <td>chr19:38543821</td>
                  <td id="rs193922842">rs193922842</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11958C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38543832" style="vertical-align: initial;">
                  <td>chr19:38543832</td>
                  <td id="rs193922843">rs193922843</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.11969G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38546460" style="vertical-align: initial;">
                  <td>chr19:38546460</td>
                  <td id="rs755088027">rs755088027</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12028G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38546496" style="vertical-align: initial;">
                  <td>chr19:38546496</td>
                  <td id="rs773040531">rs773040531</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12064A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38548253" style="vertical-align: initial;">
                  <td>chr19:38548253</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12115A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38548259" style="vertical-align: initial;">
                  <td>chr19:38548259</td>
                  <td id="rs144685735">rs144685735</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12121C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38548287" style="vertical-align: initial;">
                  <td>chr19:38548287</td>
                  <td id="rs193922844">rs193922844</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12149C>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38548380" style="vertical-align: initial;">
                  <td>chr19:38548380</td>
                  <td id="rs373406011">rs373406011</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12242C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561140" style="vertical-align: initial;">
                  <td>chr19:38561140</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12310G>C - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561185" style="vertical-align: initial;">
                  <td>chr19:38561185</td>
                  <td id="rs193922848">rs193922848</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12355A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561213" style="vertical-align: initial;">
                  <td>chr19:38561213</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12383C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561228" style="vertical-align: initial;">
                  <td>chr19:38561228</td>
                  <td id="rs201321695">rs201321695</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12398A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561236" style="vertical-align: initial;">
                  <td>chr19:38561236</td>
                  <td id="rs193922849">rs193922849</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12406C>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561243" style="vertical-align: initial;">
                  <td>chr19:38561243</td>
                  <td id="rs193922850">rs193922850</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12413T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561362" style="vertical-align: initial;">
                  <td>chr19:38561362</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12532G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561363" style="vertical-align: initial;">
                  <td>chr19:38561363</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12533G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38561383" style="vertical-align: initial;">
                  <td>chr19:38561383</td>
                  <td id="rs151119428">rs151119428</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12553G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38565023" style="vertical-align: initial;">
                  <td>chr19:38565023</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12689T>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38565034" style="vertical-align: initial;">
                  <td>chr19:38565034</td>
                  <td id="rs193922852">rs193922852</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12700G>C - Malignant Hyperthermia associated</li>
                        
                          <li>c.12700G>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38565182" style="vertical-align: initial;">
                  <td>chr19:38565182</td>
                  <td id="rs193922853">rs193922853</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12848A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38565215" style="vertical-align: initial;">
                  <td>chr19:38565215</td>
                  <td id="rs587784372">rs587784372</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12881C>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38565218" style="vertical-align: initial;">
                  <td>chr19:38565218</td>
                  <td id="rs193922855">rs193922855</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.12884C>T - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38566978" style="vertical-align: initial;">
                  <td>chr19:38566978</td>
                  <td id="rs139647387">rs139647387</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13505A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38566986" style="vertical-align: initial;">
                  <td>chr19:38566986</td>
                  <td id="rs150396398">rs150396398</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13513G>C - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38570619" style="vertical-align: initial;">
                  <td>chr19:38570619</td>
                  <td id="rs771741606">rs771741606</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13672C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38570620" style="vertical-align: initial;">
                  <td>chr19:38570620</td>
                  <td id="rs118192130">rs118192130</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13673G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38570649" style="vertical-align: initial;">
                  <td>chr19:38570649</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13702C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38572032" style="vertical-align: initial;">
                  <td>chr19:38572032</td>
                  <td id="rs143520367">rs143520367</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13760C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38572185" style="vertical-align: initial;">
                  <td>chr19:38572185</td>
                  <td id="rs118192135">rs118192135</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13913G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38572190" style="vertical-align: initial;">
                  <td>chr19:38572190</td>
                  <td id="rs756850145">rs756850145</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13918A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38572206" style="vertical-align: initial;">
                  <td>chr19:38572206</td>
                  <td id="rs193922860">rs193922860</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13934G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38572262" style="vertical-align: initial;">
                  <td>chr19:38572262</td>
                  <td id="rs759500310">rs759500310</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13990T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38572266" style="vertical-align: initial;">
                  <td>chr19:38572266</td>
                  <td id="rs193922862">rs193922862</td>
                  
                  
                    <td class="">TC/TC</td>
                  
                  <td>
                    TC
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.13994_13995delTCinsCT - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38573180" style="vertical-align: initial;">
                  <td>chr19:38573180</td>
                  <td id="rs193922863">rs193922863</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14002C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38573229" style="vertical-align: initial;">
                  <td>chr19:38573229</td>
                  <td id="rs193922864">rs193922864</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14051T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38573304" style="vertical-align: initial;">
                  <td>chr19:38573304</td>
                  <td id="rs118192140">rs118192140</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14126C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38575957" style="vertical-align: initial;">
                  <td>chr19:38575957</td>
                  <td id="rs200766617">rs200766617</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14168G>A - Normal function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38577931" style="vertical-align: initial;">
                  <td>chr19:38577931</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14186A>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38577942" style="vertical-align: initial;">
                  <td>chr19:38577942</td>
                  <td id="rs193922865">rs193922865</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14197T>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38577946" style="vertical-align: initial;">
                  <td>chr19:38577946</td>
                  <td id="rs193922866">rs193922866</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14201G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38577954" style="vertical-align: initial;">
                  <td>chr19:38577954</td>
                  <td id="rs193922867">rs193922867</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14209C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38577955" style="vertical-align: initial;">
                  <td>chr19:38577955</td>
                  <td id="rs193922868">rs193922868</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14210G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38578015" style="vertical-align: initial;">
                  <td>chr19:38578015</td>
                  <td id="rs768360593">rs768360593</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14270G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38578205" style="vertical-align: initial;">
                  <td>chr19:38578205</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14364+1G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580004" style="vertical-align: initial;">
                  <td>chr19:38580004</td>
                  <td id="rs118192167">rs118192167</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14387A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580039" style="vertical-align: initial;">
                  <td>chr19:38580039</td>
                  <td ></td>
                  
                  
                    <td class="">TT/TT</td>
                  
                  <td>
                    TT
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14422_14423delinsAA - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580041" style="vertical-align: initial;">
                  <td>chr19:38580041</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14424C>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580066" style="vertical-align: initial;">
                  <td>chr19:38580066</td>
                  <td id="rs143988412">rs143988412</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14449A>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580075" style="vertical-align: initial;">
                  <td>chr19:38580075</td>
                  <td id="rs193922873">rs193922873</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14458G>A - Uncertain function</li>
                        
                          <li>c.14458G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580088" style="vertical-align: initial;">
                  <td>chr19:38580088</td>
                  <td id="rs193922874">rs193922874</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14471T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580094" style="vertical-align: initial;">
                  <td>chr19:38580094</td>
                  <td id="rs121918595">rs121918595</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14477C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580114" style="vertical-align: initial;">
                  <td>chr19:38580114</td>
                  <td id="rs193922876">rs193922876</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14497C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580126" style="vertical-align: initial;">
                  <td>chr19:38580126</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14509C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580370" style="vertical-align: initial;">
                  <td>chr19:38580370</td>
                  <td id="rs193922878">rs193922878</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14512C>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580382" style="vertical-align: initial;">
                  <td>chr19:38580382</td>
                  <td id="rs193922879">rs193922879</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14524G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580397" style="vertical-align: initial;">
                  <td>chr19:38580397</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14539G>C - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580403" style="vertical-align: initial;">
                  <td>chr19:38580403</td>
                  <td id="rs118192168">rs118192168</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14545G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580416" style="vertical-align: initial;">
                  <td>chr19:38580416</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14558C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580425" style="vertical-align: initial;">
                  <td>chr19:38580425</td>
                  <td id="rs193922880">rs193922880</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14567C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580439" style="vertical-align: initial;">
                  <td>chr19:38580439</td>
                  <td id="rs118192181">rs118192181</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14581C>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580440" style="vertical-align: initial;">
                  <td>chr19:38580440</td>
                  <td id="rs63749869">rs63749869</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14582G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580485" style="vertical-align: initial;">
                  <td>chr19:38580485</td>
                  <td id="rs113210953">rs113210953</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14627A>G - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38580497" style="vertical-align: initial;">
                  <td>chr19:38580497</td>
                  <td id="rs193922883">rs193922883</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14639T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38584974" style="vertical-align: initial;">
                  <td>chr19:38584974</td>
                  <td id="rs118192151">rs118192151</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14678G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38584976" style="vertical-align: initial;">
                  <td>chr19:38584976</td>
                  <td id="rs193922888">rs193922888</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14680G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38584989" style="vertical-align: initial;">
                  <td>chr19:38584989</td>
                  <td id="rs118192170">rs118192170</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14693T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38585078" style="vertical-align: initial;">
                  <td>chr19:38585078</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14782A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38585099" style="vertical-align: initial;">
                  <td>chr19:38585099</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14803G>A - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38585947" style="vertical-align: initial;">
                  <td>chr19:38585947</td>
                  <td id="rs111657878">rs111657878</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14813T>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38585948" style="vertical-align: initial;">
                  <td>chr19:38585948</td>
                  <td id="rs118192159">rs118192159</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14814C>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38585951" style="vertical-align: initial;">
                  <td>chr19:38585951</td>
                  <td id="rs193922895">rs193922895</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14817C>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38585952" style="vertical-align: initial;">
                  <td>chr19:38585952</td>
                  <td id="rs118192158">rs118192158</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14818G>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38585959" style="vertical-align: initial;">
                  <td>chr19:38585959</td>
                  <td id="rs193922896">rs193922896</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14825G>T - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38586101" style="vertical-align: initial;">
                  <td>chr19:38586101</td>
                  <td id="rs193922898">rs193922898</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14879T>A - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38586140" style="vertical-align: initial;">
                  <td>chr19:38586140</td>
                  <td id="rs146876145">rs146876145</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14918C>T - Malignant Hyperthermia associated</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38586190" style="vertical-align: initial;">
                  <td>chr19:38586190</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.14968A>G - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38587362" style="vertical-align: initial;">
                  <td>chr19:38587362</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.15059G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr19_38587363" style="vertical-align: initial;">
                  <td>chr19:38587363</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>c.15060G>C - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene SLCO1B1">
        <h3 id="SLCO1B1">SLCO1B1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
        
          <div class="alert alert-warning reference-allele">The SLCO1B1 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr12_21172734" style="vertical-align: initial;">
                  <td>chr12:21172734</td>
                  <td id="rs139257324">rs139257324</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*33 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21172776" style="vertical-align: initial;">
                  <td>chr12:21172776</td>
                  <td id="rs373327528">rs373327528</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*23 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21172782" style="vertical-align: initial;">
                  <td>chr12:21172782</td>
                  <td id="rs56101265">rs56101265</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - Uncertain function</li>
                        
                          <li>*12 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21174595" style="vertical-align: initial;">
                  <td>chr12:21174595</td>
                  <td id="rs56061388">rs56061388</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3 - Uncertain function</li>
                        
                          <li>*13 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21176804" style="vertical-align: initial;">
                  <td>chr12:21176804</td>
                  <td id="rs2306283">rs2306283</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*14 - Increased function</li>
                        
                          <li>*15 - No function</li>
                        
                          <li>*20 - Increased function</li>
                        
                          <li>*24 - Uncertain function</li>
                        
                          <li>*25 - Uncertain function</li>
                        
                          <li>*27 - Uncertain function</li>
                        
                          <li>*28 - Uncertain function</li>
                        
                          <li>*29 - Uncertain function</li>
                        
                          <li>*30 - Uncertain function</li>
                        
                          <li>*31 - No function</li>
                        
                          <li>*32 - Uncertain function</li>
                        
                          <li>*33 - Uncertain function</li>
                        
                          <li>*37 - Normal function</li>
                        
                          <li>*39 - Uncertain function</li>
                        
                          <li>*42 - Uncertain function</li>
                        
                          <li>*43 - Unknown function</li>
                        
                          <li>*44 - Unknown function</li>
                        
                          <li>*46 - No function</li>
                        
                          <li>*47 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21176868" style="vertical-align: initial;">
                  <td>chr12:21176868</td>
                  <td id="rs2306282">rs2306282</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*16 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21176871" style="vertical-align: initial;">
                  <td>chr12:21176871</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*38 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21176879" style="vertical-align: initial;">
                  <td>chr12:21176879</td>
                  <td id="rs11045819">rs11045819</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*4 - Uncertain function</li>
                        
                          <li>*14 - Increased function</li>
                        
                          <li>*25 - Uncertain function</li>
                        
                          <li>*32 - Uncertain function</li>
                        
                          <li>*43 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21176883" style="vertical-align: initial;">
                  <td>chr12:21176883</td>
                  <td id="rs72559745">rs72559745</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3 - Uncertain function</li>
                        
                          <li>*13 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21176898" style="vertical-align: initial;">
                  <td>chr12:21176898</td>
                  <td id="rs77271279">rs77271279</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*41 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21178612" style="vertical-align: initial;">
                  <td>chr12:21178612</td>
                  <td id="rs141467543">rs141467543</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*42 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21178615" style="vertical-align: initial;">
                  <td>chr12:21178615</td>
                  <td id="rs4149056">rs4149056</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*5 - No function</li>
                        
                          <li>*15 - No function</li>
                        
                          <li>*40 - Uncertain function</li>
                        
                          <li>*46 - No function</li>
                        
                          <li>*47 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21178957" style="vertical-align: initial;">
                  <td>chr12:21178957</td>
                  <td id="rs79135870">rs79135870</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*30 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21196951" style="vertical-align: initial;">
                  <td>chr12:21196951</td>
                  <td id="rs11045852">rs11045852</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*24 - Uncertain function</li>
                        
                          <li>*25 - Uncertain function</li>
                        
                          <li>*28 - Uncertain function</li>
                        
                          <li>*32 - Uncertain function</li>
                        
                          <li>*33 - Uncertain function</li>
                        
                          <li>*43 - Unknown function</li>
                        
                          <li>*44 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21196975" style="vertical-align: initial;">
                  <td>chr12:21196975</td>
                  <td id="rs183501729">rs183501729</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*39 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21196976" style="vertical-align: initial;">
                  <td>chr12:21196976</td>
                  <td id="rs11045853">rs11045853</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*25 - Uncertain function</li>
                        
                          <li>*28 - Uncertain function</li>
                        
                          <li>*33 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21200544" style="vertical-align: initial;">
                  <td>chr12:21200544</td>
                  <td id="rs72559747">rs72559747</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*47 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21200595" style="vertical-align: initial;">
                  <td>chr12:21200595</td>
                  <td id="rs55901008">rs55901008</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21202553" style="vertical-align: initial;">
                  <td>chr12:21202553</td>
                  <td id="rs1228465562">rs1228465562</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*36 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21202555" style="vertical-align: initial;">
                  <td>chr12:21202555</td>
                  <td id="rs59113707">rs59113707</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*27 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21202649" style="vertical-align: initial;">
                  <td>chr12:21202649</td>
                  <td id="rs56387224">rs56387224</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*7 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21202664" style="vertical-align: initial;">
                  <td>chr12:21202664</td>
                  <td id="rs142965323">rs142965323</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*26 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21205921" style="vertical-align: initial;">
                  <td>chr12:21205921</td>
                  <td id="rs72559748">rs72559748</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21205999" style="vertical-align: initial;">
                  <td>chr12:21205999</td>
                  <td id="rs59502379">rs59502379</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*9 - No function</li>
                        
                          <li>*31 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21206031" style="vertical-align: initial;">
                  <td>chr12:21206031</td>
                  <td id="rs74064213">rs74064213</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*43 - Unknown function</li>
                        
                          <li>*44 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21222355" style="vertical-align: initial;">
                  <td>chr12:21222355</td>
                  <td id="rs71581941">rs71581941</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*45 - Unknown function</li>
                        
                          <li>*46 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21239042" style="vertical-align: initial;">
                  <td>chr12:21239042</td>
                  <td id="rs34671512">rs34671512</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*19 - Uncertain function</li>
                        
                          <li>*20 - Increased function</li>
                        
                          <li>*40 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21239077" style="vertical-align: initial;">
                  <td>chr12:21239077</td>
                  <td id="rs56199088">rs56199088</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*10 - Uncertain function</li>
                        
                          <li>*12 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21239113" style="vertical-align: initial;">
                  <td>chr12:21239113</td>
                  <td id="rs55737008">rs55737008</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*11 - Uncertain function</li>
                        
                          <li>*13 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21239145" style="vertical-align: initial;">
                  <td>chr12:21239145</td>
                  <td id="rs200995543">rs200995543</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*34 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr12_21239158" style="vertical-align: initial;">
                  <td>chr12:21239158</td>
                  <td id="rs140790673">rs140790673</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*29 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene TPMT">
        <h3 id="TPMT">TPMT allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The TPMT *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr6_18130687" style="vertical-align: initial;">
                  <td>chr6:18130687</td>
                  <td id="rs1142345">rs1142345</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3A - No function</li>
                        
                          <li>*3C - No function</li>
                        
                          <li>*41 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18130694" style="vertical-align: initial;">
                  <td>chr6:18130694</td>
                  <td id="rs150900439">rs150900439</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*20 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18130725" style="vertical-align: initial;">
                  <td>chr6:18130725</td>
                  <td id="rs72552736">rs72552736</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*7 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18130729" style="vertical-align: initial;">
                  <td>chr6:18130729</td>
                  <td id="rs139392616">rs139392616</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*40 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18130758" style="vertical-align: initial;">
                  <td>chr6:18130758</td>
                  <td id="rs398122996">rs398122996</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*37 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18130762" style="vertical-align: initial;">
                  <td>chr6:18130762</td>
                  <td id="rs56161402">rs56161402</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*8 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18130772" style="vertical-align: initial;">
                  <td>chr6:18130772</td>
                  <td id="rs377085266">rs377085266</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*25 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18130781" style="vertical-align: initial;">
                  <td>chr6:18130781</td>
                  <td id="rs1800584">rs1800584</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*4 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18132136" style="vertical-align: initial;">
                  <td>chr6:18132136</td>
                  <td id="rs72556347">rs72556347</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*26 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18132147" style="vertical-align: initial;">
                  <td>chr6:18132147</td>
                  <td id="rs79901429">rs79901429</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*31 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18132163" style="vertical-align: initial;">
                  <td>chr6:18132163</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*36 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18133845" style="vertical-align: initial;">
                  <td>chr6:18133845</td>
                  <td id="rs75543815">rs75543815</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18133847" style="vertical-align: initial;">
                  <td>chr6:18133847</td>
                  <td id="rs6921269">rs6921269</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*24 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18133870" style="vertical-align: initial;">
                  <td>chr6:18133870</td>
                  <td id="rs772832951">rs772832951</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*38 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18133884" style="vertical-align: initial;">
                  <td>chr6:18133884</td>
                  <td id="rs74423290">rs74423290</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*23 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18133887" style="vertical-align: initial;">
                  <td>chr6:18133887</td>
                  <td id="rs201695576">rs201695576</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*44 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18133890" style="vertical-align: initial;">
                  <td>chr6:18133890</td>
                  <td id="rs9333570">rs9333570</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*15 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18138969" style="vertical-align: initial;">
                  <td>chr6:18138969</td>
                  <td id="rs144041067">rs144041067</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*16 - Uncertain function</li>
                        
                          <li>*22 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18138970" style="vertical-align: initial;">
                  <td>chr6:18138970</td>
                  <td id="rs112339338">rs112339338</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*33 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18138997" style="vertical-align: initial;">
                  <td>chr6:18138997</td>
                  <td id="rs1800460">rs1800460</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*3A - No function</li>
                        
                          <li>*3B - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18139027" style="vertical-align: initial;">
                  <td>chr6:18139027</td>
                  <td id="rs72552737">rs72552737</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*10 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18139689" style="vertical-align: initial;">
                  <td>chr6:18139689</td>
                  <td id="rs72552738">rs72552738</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*11 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18139710" style="vertical-align: initial;">
                  <td>chr6:18139710</td>
                  <td id="rs200220210">rs200220210</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*12 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143597" style="vertical-align: initial;">
                  <td>chr6:18143597</td>
                  <td ></td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*19 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143606" style="vertical-align: initial;">
                  <td>chr6:18143606</td>
                  <td id="rs151149760">rs151149760</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*9 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143613" style="vertical-align: initial;">
                  <td>chr6:18143613</td>
                  <td ></td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*28 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143622" style="vertical-align: initial;">
                  <td>chr6:18143622</td>
                  <td id="rs115106679">rs115106679</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*32 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143643" style="vertical-align: initial;">
                  <td>chr6:18143643</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*27 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143700" style="vertical-align: initial;">
                  <td>chr6:18143700</td>
                  <td id="rs753545734">rs753545734</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*43 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143718" style="vertical-align: initial;">
                  <td>chr6:18143718</td>
                  <td id="rs111901354">rs111901354</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*34 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143724" style="vertical-align: initial;">
                  <td>chr6:18143724</td>
                  <td id="rs1800462">rs1800462</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*2 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18143728" style="vertical-align: initial;">
                  <td>chr6:18143728</td>
                  <td id="rs1256618794">rs1256618794</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*43 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18147838" style="vertical-align: initial;">
                  <td>chr6:18147838</td>
                  <td id="rs281874771">rs281874771</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*39 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18147845" style="vertical-align: initial;">
                  <td>chr6:18147845</td>
                  <td id="rs777686348">rs777686348</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*18 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18147851" style="vertical-align: initial;">
                  <td>chr6:18147851</td>
                  <td id="rs200591577">rs200591577</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*21 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18147856" style="vertical-align: initial;">
                  <td>chr6:18147856</td>
                  <td ></td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*35 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18147910" style="vertical-align: initial;">
                  <td>chr6:18147910</td>
                  <td id="rs72552740">rs72552740</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*5 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18149004" style="vertical-align: initial;">
                  <td>chr6:18149004</td>
                  <td ></td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*17 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18149022" style="vertical-align: initial;">
                  <td>chr6:18149022</td>
                  <td id="rs750424422">rs750424422</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*30 - Unknown function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18149032" style="vertical-align: initial;">
                  <td>chr6:18149032</td>
                  <td id="rs759836180">rs759836180</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*42 - Unassigned</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18149045" style="vertical-align: initial;">
                  <td>chr6:18149045</td>
                  <td id="rs72552742">rs72552742</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*13 - Uncertain function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18149126" style="vertical-align: initial;">
                  <td>chr6:18149126</td>
                  <td id="rs267607275">rs267607275</td>
                  
                  
                    <td class="">A/A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*29 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr6_18149127" style="vertical-align: initial;">
                  <td>chr6:18149127</td>
                  <td id="rs9333569">rs9333569</td>
                  
                  
                    <td class="">T/T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*14 - No function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene UGT1A1">
        <h3 id="UGT1A1">UGT1A1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Allele Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The UGT1A1 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr2_233759924" style="vertical-align: initial;">
                  <td>chr2:233759924</td>
                  <td id="rs887829">rs887829</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*80 - Unknown function</li>
                        
                          <li>*80+*28 - Decreased function</li>
                        
                          <li>*80+*37 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr2_233760233" style="vertical-align: initial;">
                  <td>chr2:233760233</td>
                  <td id="rs3064744">rs3064744</td>
                  
                  
                    <td class="">CAT/CAT</td>
                  
                  <td>
                    CAT
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*28 - Decreased function</li>
                        
                          <li>*36 - Increased function</li>
                        
                          <li>*37 - Decreased function</li>
                        
                          <li>*80+*28 - Decreased function</li>
                        
                          <li>*80+*37 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr2_233760498" style="vertical-align: initial;">
                  <td>chr2:233760498</td>
                  <td id="rs4148323">rs4148323</td>
                  
                  
                    <td class="">G/G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*6 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
                <tr id="chr2_233760973" style="vertical-align: initial;">
                  <td>chr2:233760973</td>
                  <td id="rs35350960">rs35350960</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>*27 - Decreased function</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene VKORC1">
        <h3 id="VKORC1">VKORC1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Variant Matched:</th>
              <td class="top-aligned genotype-result">
                
                  rs9923231 reference (C)/rs9923231 reference (C)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles and Function</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr id="chr16_31096368" style="vertical-align: initial;">
                  <td>chr16:31096368</td>
                  <td id="rs9923231">rs9923231</td>
                  
                  
                    <td class="">C/C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    
                      <ul class="noBullet mt-0 mb-0">
                        
                          <li>rs9923231 variant (T) - Higher coumarin sensitivity</li>
                        
                      </ul>
                    
                  </td>
                  <td>
                    
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    

  </section>

  <section id="disclaimer">
<h2 id="disclaimers-and-other-information">Disclaimers and Other Information</h2>
<p><strong>Liability: PharmCAT assumes no responsibility for any injury to person or damage to persons or property arising out of,
or related to any use of PharmCAT, or for any errors or omissions. The user recognizes that PharmCAT is a research tool
and that they are using PharmCAT at their own risk.</strong></p>
<h3 id="a-allele-and-genotype-determination">A. Allele and Genotype Determination</h3>
<ol>
<li><p>PharmCAT uses gene allele definitions included in the CPIC database, with exceptions as noted
in <a href="https://pharmcat.org/methods/Gene-Definition-Exceptions/">Gene Definition Exceptions document</a>. For allele
definitions and the positions used in PharmCAT, see
the <a href="https://github.com/PharmGKB/PharmCAT/releases">gene definition tables</a>.</p></li>
<li><p>Genes with DPWG recommendations that are not included in CPIC are discussed in Section C.   </p></li>
<li><p>PharmCAT results are dependent on the supplied VCF calls for the queried positions (for technical information about
PharmCAT input formatting and requirements, please go to <a href="https://pharmcat.org/">pharmcat.org</a>). PharmCAT does not
assume any reference calls for positions missing from the submitted VCF file; all missing queried positions are not
considered in the allele determination process. See the
<a href="https://github.com/PharmGKB/PharmCAT/releases"><em>pharmcat_positions</em> file</a> for which positions are
queried in the VCF file. Missing positions might alter the assigned genotype and subsequent phenotype prediction and
CPIC recommendation. If the supplied VCF file has missing positions, those positions will be noted in
Section III: Allele Matching Details for each gene of this report. For the most reliable allele determination,
reference calls as well as variant calls in the VCF file for every queried position must be provided by the user.
If an allele that includes a missing position is defined by an additional position(s) for which calls are provided,
the allele will be considered in the matching process based on the available information. This might lead to the output
of multiple possible genotypes that received the same highest matching score. In addition, alternate calls with a lower
score is also possible. For instructions on getting PharmCAT to output all possible matching genotypes, consult
<a href="https://pharmcat.org/using/Running-PharmCAT/#named-allele-matcher">the documentation</a>.</p></li>
<li><p>For cytochrome P450 genes, TPMT, NUDT15, UGT1A1, and SLCO1B1, the *1 allele is defined by the absence of variation
specified in the gene definition tables. This allele cannot be identified by variants; rather, *1 is assigned by
default when no variation for the queried positions is reported in the submitted VCF file. The same is true for all
other genes with multiple variant positions in the definition table (CACNA1S, CFTR, DPYD, RYR1): the reference
sequence is the default result when variants are not reported in the VCF file. It is always possible un-interrogated
variation can occur which could potentially affect allele function, but because it is undetected, the assignment
would be defaulted to a *1 (or reference) allele and normal function.</p></li>
<li><p>For all genes, variation reported in the VCF file but NOT included in the gene definition table will not be
considered during allele assignment. There is a possibility that any such variation results in a reduced or no
activity allele which could lead to inaccurate phenotype and CPIC recommendation, similar to the situation in point
3, above.</p></li>
<li><p>Nucleotide base calls are displayed on the positive chromosomal strand regardless of the gene strand; further
information is provided under Gene-specific warnings in Section III: Allele Matching Details.</p></li>
<li><p>Structural variation star alleles that cannot be detected using VCF file data:</p>
<ul>
<li>CYP2B7-CYP2B6 hybrids: CYP2B6*29, CYP2B6*30</li>
<li>Partial and whole gene deletions: CYP2C19*36, CYP2C19*37, CYP4F2*16, SLCO1B1*48, SLCO1B1*49  </li></ul></li>
<li><p>PharmCAT matches variants to genotypes assuming unphased data (unless phased data is provided in the VCF file and
noted as such, see <a href="https://pharmcat.org/">pharmcat.org</a> for details). The assumption is that defined alleles exist
in trans configuration, i.e. on opposite chromosomes, with exceptions noted in Section III: Allele Matching Details
under "Gene-specific warnings." However, in cases where an allele is defined by a combination of two or more
variants, where each variant alone also defines an allele, the match is based on the longer allele. For example,
TPMT*3B is defined by one SNP, *3C is defined by another SNP, and *3A is defined by the combination of those two
SNPs. In the case of unphased data that is heterozygous for both SNPs, the *1/*3A genotype is returned though the
possibility of *3B/*3C cannot be ruled out.</p>
<p>Below cases are summarized for which two calls with different scores are possible when provided unphased data and
heterozygous calls for the variants that define the two alleles. The genotype with the higher score (longer allele)
will be used to determine allele functionality, phenotype, and recommendation but the genotype with the lower score
cannot be ruled out.</p></li>
</ol>
<p>Table 1: Cases for which there is an overlap in the allele definitions.</p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Genotype (Higher Score)</th>
<th>Phenotype</th>
<th>Genotype (Lower Score)</th>
<th>Phenotype</th>
</tr>
</thead>
<tbody>
<tr>
<td>UGT1A1</td>
<td>*1/*80+*28</td>
<td>Intermediate</td>
<td>*28/*80</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>UGT1A1</td>
<td>*1/*80+*37</td>
<td>Intermediate</td>
<td>*37/*80</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>TPMT</td>
<td>*1/*3A</td>
<td>Intermediate</td>
<td>*3B/*3C</td>
<td>Poor</td>
</tr>
<tr>
<td>NUDT15</td>
<td>*1/*2</td>
<td>Intermediate</td>
<td>*3/*6</td>
<td>Possible Intermediate</td>
</tr>
<tr>
<td>CYP2C9</td>
<td>*1/*71</td>
<td>N/A</td>
<td>*10/*22</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*36</td>
<td>Intermediate</td>
<td>*6/*22</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*34</td>
<td>Intermediate</td>
<td>*33/*36</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*6</td>
<td>Intermediate</td>
<td>*4/*9</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*7</td>
<td>Intermediate</td>
<td>*5/*6</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*13</td>
<td>Intermediate</td>
<td>*6/*8</td>
<td>Intermediate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*46</td>
<td>Decreased function</td>
<td>*15/*45</td>
<td>Possible Decreased Function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*20</td>
<td>Normal Function</td>
<td>*19/*37</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*12</td>
<td>Indeterminate</td>
<td>*2/*10</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*13</td>
<td>Indeterminate</td>
<td>*3/*11</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*14</td>
<td>Normal Function</td>
<td>*4/*37</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*15</td>
<td>Decreased function</td>
<td>*5/*37</td>
<td>Decreased function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*25</td>
<td>Indeterminate</td>
<td>*4/*28</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*31</td>
<td>Decreased function</td>
<td>*9/*37</td>
<td>Decreased Function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*32</td>
<td>Indeterminate</td>
<td>*4/*24</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*40</td>
<td>Indeterminate</td>
<td>*5/*19</td>
<td>Possible Decreased Function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*43</td>
<td>Indeterminate</td>
<td>*4/*44</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>CYP4F2</td>
<td>*1/*4</td>
<td>N/A</td>
<td>*2/*3</td>
<td>N/A</td>
</tr>
<tr>
<td>CYP3A4</td>
<td>*1/*37</td>
<td>N/A</td>
<td>*3/*22</td>
<td>N/A</td>
</tr>
<tr>
<td>CYP3A4</td>
<td>*1/*38</td>
<td>N/A</td>
<td>*3/*11</td>
<td>N/A</td>
</tr>
<tr>
<td>G6PD</td>
<td>A- 202A_376G/B (reference)</td>
<td>Variable</td>
<td>A/Asahi</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Mt Sinai</td>
<td>Variable</td>
<td>A/Guadalajara</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Santa Maria</td>
<td>Variable</td>
<td>A/Malaga</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>Ananindeua/B (reference)</td>
<td>Variable</td>
<td>A/Viangchan, Jammu</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Hechi</td>
<td>Variable</td>
<td>Asahi/Viangchan, Jammu</td>
<td>Deficient</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Hermoupolis</td>
<td>Variable</td>
<td>Cassano/Union,Maewo, Chinese-2, Kalo</td>
<td>Deficient</td>
</tr>
</tbody>
</table>
<p>Table 2: Cases for which there is an overlap in the allele definitions because the definition of the non-*1 allele in
the genotype with the higher score allows for reference or variant at the position that defines the first allele listed
in the genotype with the lower score. Both genotypes cannot be ruled out with unphased data if the position that
overlaps between the respective alleles is heterozygous (0/1) in addition to heterozygous calls for the other variants
that define the non-*1 allele in the genotype with the higher score.</p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Genotype (Higher Score)</th>
<th>Phenotype</th>
<th>Genotype (Lower Score)</th>
<th>Phenotype</th>
</tr>
</thead>
<tbody>
<tr>
<td>CYP2C19</td>
<td>*1/*4</td>
<td>Intermediate</td>
<td>*17/*4</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2C19</td>
<td>*1/*2</td>
<td>Intermediate</td>
<td>*11/*2</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2C19</td>
<td>*1/*35</td>
<td>Intermediate</td>
<td>*15/*35</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*18</td>
<td>Intermediate</td>
<td>*4/*18</td>
<td>Indeterminate</td>
</tr>
</tbody>
</table>
<h3 id="b-cpic-allele-function-phenotype-and-recommendation">B. CPIC Allele Function, Phenotype and Recommendation</h3>
<p>All content is sourced from the <a href="https://github.com/cpicpgx/cpic-data">CPIC database</a>.</p>
<h3 id="c-dpwg-allele-function-phenotype-and-recommendation">C. DPWG Allele Function, Phenotype and Recommendation</h3>
<ol>
<li><p>PharmGKB annotates PGx-based drug dosing guidelines published by the <a href="https://www.pharmgkb.org/page/dpwg">Royal Dutch Association for the Advancement of
Pharmacy - Pharmacogenetics Working Group (DPWG)</a>. PharmGKB curates allele 
function assignments and phenotype mappings from the DPWG to provide genotype specific DPWG guideline
recommendations. Where possible, PharmGKB maps DPWG terms to CPIC terms, as outlined on
<a href="https://www.pharmgkb.org/page/dpwgMapping">PharmGKB</a>.</p></li>
<li><p>CYP3A4 is currently not part of a CPIC guideline. Since the DPWG CYP3A4 documentation includes limit variant
notations for the included alleles (only *16, *20, and *22 are specified) PharmCAT relies on
<a href="https://www.pharmvar.org/gene/CYP3A4">PharmVar CYP3A4 allele definitions</a>. However, the CYP3A4*16, *20 and *22
definitions are the same in both sources.</p></li>
<li><p>The CPIC UGT1A1 allele definition file includes *6, *27, *28, *36, *37, and *80. Since the DPWG UGT1A1 document
does not include allele definitions besides for the UGT1A1 TA box promoter polymorphism, PharmCAT only includes the
UGT1A1 positions from the CPIC UGT1A1 allele definition file. Other UGT1A1 alleles can be supplied as
<a href="https://pharmcat.org/using/Outside-Call-Format/">outside calls</a> but not be determined from the VCF file by the
Named Allele Matcher.</p></li>
</ol>
<h3 id="d-fda-drug-label-and-table-of-pharmacogenetic-associations-recommendations">D. FDA drug-label and Table of Pharmacogenetic Associations recommendations</h3>
<p>PharmCAT includes recommendations from PharmGKB-annotated FDA drug labels and the FDA Table of Pharmacogenetic Associations. 
It only contains FDA information for genes with CPIC or DPWG guidelines because the FDA does not offer any genotype-to-phenotype mapping information. PharmCAT uses CPIC genotype-to-phenotype mappings when they exist, and DPWG genotype-to-phenotype mappings when no CPIC mappings exist, to determine the phenotypes to use with FDA label annotations and Table of Pharmacogenetic Associations entries. Results presented for <a href="https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations">FDA Table of Pharmacogenetic Associations</a> use wording and “Affected Subgroups” taken directly from the Table. Results presented from PharmGKB-annotated drug labels present wording from the specific label that was curated. In many cases, multiple FDA labels may exist for a particular medication. Typically, PharmGKB annotates the label linked to from the FDA <a href="https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling">Table of Pharmacogenomic Biomarkers in Drug Labeling</a> but in some cases a different label may be annotated. Follow the “FDA Label Annotation” link in section II of the report to access the annotated label and more information.</p>
<h3 id="e-source-tags-in-section-ii">E. Source Tags in Section II</h3>
<p>Part of PharmGKB’s annotations of guidelines, drug labels and Table of Pharmacogenetic Associations is the assignment of labels that are meant to provide a high-level indication of the provided action. If recommendations or FDA Table wording exists, yellow boxes display if the guidance/wording is regarding (1) a dosing change, (2) recommending an alternate drug be used, or (3) other guidance. These boxes are included in the Source column in Section II of the PharmCAT report. More detailed information about what the yellow boxes mean is available on <a href="https://www.pharmgkb.org/page/clinicalGuidelineLegend#clinical-guideline-annotation-tags">PharmGKB</a>.</p>
<h3 id="f-pharmcat-exceptions-to-the-cpic-guideline-gene-list">F. PharmCAT Exceptions to the CPIC Guideline Gene List</h3>
<ol>
<li><p>PharmCAT does not determine CYP2D6, MT-RNR1, HLA-A, or HLA-B genotypes from the VCF file, but genotypes for CYP2D6,
MT-RNR1, HLA-A, or HLA-B can be provided to PharmCAT from an outside source and the corresponding phenotype 
prescribing recommendations will be included in the generated report. For the required format of the outside calls
refer to the PharmCAT <a href="https://pharmcat.org/using/Outside-Call-Format/">outside calls documentation</a>.</p></li>
<li><p>CPIC has assigned function to the following CYP2D6 CNV alleles: *1x2, *1x≥3, *2x2, *2x≥3, *3x2, *4x2, *4x≥3,
*6x2, *9x2, *10x2, *17x2, *29x2, *35x2, *36x2, *41x2, *41x3, *43x2, *45x2, *146x2. These alleles are part
of the CPIC diplotype to phenotype translation and can be connected to recommendations. Other CNV notations from
outside calls need to be mapped accordingly. </p></li>
</ol>
<h3 id="g-cpic-guideline-disclaimers-and-caveats">G. CPIC Guideline Disclaimers and Caveats</h3>
<ol>
<li><p>A version of the following quoted disclaimer is part of each CPIC guideline and applies to the CPIC recommendations
as used in PharmCAT. For the full description of potential benefits and risks, additional considerations (general and
specific to gene-drug pairs), limitations, information about respective gene nomenclature systems, potential
drug-drug interactions and clinical factors to consider, please see individual CPIC guidelines at
(<a href="https://cpicpgx.org">cpicpgx.org</a>).</p>
<ol>
<li><p>"CPIC guidelines reflect expert consensus based on clinical evidence and peer-reviewed literature available at
the time they are written and are intended only to assist clinicians in decision-making and to identify questions
for further research. New evidence may have emerged since the time a guideline was submitted for publication.
Guidelines are limited in scope and are not applicable to interventions or diseases not specifically identified.
Guidelines do not account for all individual variations among patients and cannot be considered inclusive of all
proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care
provider to determine the best course of treatment for a patient. Adherence to any guidelines is voluntary, with
the ultimate determination regarding its application to be made solely by the clinician and the patient. CPIC
assumes no responsibility for any injury to persons or damage to persons or property arising out of or related to
any use of CPIC's guidelines, or for any errors or omissions." (PMID:
<a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040">27997040</a>)</p></li>
<li><p>"Caveats: appropriate use and/or potential misuse of genetic tests. The application of genotype-based dosing is
most appropriate when initiating therapy with a tricyclic. Obtaining a pharmacogenetic test after months of drug
therapy may be less helpful in some instances, as the drug dose may have already been adjusted based on plasma
concentrations, response, or side effects. Similar to all diagnostic tests, genetic tests are one of several
pieces of clinical information that should be considered before initiating drug therapy." (PMID:
<a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040">27997040</a>)</p></li></ol></li>
<li><p>CPIC guidelines reflect the alleles/genotypes known and considered by the guideline authors for inclusion by the time
of publication, however they may be updated online at
<a href="https://cpicpgx.org">cpicpgx.org</a> and in the CPIC database in between publications. Additional alleles and/or more
extensive allele definitions might exist by the representative gene nomenclatures for various genes.</p></li>
<li><p>CPIC is a registered service mark of the U.S. Department of Health &amp; Human Services (HHS).</p></li>
</ol>
<h3 id="h-pharmgkb-disclaimers-and-caveats">H. PharmGKB Disclaimers and Caveats</h3>
<p>PharmGKB is a registered service mark of the U.S. Department of Health &amp; Human Services (HHS).</p>
</section>


</main>
</body>
</html>
